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Abstract 
Zinc is now firmly established as an essential trace element in the human body. Whilst it 
has many key structural and catalytic fixed roles, it is also found in “mobile” pools in many 
essential organs and organelles that are readily chelatable.  The presence and trafficking of 
these zinc pools are thought to contribute in some form to many human disease states 
associated with these organs, for example, Type 2 diabetes in the pancreas, some forms of 
cancer in the prostate, and even ischemic stroke, epilepsy and Alzheimer’s disease. The 
exact role however, remains largely unknown and this is due to our current limitations with 
the methods in which we monitor the movement of this important element in our body.  
This thesis presents our efforts to develop novel Zn2+ selective chemosensors that can meet 
contemporary criteria for successful and simple imaging. Many efforts are being made to 
develop simple fluorescent molecular probes to monitor the trafficking and progress of Zn2+ 
through these cells and organs in real time via these chelatable “mobile” pools. Chapter 1 
will outline some successful efforts towards these and discuss their relevance and 
mechanisms of action, as well as outlining “click”-chemistry and its’ role in chemosensing 
to date. 
Chapter 2 describes a novel “click”-chemistry approach designed to aid with the simple 
construction of novel zinc-chelating probes in a facile and high yielding manner. This 
methodology was taken forward to the synthesis of 6 novel Zn2+-selective small molecule 
fluorescent probes that incorporate a cell organelle targeting motif in their structure. These 
are described in Chapter 3, and their successful testing both in-vitro and in-cellulo in murine 
pancreatic islet cells is presented and discussed. 
Finally, Chapter 4 discusses the development of some modified fluorescent [2]rotaxanes as 
molecularly interlocked architectures capable of binding and sensing metals, and will 
specifically focus on how small structural changes led to vast differences in their 
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fluorescence properties, ultimately resulting in a Zn2+-selective [2]rotaxane in organic 
media.  
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Chapter 1: Introduction 
 
1.1. What is a Sensor? 
A sensor, by definition, is an entity designed to detect and provide a signal for an aspect of 
its environment. They exist in both everyday items and complicated systems; from mercury 
in thermometers to measure temperature, to seismometers to measure ground motion 
during and after natural disasters. These sensors provide a readable output for the end 
user to make sense of the signals, generally in an optical or electrical format.  
Even humans and living organisms contain sensors for the detection of important changes 
in external and internal environments. We have specialised cells that can act as sensors for 
various stimuli, such as temperature, sound, light, and especially for allergens and toxins. 
The detection of toxins and poisons is as essential in industry as in biology. The detection of 
ultra-low concentrations of toxins, for example lead deposits in everyday substances such 
as make up, requires a rapid, facile and efficient measurement during quality control 
procedures, with a simple readable signal to provide the level and/or absence of the 
analyte being detected. Similarly, in biotechnology and medicine, the ability to quickly 
detect the presence of biomarkers and/or the expression of abnormal proteins in many 
disease states allows for faster diagnosis and treatment for the patient. In these instances, 
chemosensors are the specific sensors of choice.  
Chemical sensors (also interchangeably called chemical probes1) provide a response to the 
detection of otherwise silent chemical analytes in the form of a measurable signal related 
to the amount of analyte it is detecting. This signal is often colorimetric, fluorescent, or 
luminescent, but can also be electrochemical (Figure 1.1). All chemosensors have a 
recognition element to their structure and composition, for selective interaction with the 
Introduction 
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intended analyte, be it a binding event or inducing a change in the receptors’ shape and 
structure. 
 
Figure 1-1 Schematic representation of an optical response from a probe, induced by analyte binding. 
 
1.2. General Targets for a Sensor or Probe 
In general, the common targets for a chemosensor include poisons, proteins, and other 
biomarkers for disease. A particularly successful field of chemosensing, and one in which 
this body of work is focused on, is metal cation sensing. 
The burgeoning field of chemical biology and bioinorganic chemistry has been helping to 
ascertain the roles and functions of these metal cations in biology. Redox-active copper and 
iron are the two most studied metal cations, along with calcium, potassium and 
magnesium. All of these, and many others, play an active role in cellular and organ-level 
support and function. Their uses can be structural or enzymatic. Iron for example, is 
essential to life due to its role in the oxygen carrier protein haemoglobin. This often means 
that alterations in their abundance, location and function can lead to severe disorders in 
the organism. Other heavier metals such as mercury, lead and cadmium can promote 
serious toxicity and aging in biological systems, so their detection could be vital to help to 
identify a need for treatment. 
Introduction 
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The ability to successfully image these metal ions in vivo, and study their normal, abnormal 
and toxic behaviours in real time can help to determine whether they are a cause or effect 
of these disorders, and even utilise them as markers or indicators for the presence of 
abnormalities in the cells or organs.  
1.3. Targeting Biological Zinc 
Zinc is the second most abundant d-block metal in the body, and its role in a number of 
biological processes in the body has come to the forefront of contemporary research in the 
field of chemical biology. In 1996, a key paper by Berg and Shi was published, as a call for 
scientists to study zinc in the same way as iron and calcium had been investigated.2 Berg’s 
manifesto drew attention to the nature of bound zinc cations as key structural features of 
many proteins, and the core role it plays in the activity of enzymes, such as carbonic 
anhydrase.  It is now known to be associated with over 3000 enzymes and proteins in the 
human body compared, for example, to 178 for iron and 63 for copper. As an example, 
alcohol dehydrogenase contains a zinc atom at its active site which is vital to enzymatic 
activity, but a second zinc ion is also present in a structural site that is key to the stability of 
the protein. Berg highlighted the importance of zinc ions as part of important biological 
components, specifically for the role they play in interactions with important 
macromolecules such as DNA; zinc finger proteins have been found to be involved in 
transcription of DNA, where a zinc transcription factor facilitates the interaction between 
the protein chain and the DNA helix. 
As well as these bound forms, zinc is also present in many cells in a loosely bound and 
chelatable form, often referred to in literature as ‘free’ or ‘mobile’ zinc.3 It is these pools of 
zinc that have attracted particular interest. Berg briefly mentioned the potential for zinc to 
work as an ‘information carrier’, and indeed, it has since been found to play a vital role in 
stimulating regulation of cellular function, or homeostasis.4 These pools exist in many vital 
Introduction 
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organs in the body, such as the brain, pancreas, eyes, intestine, prostate and nervous 
system, and as such, zinc is implicated in regulating brain function and pathology, cell 
growth and proliferation, and in the maintenance of the normal function of these organs.  
Many investigations have highlighted the potential link between the role that zinc plays at 
a cellular level, and a range of disease states, indicating the potential use of ‘mobile’ zinc as 
a marker for specific pathologies. As a specific example, Type 2 Diabetes mellitus (T2DM) is 
a global epidemic and as of 2013, cases in the UK hit an all-time high of 3.2 million.5 
Scientists have identified polymorphisms in the gene which encodes for the secretory 
granule zinc transporter ZnT8 in insulin-producing pancreatic -cells, thus directly linking 
zinc deficiency with the presence of the disease. The biological trafficking of zinc has also 
been linked with other diseases including Alzheimer’s disease,6 epilepsy,7 ischemic stroke,8 
infantile diarrhoea,9,10 age related macular degeneration11 and prostate cancer.12   
 
Figure 1-2 Some of the disease states linked to the abnormal homeostasis of Zn
2+
 
 
All of these disease processes are examples that arise from the breakdown of zinc 
homeostasis in the body, where the increase or reduction in the amount of zinc has been 
highlighted to be extremely significant. The exact role of zinc in the progression of these 
diseases, however, is still largely unknown. There is still a need to monitor the regulation of 
zinc in cells, its trafficking in and out of cells and around the body, and to study the pools of 
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chelatable zinc, to develop a better general understanding of the processes zinc is 
intrinsically involved in and how zinc-related diseases develop.  This in turn, may help 
scientists use zinc to find and create efficient tools for diagnosis, or perhaps even 
treatment of these diseases. 
Traditional methods of detecting zinc levels in vivo have involved invasive techniques to 
identify the cellular content or, as an example, using a zinc selective stain such as dithizone 
in tissues.13 For obvious reasons, invasive procedures are undesirable, and dyes such as 
dithizone are very dependent on the external environment (factors such as light and heat), 
and as such there is a move to use alternative non-invasive imaging agents. 
There are already many detection systems available for a range of other biologically 
relevant metal cations, like calcium, magnesium and potassium. Even though there is 
between 2 and 3 grams of zinc in the adult human, ‘mobile’ chelatable zinc is significantly 
less abundant than these cations, with concentrations varying in different compartments 
from micromolar to picomolar. Consequently any sensing systems would also need to be 
carefully tuned to have the required sensitivity over this range of concentrations.  
1.4. Mechanisms for Zinc Sensing 
It is important to appreciate the co-ordination chemistry of the zinc cation. Zinc in the body 
is in the divalent ion form, Zn2+, and this gives it a number of important properties. Firstly, it 
has a d10 configuration, giving it a filled d-shell. The most important outcome of this is that 
it is rendered spectroscopically silent for the majority of techniques that have proved 
useful in probing the action of other cations in biological systems, such as UV-Vis and EPR 
spectroscopies. Ideas towards the design of chemical sensors for it can be obtained by 
looking at the factors that make it so successful in its biological roles in enzymes and 
proteins. Zn2+ is not redox active, the filled d-shell also means it has no preference for 
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coordination geometry and it can interact very strongly with a wide variety of ligands.2,14 
With this in mind, the majority of detection systems developed in the last fifteen to twenty 
years have concentrated on small molecule bio-imaging agents, in particular fluorescent 
probes. 
Due to their high sensitivity and operational simplicity, fluorescent sensors have been used 
by a number of research groups in testing for many biologically relevant species, which has 
also become easier due to advancements in technology and fluorescence instrumentation. 
These types of probes are small, relatively easy to synthesise, are often able to cross cell 
membranes to successfully access the zinc sources in vivo, and are well suited to real-time 
in cellulo study.  
These zinc reporters have many interesting mechanisms of action which determine the 
sensitivity and output signal, and whilst in this section some successful sensors of each 
example will be highlighted, the reader is directed to more comprehensive reviews of small 
molecule zinc sensors for a more exhaustive list of examples.4,15–19  
The majority of chemosensors reported follow the same basic supramolecular structure 
(Figure 1-3). They typically consist of a fluorophore as the output site for the response to a 
binding event, attached to a receptor as the binding or chelation site for the species to be 
detected, in this case zinc. They can be directly ligated, but commonly are separated via a 
small spacer, typically C2-3.  
 
Figure 1-3 Representation of the typical structure of a small molecule fluorescent chemosensor 
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The photophysical mechanisms these constructs use to act as a sensor vary with structure, 
and the most common mechanisms of response are: 
- Photoinduced Electron Transfer 
- Internal/intramolecular Charge Transfer (and its related processes) 
- Förster Resonance Energy Transfer 
- Excimer/Exciplex formation 
 
A summary of each approach of sensing is noted here. Again, these processes have been 
extensively reviewed, and these reviews also include accounts of other emerging and less 
common pathways of fluorescent signalling not discussed here.15,20 
1.4.1. Photoinduced Electron Transfer (PET) 
PET is one of the most common mechanisms of zinc sensing. PET sensors commonly adopt 
the fluorophore-spacer-receptor scaffold. The receptor contains high energy non-bonding 
electron pairs from heteroatoms like nitrogen and oxygen. Upon excitation of the system in 
the absence of the analyte, electron transfer that takes place from these high-energy 
electrons to the excited state of the fluorophore, inducing quenching of the fluorescent 
output and giving an ‘off’ state in this form. (Figure 1-4) 
Chelation of zinc to the receptor lowers the HOMO of the ligand lone pair, 
thermodynamically disfavouring the quenching process via electron transfer, thus resulting 
in an emissive process upon excitation of the molecule. This is known as the ‘switch-on’ 
process that quenching of PET can provide upon chelation, resulting in Chelation Enhanced 
Fluorescence (CHEF). The role of the spacer is merely to keep the receptor and emissive 
components separate, but still close enough to allow the electron transfer process to 
efficiently occur.  
Introduction 
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Figure 1-4 Orbital energy diagram to demonstrate the ‘off’ and ‘on’ states of a fluorescent chemosensor upon 
photoinduced electron transfer, or the blocking thereof. 
 
Figure 1-5 demonstrates four successful examples of sensors selective for zinc using the 
PET ‘off-on’ mechanism for sensing.21–24 All show selectivity for zinc, and in particular 
bodipy-based probe 5 was used to image zinc in living cells (Figure 1-5 (a) and (b)). These 
probes do also respond to Cd2+ ions in a similar manner to zinc, but as cadmium is not 
biologically relevant, this result is considered unimportant. 
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Figure 1-5 Selected examples of probes employing PET mechanisms for zinc sensing.  a) Fluorescence image of 
TCA cells loaded with probe 5 (10 μM). b) Fluorescence image of stained cells loaded with Zn
2+
 (50 μM) for 30 
min. Images reproduced with permission from the Royal Society of Chemistry. 
24
  Copyright © 2005, Royal 
Society of Chemistry.   
 
1.4.2. Internal/Intramolecular Charge Transfer (ICT) 
Sensors that utilise ICT mechanisms often consist of a fluorophore and receptor with no 
spacer, forming a π-electron rich conjugated system with an electron-rich and electron-
deficient region. If the charge distribution in the molecule is altered, this is manifested as a 
change in fluorescent signal. Binding of zinc to an ICT-based chemosensor causes an 
observable change in fluorescence emission, often accompanied by a red or blue shift 
depending on whether the receptor is the electron donor or acceptor. This is distinctly 
different to the PET-mechanism of sensing, which generally has no observable band shift 
but merely a hyperchromic enhancement. ICT mechanisms are also often highly solvent 
dependent, as polarity plays a role in stabilising the electronic state of the molecule.  
This behaviour often lends to ICT sensors being ratiometric, meaning the emission ratio at 
the two different wavelengths can be attributed to cation concentration, and these sensors 
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can potentially allow for the quantification of zinc present in the sample, be it solution, 
cells or tissues.  
 
Figure 1-6 Examples of ICT-based probes 6 – 8  
 
FuraZin 6, and its related derivatives ZnAF-R1 7 and R2 8 are successful examples of ICT 
based probes, with the latter also being ratiometric.17,25 In these examples, the binding of 
zinc alters the electron donating properties of the electron rich ligands used in these 
examples, thus affecting the photophysical properties of its response to a binding event. 
Probes 6-8 have been used to successfully image zinc in cellular environments.25,26 
Recently, an ICT-based zinc selective probe 9 was reported by Liu et al. that demonstrates 
effective imaging in zebrafish as a living animal model, with a ratiometric response and 
excellent selectivity for zinc.27 
 
Figure 1-7  ICT-based Zn
2+
 selective probe 9 designed by Liu et al. and its ratiometric emission profile. Image 
reproduced with permission from the Royal Society of Chemistry.
27
 Copyright © 2014, RSC. 
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1.4.3. Förster Resonance Energy Transfer (FRET) 
Sensors that utilise the FRET mechanism to elicit a fluorescence response to binding always 
incorporate a ‘switch-on’ response. FRET is classified as a distance-dependent transfer of 
energy from an excited donor fluorophore to a ground-state acceptor fluorophore which is 
consequently excited and exhibits fluorescence.  
The fluorophores of the FRET pair need to have the appropriate degree of spectral overlap 
between the emission of the donor fluorophore and the absorption spectra of the 
acceptor. By binding a cation to these types of probes, the distance between the FRET pair 
can be altered, thereby altering/arresting the FRET mechanism. This type of mechanism is 
generally employed when using two fluorescent proteins for a FRET-based probe. 
Alternatively, in the case of small molecule probes, it is possible to disrupt the degree of 
overlap between the FRET pair of fluorophores by altering the emission of the donor 
fluorophore upon a binding event.  
 
Figure 1-8 FRET-based chemosensor selective for Zn
2+
 in EtOH, and its binding mode with Zn
2+
 
 
In 2010, a novel FRET-based chemosensor 10 was designed and demonstrated to show a 
CHEF response for zinc in ethanol solution. 28 The aminoquinoline moiety acts as the donor, 
and binding of zinc at the donor site causes ring opening and a change in FRET to occur 
between that and the acceptor moiety, resulting in a ratiometric response to binding. 
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Whilst this is advantageous, the inability to test this probe in an aqueous environment 
limits this probe’s use in biological settings. This mechanism has been used successfully in 
genetically encoded zinc sensors with pairs of fluorescent proteins as donor and acceptor 
(see Section 1.6.1). 
 
1.4.4. Excimer/Exciplex Formation 
An excimer is defined as a complex formed when an excited fluorophore interacts with 
another fluorophore of the same structure in its ground state. Either a dual emission is 
observed, with excimer emission distinctly red shifted from that of the monomer, or only 
the excimer emission is observed.  
When the molecule in the ground state is not identical, the excited complex formed is 
known as an exciplex. Often the emission bands for excimers/exciplexes are broad. With 
these sensors, the analyte can be used to template formation of, and promote emission of 
the complex, or peturb the interaction between the two fluorophores and switch off the 
emission. 
A recent example of a zinc chemosensor exploiting this type of behaviour is shown in Figure 
1-9.29 Pyrene-based molecules are particularly known for their propensity to form excimers. 
The incorporation of them into this sensor meant the group observed characteristic pyrene 
excimer bands in the fluorescence spectra of sensor 11 in a H2O/MeCN mixture. Upon 
binding of zinc however, no pyrene stacking occurs, and so monomer emission is observed. 
The subsequent addition of pyrophosphate means zinc is no longer bound inside the 
molecule, allowing the pyrene molecules to stack and so the excimer emission is once again 
observed. 
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Figure 1-9 Zn
2+
 selective probe 11 and its emission profile in the presence of other analytes. Image reproduced 
with permission from the Royal Society of Chemistry. 
29
 Copyright © 2014, RSC. 
 
1.5. Characteristics of an Ideal Zinc Sensor 
Regardless of its mechanism of action, there are a number of rules that it is important to 
follow when designing a zinc-selective chemosensor. Many reviews and publications from 
zinc biologists and chemists alike often refer to the following essential criteria required for 
zinc sensing in vivo in real time.4,16,18 
a) Selectivity for zinc over other competing cations, including protons 
One of the strictest requirements for a successful probe is that it has high selectivity for 
zinc and retains this selectivity in the presence of other biologically abundant cations. 
Sensors must also be able to give a response over a wide range of concentrations of the 
cation and so display appropriate binding constant, as the concentration of zinc varies 
significantly according to biological setting. 
b) Biological properties – toxicity/availability/solubility 
The sensor molecule should ideally be completely biocompatible. Essential features include 
water solubility, very low or no toxicity, and insensitivity and high stability towards varying 
changes in environment such as pH and ionic strength of solution. 
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c) Optimal brightness and luminescence profile  
There are also optical requirements for the fluorescent component of the molecule; the 
ideal sensor should have a large extinction coefficient and quantum yield to give high 
brightness or high fluorescence in response to a binding event, for ease of detection 
(visually or microscopically). Additionally, brighter probes can often be detected at lower 
concentrations, so reducing the disruption to metal homeostasis in vivo. Ideally the 
excitation and emission wavelengths of the sensors should be in the visible or low energy 
range. UV-radiation causes undesired photo-damage to tissues and cells, and also evokes 
cellular autofluorescence, which can contaminate the signal from the sensor. Near infra-red 
wavelengths are also of interest as these wavelengths can penetrate tissues more deeply. 
d) Optimal sensitivity, with the ability to quantify the amount of analyte  
A ‘switch-on’ response is preferred, as this can provide an ideal method of real-time 
observation of zinc chelation. A ratiometric response is also highly desirable to quantify the 
levels of zinc available in real time. 
e) Simple and high yielding synthesis 
One of the biggest drawbacks of the use of small molecule probes is that there is no 
guarantee that any probe will work in-cellulo. There is a need to be able to rapidly diversify 
and synthesise new probes quickly, so the synthetic route is very important. This can be 
likened to the pharmaceutical industry, where methodology is put in place for rapid 
synthesis, screening, and re-synthesis if needed of a large number of substrates to find a 
lead compound for drug molecules. To maximise the probability of efficacy in biological 
systems, access to multiple modified probes through a facile and expedient synthesis could 
prove to be highly beneficial for the field.   
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f) Control of probe distribution to monitor movement/presence of zinc.  
A key current challenge is to develop these sensing systems further as targeted probes in 
vivo. This is to aid the study of chelatable pools of zinc in specific organs or cellular 
organelles, in order to develop a better understanding of the disease processes they are 
intrinsically involved with. All eukaryotic cells contain defined compartments, from the 
nucleus to vesicles, and zinc has a different role in each one. Control of probe localisation is 
vital as the user can then visualise zinc in specific areas. The ideal sensor or detection 
system for zinc should be able to detect zinc in cells and tissues with very little or no 
interference from any other factors. 
1.6. Targeted Small Molecule Zinc Sensors – Evaluation of the Field 
Whilst the development of probes for zinc with targeting capabilities is still in its infancy, 
there are successful examples of probes that have demonstrated subcellular localisation in 
an effort to meet all of the above criteria. 
1.6.1. Protein Based Targeted Sensors 
Protein-based fluorescent probes for zinc detection were amongst the first designed to 
localize to specific cellular compartments. These types of targeted sensors can essentially 
be divided into two categories. 
The first are genetically encoded FRET sensors, where a zinc binding unit is placed between 
two different fluorescent proteins that alter in conformation upon binding of a zinc 
cation.30 The genetically encoded sensor 12 developed by Dittmer et al. relies on zinc finger 
protein interactions to bind zinc, and their study found mitochondria to be a source and a 
sink for Zn2+ under different conditions, accumulating and releasing zinc in response to 
stimuli.  The group also recently used these sensors to monitor the processes in the Golgi 
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apparatus and endoplasmic reticulum (ER), determining that elevated levels of Ca2+ in the 
cell gives rise to Zn2+ release from the ER.31 
The second are sensors generated by labelling a genetically encoded tag with a small 
molecule sensor, as the Lippard group did with their SNAP-Tag based sensors.32 The group, 
well-known for synthesising zinc-selective probes,33 immobilized one of their family of 
Zinpyr fluorescent zinc probes onto targeted organelles, such as the Golgi apparatus and 
mitochondria, via labelling with alkylguaninetransferase (AGT) (Figure 1-10, 13). The 
enzyme targets a protein known to be expressed in specific cellular compartments, to 
enable the localised imaging of Zn2+. An advantage of sensors of this type is their ability to 
image zinc in localised compartments without worrying about the spontaneous distribution 
of the probe in the tissue or organ. Only the immobilised sensor is responsive to zinc, giving 
a desirable ‘switch-on’ response only when anchored and fused to the expressed protein.34  
 
Figure 1-10 Protein based fluorescent sensors 12 and 13.
1
  
                                                          
1
 Image for probe 12 reprinted from Current Opinion in Chemical Biology, volume 14, Elisa Tomat 
and Stephen J. Lippard, ‘Imaging Mobile Zinc in Biology’, p 225 – 230, Copyright © 2010, with 
permission from Elsevier. 
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Although these strategies have advantages in terms of the precise localisation of the probe 
they can give, both methods require extensive genetic modification procedures and long 
protein syntheses, which results in an undesirably complicated route to a simple imaging 
tool. These probes also suffer from low fluorescence outputs, but are available with a good 
range of binding constants needed to assess zinc levels in different biological settings.35,36  
1.6.2. Biological Targeting with a Functional Group or Molecule 
An alternative strategy is to use a sensor with a specific functional group or molecule, one 
that is not gene or protein based, and is known to interact at specific cellular sites, or 
localise at particular organelles. There are a growing number of recent examples in this 
field, some of which are described below. It is interesting to note that in many cases these 
probes are merely simple modifications of existing sensors with the additional functionality 
being applied via a synthetic handle on the probe. Whilst many of these sensors have a 
successful function, their synthesis is often challenging and low yielding. 
1.6.2.1. Targeting Mitochondria 
Mitochondrial zinc uptake occurs to clear the cytosol of the cell of zinc accumulation, but it 
is known that excessive accumulation of zinc inside the mitochondria promotes their 
dysfunction, and an increase in production of reactive oxygen species leading to toxicity 
and apoptosis. 37  To understand the implications of this, it is vital to monitor mitochondrial 
zinc uptake/movement in tissues or cells in real time. 
In 2003, Rhod-Zin3 14 (Figure 1-11) was found to detect changes in mitochondrial zinc at a 
nanomolar level, and the group made some important observations regarding the role of 
mitochondrial zinc and intracellular homeostasis in neuronal cells.38 However, the 
localisation was serendipitous as it was not designed to image mitochondrial zinc 
specifically. Charged compounds are now commonly known to interact strongly with the 
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mitochondrial membrane, and in particular, lipophilic cations can accumulate inside the 
mitochondrial space. Therefore using cationic species as a way to target mitochondria is 
now a widely used and successful methodology.39  
 
Figure 1-11 Lipophilic cation-bearing probes RhodZin 14and DQZn2 15, for imaging of mitochondrial zinc. 
 
In 2012, the development of a targeted fluorescent probe for zinc was published, DQZn2 
15.40 The sensor consists of a commonly-used di-2-picolylamine (DPA) metal chelating unit, 
with a quinoline based fluorophore and a triphenyl phosphonium targeting unit, separated 
from the sensor by a long linker to minimise its influence on the photophysical properties 
of the molecule. 41 Triphenylphosphonium cations are often used for anchoring a probe or 
other cargo to mitochondria in cells.42,43 The sensor provided a basic quantitative 
measurement, as fluorescence intensity increases upon addition of zinc, but this is heavily 
influenced by pH, concentration of sensor, and photobleaching. 
SZn-Mito 16 is another probe with an identical targeting group and metal chelating unit, 
but a different fluorescent reporter.41  This PET-based probe was used to image zinc in the 
mitochondria in HeLa cells using both regular fluorescence and two-photon microscopy, to 
overcome unfavourable excitation and emission values of the probe and for imaging over 
extended periods of time with high resolution.44  With 1:1 binding of probe and analyte, a 
7-fold ‘switch on’ response to binding, excellent selectivity for zinc over other biologically 
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relevant metal cations, pH insensitivity and a Kd value of 3.1 nm, this probe has excellent 
characteristics to apply to real time in cellulo imaging. 
 
Figure 1-12 Other mitochondria-targeted Zn
2+
 probes 16 – 18 synthesised by the Cho Group. 
 
The group followed this up with SZn2-Mito 17, observing an improvement in fluorescent 
enhancement and a smaller Kd value of 1.4 nM, but with retention of the excellent 
characteristics of the parent probe.45  They also synthesised a third probe, FZn-Mito 18, 
with a different fluorophore core, but similar two photon characteristics and behaviour.46  
It displayed a 16-fold switch on CHEF in the presence of zinc and a favourable emission at 
550 nm for both one- and two-photon imaging in HeLa cells. Mitochondrial presence was 
confirmed by co-localisation with the Mitotracker dye, with a Pearson’s co-localisation 
coefficient of 0.86. 
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Figure 1-13 ICT-based Zn
2+
 probe Mito-ST 19 for monitoring mitochondrial zinc. 
 
In a similar manner, Guo and co-workers developed Mito-ST 19, an ICT-based ratiometric 
probe used to monitor zinc release from mitochondria in response to stimuli like H2O2 and 
NO.47  This provided a reliable method of monitoring the efflux of zinc from the 
mitochondria in response to toxic cell stimuli such as excess H2O2.  
 
Scheme 1-1 Mitochondrial probe DA-ZP1-TPP 20 synthesised by Lippard et al., and its binding mode with Zn
2+
 
(1:2) to give complex Zn
2+
[ZP1-TPP] 
 
The Lippard group extended the utility of their commercially available Zinpyr-1 probe by 
appending a triphenylphosphonium cation to target the probe to mitochondrial space 
(Scheme 1-1, DA-ZP1-TPP 20).48  Acetylating the probe completely quenched fluorescence 
in the ‘off’-state, resulting in a large ‘on-off’ difference and increasing the dynamic range of 
the probe, as zinc both mediates the hydrolysis of the acetyl groups and binds the ligand to 
produce a selective switch-on response. Without acetylation, the probe was sequestered in 
lysosomes and endosomes, and so the structure as well as the targeting group became vital 
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for successful in-cellulo imaging. DA-ZP1-TPP-stained cells responded to changes in 
intracellular zinc levels in both healthy and cancerous prostate cells, and showed the 
diseased cells lose the ability to accumulate zinc into the mitochondria. 
1.6.2.2. Targeting the Cell Membrane 
The extracellular membrane is another region of interest when studying zinc trafficking. 
Visualisation of zinc influx/efflux at a cell membrane can contribute to studies on zinc 
release related to neuronal activity, disease states of a cell, or of apoptosis. 
The Taki group have recently synthesised a cholesterol conjugated fluorescent sensor, 
which binds to the plasma membrane of cells.49  The probe 21 follows a modular design 
consisting of three clear units; a zinc-binding moiety, a fluorescent reporter component 
based on fluorescein, and a cholesterol molecule, linked to the fluorophore with a 
triethylene glycol linker (Figure 1-14). The cholesterol molecule has a high affinity for lipid 
membranes, and using this, the group demonstrated this sensor localised to the cell 
membrane. This was proved by fluorescence microscopy studies, confirming its presence in 
the extra cellular region due to the hydrophilic properties of the rest of the compound. The 
group commented on the ability to change the fluorophore in future, as well as the 
bioconjugation component, to allow multi-colour imaging at different compartments to 
facilitate our understanding of the way zinc is trafficked in a cell, though no further studies 
have been reported to date.  
In a further demonstration of extracellular imaging, Li, Rutter and co-workers have 
synthesised ZIMIR 22, a variant of the ZnAF sensor developed by Lippard, functionalised 
with two long alkyl chains that anchor the sensor to the extracellular region of the cell 
membrane, aiming to monitor the influx and efflux of zinc.50  In particular, 22 was used to 
image intact murine pancreatic islet β-cells to exploit the fact that insulin granules contain 
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high levels of ‘free’ zinc co-ordinated to insulin, and both are co-released upon insulin 
secretion. This has been carried out before with commercial probes such as Newport Green 
DCF, RhodZin-3 (14) and Zinquin, but these all suffer from a lack of localisation, selectivity 
and also from operational problems associated with background fluorescence from the 
bulk solution in the extracellular space upon loading of the cells. ZIMIR-labelled cells were 
stable in the presence of the probe, and reliably reported changes in zinc concentration at 
the cell surface into the extracellular space upon stimulation to promote insulin release. It 
also aided the discovery of new information about the methods and precise locations of 
exocytosis from these types of cells, which could prove important in helping the study of 
type-2 diabetes melitus. 
  
 
Figure 1-14 Zn
2+
 specific probes 21 – 23 designed to target extracellular membranes. 
 
In a similar vein, the Cho group also synthesised a zinc-specific probe 23 with a dodecyl arm 
like ZIMIR, to anchor the probe extracellularly.51  Much like FZn-Mito 18, FZn-mem 23 had 
the extra advantage of being a two-photon chemosensor, with a 7-fold increase in emission 
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upon binding of zinc. The probe proved to be highly stable, imaging extracellular zinc ions 
in intact HeLa cells for extended periods of time, with little interference from other metal 
ions. 
1.6.2.3. Targeting Lysosomes 
The lysosome is an acidic compartment in the cell designed to aid degradation of other 
cellular elements. Like the mitochondria, the influx and accumulation of zinc into lysosomes 
have been known to contribute to their dysfunction, and particularly contributes to cell 
death in neurons under oxidative stress by causing lysosomal membrane 
permeabilization.52  A better understanding of these mechanisms could contribute to the 
study of the causes and effects of various neurodegenerative disorders.  
After their development of DQZn2 15 as a successful mitochondrial stain (vide supra), the 
Jiang group also synthesised DQZn4 24 with an identical core of fluorophore and DPA 
receptor, but a different targeting group.53  The dimethyl ethylamino moiety is known to 
accumulate in acidic lysosomal space after being protonated and so can be used to help 
deliver cargo and probes to these compartments.54–56  This was the first known example of 
a small molecule lysosomal-targeted zinc probe.  Probe 24 retains the selectivity and 
sensitivity of 15, despite the change in targeting group, performs well at the acidic pH of its 
intended compartment and was successfully utilized for imaging lysosomal zinc changes in 
living cells. 
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Figure 1-15 Small molecule probes DQZn4 24 and LysoZn-1 25 designed to target lysosomal space in cells. 
 
Following this, Zhu et al. also designed a ratiometric zinc selective sensor 25 designed to 
localise in lysosomal space, based on a BODIPY scaffold with DPA again as the receptor 
unit.57 They used a similar targeting group, also based on ethylenediamine, designed to 
protonate in acidic conditions and channel the probe into lysosomal compartments, but 
terminated with a morpholine unit rather than the dimethylamine moiety used in 24. This 
ratiometric probe 25 was effective across an acidic pH range (pH 3–8), and was successfully 
used to monitor zinc concentrations in lysosomes in neural stem cells upon stimulation 
with H2O2. Considering H2O2 is a strong oxidant, the group found it has no effect on the 
behaviour of the probe, meaning any changes observed in fluorescence could be attributed 
solely to a change in zinc concentration. 
1.6.2.4. Other Cellular Compartments 
Cho and co-workers reported the synthesis and testing of BZn-Cyto 26 46 alongside the 
report of FZn-Mito 18 and used both probes in live HeLa cells to demonstrate multicolour 
imaging of different compartments. BZn-Cyto was designed to localise in cytosolic space, 
and successful in-cellulo imaging via two photon microscopy was demonstrated, with a 
fluorescent enhancement of 27 fold in the presence of zinc and a nanomolar Kd, although 
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the localisation of 26 to cytosolic space was only qualitiatively observed and noted, not 
confirmed. 
 
Figure 1-16 Cytosolic Zn
2+
 specific probe BZn-Cyto 26 
 
Mikata and co-workers designed a quinoline based, glucose appended sensor 27 that was 
selective for Zn2+.58  They hypothesised that the glucose units would aid cellular uptake via 
glucose transport channels in cells for visualisation in the membrane. Whilst the sensor 
proved selective for zinc with some favourable characteristics in vitro, the group found only 
a small enhancement of fluorescence in the presence of zinc during in vitro screening (two-
fold) and during fluorescence microscopy (1.8 fold) in PC-12 cells (typical cell line for 
neurobiology study). The fluorescent response was only observed upon destruction of the 
cell membrane and addition of extra zinc, confirming its internalisation. However, sugars 
also have applications in targeting the surface of cells by binding subcellular lectins. This 
has been used by the Scanlan group in developing targeted zinc-porphyrins as 
photodynamic therapy agents, with various mono and di-saccharides.59  Dong and co-
workers recently reported the glycosylation of a naphthalimide-based Zn2+ probe enhances 
aqueous solubility and its targeting capabilities, whilst reducing its cytotoxicity.60  
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Figure 1-17 Glycosylated zinc probe 27 for intracellular imaging of Zn
2+
 
Most probes for other compartments are genetically encoded, hybrid or peptide sequence-
based sensors. Spontaneous localisation has in fact been observed with some small 
molecule probes to other cell compartments. Whilst these probes, just as with RhodZin 14, 
are successful at imaging zinc in certain cellular compartments, this is unplanned and 
unpredictable and can even vary between cell types/lines for the same probe. Nevertheless 
there are some examples of successful imaging of different compartments.  
The ZBR probes 28a – c (Figure 1-18), though not designed to show specific localisation, 
were found to localise in the endoplasmic reticulum (ER) in various cell lines.61 This was 
confirmed by co-localisation studies with many known cell stains, and the consistency 
throughout the cell lines tested supports its reliability. These probes were used to image 
zinc exocytosis from the ER in response to stress in neural cells. 
                 
Figure 1-18 Small molecule probes for Zn
2+
, ZBR 28 and QZ2E 29, that showed spontaneous localisation in cell 
lines. 
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A probe designed in the Lippard laboratory was shown to localise spontaneously in the 
Golgi apparatus, known as QZ2E (29).62 The di-ester is cell permeable, and upon hydrolysis 
by intracellular esterases becomes trapped inside the cell. This probe in particular has a 
large dynamic range for zinc with an exceptional ‘switch-on’ response to zinc (φ(29) = 0.4 
+/- 0.1%, φ(29 + Zn2+) = 73 +/- 3%), and excellent co-localisation demonstrated with a Golgi-
specific stain in HeLa cells.  
1.6.2.5. General Remarks 
Despite the utility and success of these reported probes, their drawbacks are also notable. 
Often the overall yields of the targeted probes discussed here were less than 10%, with 
ZIMIR 22 for example being as low as 3%, due to complicated synthetic routes.  The work of 
the Cho group in synthesising a variety of probes (16 – 18, 23, 26) for targeting different 
cellular compartments also demonstrates that despite having the same or similar core 
structure, the modifications required to alter the targeting capabilities of each probe were 
not easy to carry out.  
The nature of probes such as the ZBR probes (28) showing spontaneous localisation, and 
the unpredictability of a probe’s behaviour in cellulo is also another concern in the field. 
The rapid generation and study of these types of successful probes could help to study the 
factors governing their behaviour and localisation, and incorporate these advantageous 
characteristics into a general marker for the study of zinc in vivo. 
1.7. Overall Aims of this Project 
We set out to work towards overcoming these limitations and this thesis presents efforts to 
develop novel Zn2+ selective chemosensors that can meet contemporary criteria for 
successful and simple imaging of specific cellular regions with a modular and facile 
synthesis. 
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We aimed to utilise ‘click’ chemistry to a) synthesise novel sensors that incorporate a 
targeting unit to develop successful zinc-specific imaging tools, and b) to develop a zinc 
selective version of a novel structure with the potential to bind metals, with a new 
mechanism of sensing. Overall we wanted to demonstrate that ‘click’ chemistry can help to 
rapidly diversify the probe structures available to meet specific criteria for functional 
supramolecular structures. 
1.8. Copper(I)-catalysed Azide-Alkyne Cycloaddition (CuAAC) and its Merits 
‘Click’ chemistry is a term coined by Barry Sharpless,63  as an easy, effective way to join two 
small, separate units together. There are many different reactions under the ‘click’ 
chemistry umbrella, but the reaction utilized most commonly is copper catalysed, and 
works via a cycloaddition of an azide group to an alkyne group, hence the term copper(I)-
catalysed azide-alkyne cycloaddition (CuAAC).64,65 It provides regiocontrol, only giving the 
1,4- triazole (unlike the thermally driven cycloaddition which produces both the 1,4 and 1,5 
triazoles), and proceeds as shown in Figure 1-19 to generate a 1,2,3-triazole bridge 
between the two ‘click’ units. 
 
Figure 1-19 Schematic diagram to show the copper-catalysed reaction between an azide and an alkyne to 
regioselectively form a 1,4-triazole 
 
While the reaction appears simple, it is in fact mechanistically very complex, and this 
complexity accounts for the regioselectivity of CuAAC reactions in exclusively forming 1,4-
substituted triazole products.66   The formation of a copper acetylide species is thought to 
account for the directing nature of the catalysis. However, as there are thought to be many 
other fast forming organocopper species in equilibrium in the reaction, the full mechanism 
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has yet to be conclusively elucidated. The cycle shown in Scheme 1-2 has recently been 
proposed by Fokin et al. following extensive study, calculations and calorimetry 
experiments.67 Whilst it is widely accepted that the formation of a terminal copper 
acetylide species plays an important role in the catalytic cycle, Fokin and others 68 have 
proposed that this is not the only catalytically active species and argue a case for a weak -
bond interaction with another copper atom which leads to the regiocontrol observed. 
 
Scheme 1-2 Proposed catalytic cycle from Fokin et al., for a typical CuAAC reaction to account for the observed 
1,4- regioselectivity 
 
Despite such points of contention, since Sharpless described it as the “premier example of 
a ‘click’ reaction”,69 the effectiveness of the CuAAC has led to its use as a robust method to 
introduce covalent linkages in an enormous number of molecular structures. It has 
applications in organic synthesis, medicinal chemistry, the generation of large 
supramolecular structures, and biomimetic polymers, dendrimers and chains.70  
1.9. Existing Triazole-containing Zinc Sensors  
In terms of chemosensing, many groups have chosen to use this reaction to join together 
their fluorescent reporter and metal binding unit. This allows not only for chemoselective 
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ligation but also maintains a small enough distance between the fluorophore and ligand to 
allow for optimal electron transfer processes upon a binding event. As well as acting as a 
spacer, in some instances the triazole can act as an additional co-ordinating motif to the 
metal centre in question. This is true in the case of chemosensor 2 (vide supra) synthesised 
by Zhu et al., whereby the triazole plays both a structural (ligating) role, alongside one 
contributing to the sensor’s function.22 For a full comprehensive review up to 2010, the 
review by Todd and Watkinson et al., covers many examples of triazole-containing sensors. 
71 Some recent notable and successful examples since the 2010 review include those 
chemosensors shown in Figure 1-20Figure 1-21Figure 1-22.  
 
Figure 1-20 Triazole containing probes 30 and 31 studied by Todd et al. for their differing photophysical 
response to Zn
2+
, and their biotinylated complex 32 for binding studies with avidin. 
 
The Todd group have synthesised many triazole-ligand scaffolds with a fluorescent reporter 
for zinc sensing in aqueous media. The probes 30 (originally synthesised in 200972) and 31 
are identical apart from a reversed orientation of the triazole.73,74 The study of both PET 
based sensors concluded that they are selective for zinc with a 7-fold and 5 fold CHEF effect 
observed respectively. Probe 31 was found to be a brighter probe, and differential pulse 
voltammetry was used to elucidate a reason for the reduced efficiency of PET quenching 
upon binding of zinc to this sensor. Noting the photophysical properties of these probes 
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were not optimal due to their UV-emission, the group attempted to incorporate a 
piperidinyl group to alter the excitation/emission wavelengths and extend the fluorescence 
lifetime of the probe, and whilst this was successful, the probes lost their selectivity for 
zinc, demonstrating the often unpredictable nature of designing zinc sensors.75   
Complex 32 was also synthesised and was noted as the first fluorescent biotinylated metal 
complex. The zinc complex was used to monitor binding of biotin to avidin, as a more 
sensitive alternative to EPR methods previously used to study this interaction.76  
There are many examples of calixarenes furnished with other groups via CuAAC reactions 
to function as zinc sensors, such as 33 (Figure 1-21).77 Similar triazole-appended calixarenes 
have been used as PET sensors and excimer/monomer emission sensors for selective 
recognition of zinc,78 and these fluorescent zinc complexes have been used for sensing 
pyrophosphate and display reversible logic-gate properties.79  
 
Figure 1-21 Calixarene probe 33 and tris-triazole pyrene probe 34 
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Sensor 34 is also of note as a triazole-furnished sensor, as the pyrene units ‘clicked’ to the 
tripropargylamine core strongly encourage excimer formation and stacking of the units. 80  
Upon binding of zinc, the group observe breakdown of the excimer and an increase in the 
emission band of the monomer, making it ratiometric. 
Peptide based sensor 35 synthesised by Datta et al. shows 2:1 sensor:Zn2+ binding, 
excellent selectivity and some reversibility, with an ON-OFF phenomenon observed with 
alternative additions of Zn(ClO4)2 and HClO4.
81  These properties indicate its potential use as 
an optical tool/switch.  
 
Figure 1-22 Peptide based Zn
2+
 probe 35 and quinoline appended ‘click’ probe 36 
 
Triazole containing sensor 36, with a hydroquinoline chromophore, was synthesised in 2 
steps using CuAAC.82  In an aqueous environment the probe acts as a ‘turn-on’ CHEF sensor 
with a 10 fold increase in fluorescence upon binding together with a marked blue shift in 
the emission of 62 nm. In MeCN, the sensor demonstrates a ratiometric response to zinc, 
which the authors attributed to a lack of photoinduced proton transfer in the aprotic 
solvent. 
Combined with the selectivity of the molecules for zinc over other transition metals, these 
are all excellent examples of simple CuAAC reactions successfully building bright functional 
molecules. As outlined previously the simple, rapid and high yielding nature of the CuAAC, 
combined with the wealth of reaction conditions available, can provide groups with a 
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simple method to construct novel potential sensors using this versatile reaction in a facile 
manner. 
1.10. One-pot Multicomponent CuAAC Reactions 
1.10.1. Introduction to Iterative ‘Click’ Chemistry 
In our efforts towards the synthesis of an ‘ideal sensor’, we turned to the wealth of 
literature available regarding multicomponent coupling reactions, and in particular those 
utilising the copper-catalysed azide-alkyne cycloaddition (CuAAC). 
Molecules with multiple triazoles can be synthesised in a stepwise manner, but this can 
decrease the efficiency of the reaction through the extra manipulations required for 
working up reactions and purification techniques. However, there are many excellent 
examples of the synthesis of complex molecules containing triazole moieties in a one-pot 
fashion. They benefit from using simple pre-functionalised units, high atom economy, huge 
savings in waste and purification costs, control of the final product outcome (i.e., the ability 
to avoid unwanted oligomerisation) and excellent yields. 
Examples from the literature can be grouped by their synthetic strategy used into four 
distinct areas; 
a) Using a CuAAC reaction in combination with another alternative coupling to build a 
molecule, 
b) The use of ‘masked’ azides, introduced at a later stage via a chemical transformation, 
c) The use of alkynes with and without protecting groups (commonly silyl-based), and 
d) Control via reactivity, with no protecting groups involved. 
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These types of reactions are commonly used in peptidomimetic strategies, other large 
biomolecule mimics such as DNA analogues, and to synthesise bi-aryl ligand scaffolds for 
large supramolecular structures like cages and rotaxanes.  
1.10.2. Using a CuAAC/Alternative Coupling Combination 83 
The high chemoselectivity of an azide and alkyne in the CuAAC reaction often means it can 
be used in tandem with other reactions in a synthetic route, as many other functional 
groups, with or without protecting groups, are tolerated under the reaction conditions. This 
is particularly common in peptide synthesis, where a triazole unit is commonly used as a 
bioisostere of an amide bond. The dimensions of a triazole are somewhat similar to that of 
an amide bond (Figure 1-23), and it is of note that the triazole moiety is known to be 
biocompatible and has been incorporated into small molecule drug candidates.84  
 
Figure 1-23 Demonstrating the use of a triazole as a bioisostere of an amide bond. 
 
A particularly elegant example of a one-pot Ugi/CuAAC reaction was demonstrated by Cai 
and co-workers, to synthesise triazole-containing amino acid derivatives and 
peptidomimetic fragments.85 The group employed a classical 4-component Ugi reaction in 
MeOH to readily furnish two bis-amides 37 and 38 with an azide and alkyne respectively, 
and then carried out the CuAAC reaction using copper(II) acetate, sodium ascorbate and 
NEt3 in the same pot to construct the peptidomimetic 39. (Scheme 1-3)  
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Scheme 1-3 One pot tandem Ugi/CuAAC reaction to construct peptidomimetics as reported by Niu and co-
workers. Conditions: i) MeOH, rt. , ii) Cu(OAc)2, Na. ascorbate, NEt3, r.t. 
 
CuAAC reactions are also commonly employed alongside palladium-based cross-coupling 
reactions, as the conditions can be complementary and, if the substrates are added in the 
correct sequence, can synthesise the desired product efficiently in high yields. Often used 
in the synthesis of bi-aryl and other cyclic and aromatic small molecule drug candidates or 
biologically active molecules, a common synthetic route incorporates the CuAAC first, 
followed by a cross coupling reaction on the combined molecule. Many examples of this 
have been noted in the review by Sokolova and Nenajdenko, but there are some notable 
examples in which the CuAAC has been utilised as the final step of the synthetic route.83  
An efficient one-pot Sonogashira-CuAAC reaction was reported by both Novak et al. in 
2009,86 carried out under ambient temperature and pressure, and by Friscout and Boons in 
2010 in a microwave-assisted reaction.87  
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The reaction typically follows the sequence in Scheme 1-4, with some variation. In the 
conditions by Novak et al., the CuI employed for the Sonogashira reaction was also utilised 
for the CuAAC, which occurs concurrently with the slow addition of a solution of TBAF to 
deprotect the TMS-alkyne. The authors state that no particular care was taken to ensure air 
was excluded from the reaction, and that the slow addition of TBAF was to avoid the 
homocoupling of the deprotected alkyne moieties under their conditions. The yields are 
still only good to moderate (53-77%), and particularly low in the case of 4-nitro 
phenyliodide as the starting material, and also with bulky adamantyl azide as the CuAAC 
partner.  
 
Scheme 1-4 A general one pot Sonogashira-CuAAC reaction to install and alkyne and perform a CuAAC to 
synthesise triazoles, as exemplified by Novak et al. 
 
Nevertheless, this was advanced to a microwave assisted version by Friscourt and Boons, 
with high yielding results within the scope of substrates they examined.  The group also 
observed low yields using a 4-nitro phenyl-halide starting material, but higher catalyst 
loadings and longer reaction time for the Sonogashira coupling vastly improved the final 
yield of the ‘click’ product from 11% to 53%, suggesting that electron-withdrawing moieties 
require longer reaction times. 
This methodology has been put into practice for the synthesis of complex molecules, such 
as N-heterocyclic kinase inhibitors,88 and also in the synthesis of some fused heterocycles 
of biological interest, also including the use of acetylene gas as the alkyne component.89  In 
Introduction 
 
 
49 
 
2012 Kim et al. suggested the TMS protected alkyne intermediates produced in the 
previous one-pot reactions mentioned were unstable intermediates, and proposed that the 
use of TIPS-protected alkynes was bulky enough to provide extra stability, leading to higher 
yields of triazole-containing products.90  
1.10.3. The Use of ‘Masked’ Azides, Introduced at a Later Stage via a Chemical 
Transformation 
One of the drawbacks of the one-pot Sonogashira-CuAAC reaction, especially with some 
smaller substrates, involves the synthesis, isolation and handling of organic azides.91  This is 
because some azide-containing substrates, particularly those that are polyvalent or of a low 
molecular weight, can be very unstable, difficult to handle and unsafe to work with due to 
their potentially explosive nature. In the last ten years a large number of papers report the 
synthesis of these organic azides in-situ before the addition of an alkyne-containing 
substrate to perform the CuAAC in a two-step one-pot fashion.  
The first important example of this was demonstrated by Fokin et al. in 2006, in which 
triazole-containing structures were prepared from alkyl, aryl and vinyl halides, sodium 
azide and a chosen acetylene partner under classical CuAAC conditions with CuSO4 and a 
reductant.92  The reaction conditions were relatively mild and simple, and in most cases the 
final product was simply isolated by filtration in very high yields, including some structures 
with multiple triazole moieties (40–42, Scheme 1-5). The utility of this procedure was 
further extended by the group’s report of a microwave assisted three component ‘click’ 
reaction, using slightly modified conditions to those previously employed (vide supra) but 
still with excellent yields.93  The procedure was used to synthesise a conjugated variant of 
TBTA, a common ligand used in the CuAAC reaction to stabilise Cu(I) species.94  
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Scheme 1-5 Standard conditions for in-situ generation of azides for direct CuAAC reactions in one pot, as 
exemplified by triazole 40, and other examples 41 and 42. (a) uses alkyl chloride as the halide component. 
 
Many other reports have appeared using this type of halide substitution method for 
forming azides,95–97 and this was used to great effect by the Crowley group in a simple, 
modular and high yielding method to generate functionalised ligand scaffolds. 
Circumventing the isolation of potentially dangerous low molecular weight organic  azides, 
the group obtained alkyl, benzyl and aryl substituted pyridyl-1,2,3-triazole ligands from the 
one-pot, three-component reaction in high yields, and in some cases in higher yields than 
from the corresponding isolated azide. A typical example (Scheme 1-6) demonstrates the 
mild reaction conditions employed and typical yields obtained, i.e., for compound 45, 92%. 
The ligands were used for complexation with silver and copper salts.98 They also 
synthesised some novel polydentate triazole ligands in the same manner with a view to 
their use in large metallosupramolecular structures.99  
 
Scheme 1-6 A typical one pot procedure followed by Crowley et al. for a multicomponent CuAAC reaction. 
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Many other reports have appeared with a view to making this process ‘green’ as well as 
safe, and discuss the use of recyclable catalysts, ionic liquids, ball-milling procedures, and 
using water as the reaction solvent.100–106  
Boronic acids are also synthetically useful in the context of forming these types of low 
molecular weight azides. After noting that other nitrogen containing nucleophiles have 
been able to substitute boronic acids, Guo and co-workers used inorganic NaN3 to 
substitute aryl and vinyl boronic acids with an azide moiety, and demonstrated the 
reaction’s efficacy in a one-pot reaction to synthesise the corresponding ‘click’-products in 
moderate to high yields (Scheme 1-7).107 They state this method to be better than using 
aryl and vinyl halides as the conditions are mild and a higher substrate tolerance was 
observed, but since this publication appeared, methodology for these halide substitutions 
has been optimised and vastly improved, as shown in the many examples previously 
discussed.  
 
Scheme 1-7 One pot substitution-CuAAC reaction to generate aromatic triazole products 48 from boronic acid 
precursors 46. Conditions: i) CuSO4 (10 mol%), MeOH, rt., ii) PhCCH, rt.. 
 
This methodology was used in a one-pot, iterative CuAAC reaction on ferrocene boronic 
acid with a protected acetylene group installed, as the corresponding azide compound was 
found to be unstable when isolated. The group synthesised a double-triazole functionalised 
ferrocene compound in moderate yields, and demonstrated the efficiency of the one-pot 
route over the stepwise synthesis.108  
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The direct transformation of alcohols to azides, without the prior need to convert the 
alcohol into a leaving group first, is another strategy implemented into a one-pot scheme 
for synthesising triazoles. Most of the work in this area has been carried out by the 
Sreedhar group from India. They first reported a multicomponent coupling of secondary 
alcohols, trimethylsilyl-azide (TMS-N3) and alkynes in the presence of copper to furnish 1,4-
substituted triazoles in excellent isolated yields, including alkyne coupling partners with 
heterocycles such as pyridine.109 TMS-N3 is necessary as the azide nucleophile, as sodium 
azide (NaN3) gave no reaction, and while common solvents such as DMSO and MeCN gave 
moderate yields, nitromethane gave the highest yields. This is a drawback as it is not 
generally regarded as a conventional solvent. The group also developed a method to 
convert homoallylic secondary alcohols in a similar manner, but with the addition of PdCl2 
to help avoid any sigmatropic rearrangement of the allylic azide formed.110 This not only 
gave access to challenging allylic azides, but also their CuAAC products in one pot in good 
yields, this time in a simple solvent mixture of CHCl3/H2O.   
One of the most common routes to azides, after halide substitution, is a simple 
diazotransfer method to transform an amine into an azide. In 1991, Eaton et al. first 
reported the use of trifluoromethylsufonyl azide, or TfN3, in the preparation of 
azahomocubanes.111 They reacted a cubyl amine with this reagent in the presence of 
triethylamine to produce cubyl azide precursors in high yields (74-85%). Azides also 
originally found their use as amine protecting groups,112 and in 1996 Wong and co-workers 
reported a useful metal-catalysed method of preparing azides from amines using TfN3, and 
demonstrated a diazotransfer on many representative amine-functionalised sugars such as 
49 in a process they deemed to be mild and scaleable (Scheme 1-8).113  
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Scheme 1-8 Typical diazotransfer reaction to protect amines using TfN3, as reported by Wong et al. 
 
This procedure has found many applications for one-pot synthetic routes,114–116  notably 
with Arora and co-workers who combined this diazotransfer with a CuAAC to develop a 
one-pot multicomponent procedure to synthesise triazole-containing biomimetic oligomers 
(replacing the amide bond).117,118  The iterative sequence recycles the copper source used 
as a Lewis acid to perform the cycloadditions, and results in high yields both in solution and 
solid state syntheses of oligomers containing up to four triazoles.  
A particularly important point to highlight at this stage is the great dangers and drawbacks 
that these procedures could potentially create in the laboratory. Aside from Tf2O being an 
expensive starting material, limiting its use in scale-up, TfN3 is a huge detonation hazard. It 
is often made in solutions of CHCl3 or CH2Cl2, but the volatility of these solvents could prove 
to be dangerous upon storage as dry TfN3 is highly explosive.
119  Moreover, these azide 
sources in chlorinated solvents could generate the very explosive azido-chloromethane or 
diazido-methane. Using these reagents in safer conditions, making fresh reagents each 
time without storing them and not isolating any intermediate until the final stage of the 
reaction makes TfN3 easier to manipulate and handle, hence the utility of the one-pot 
pseudo-peptide scheme from Arora et al..  
This was further demonstrated by a one-pot multicomponent reaction reported by 
Wittman and Beckmann in 2007, using these reaction conditions to perform a 
diazotransfer-CuAAC iterative sequence which was not limited to amino acid residues 
(Scheme 1-9).120  They demonstrated short reaction times using a microwave reactor. No 
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reaction intermediates were isolated, and a freshly prepared solution of TfN3 in 
dichloromethane was made before each reaction. They also investigated the reaction in 
toluene instead of CH2Cl2 due to the potential hazard it presents, and whilst the yield of the 
final triazole product 52 drops from 94% to 77%, it is still a moderate result that could be 
utilised in scale-up procedures. Even so, each solution of TfN3, however freshly and 
carefully made, does not have the same concentration due to variable reaction yields, and 
as a consequence the reactions always require a significant excess of the reagent to be 
used. Combined with its poor shelf life and huge safety concerns, this does not make TfN3 
an ideal candidate for a simple iterative CuAAC in the laboratory on any scale.  
 
Scheme 1-9 One pot diazotransfer-CuAAC reaction using TfN3 reported by Wittman and Beckmann. 
 
Alternative conditions have been investigated for diazotransfer reactions of this 
nature.121,122  TMS-N3 is regarded as a ‘safer’ reagent as there are no inherent explosive 
properties associated with it. However it is very sensitive to moisture and oxidising agents, 
where it will decompose to hydrogen azide, and so must be stored in a dry moisture-free 
atmosphere.123  TMS-N3 (and 
tBuONO) was the diazotransfer reagent of choice for Moses et 
al. in their development of a one-pot procedure, in a simple and atom-efficient 
multicomponent reaction to give triazole containing aromatic compounds in high yields.124 
However, they only investigated the transformation of simple substituted anilines, and did 
not demonstrate any scope in the acetylene coupling partner used in the one-pot 
procedure either, limiting the utility of their study.  
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An important advancement in the development of safe and easy to handle diazotransfer 
reagents came with the characterisation and use of imidazole-1-sulfonyl azide 54. 
Imidazole-1-sulfonates demonstrate a similar reactivity to trifluoromethanesulfonates, but 
this has the added benefits of being more stable and less expensive. Goddard-Borger and 
Stick reported imidazole-1-sulfonyl azide to have analogous behaviour to TfN3 in 
synthesising azide containing compounds.125  The HCl salt was crystalline, did not require 
purification and could be stored safely, with no detonation occurring upon severe impact 
testing and high temperatures. It furnished a wide range of azide-containing alkyl, 
aromatic, amino acid and carbohydrate compounds from their corresponding amines in 
high yields under mild conditions. This reagent was utilised in an interesting example of a 
one-pot three step synthesis of triazole containing compounds from aldehydes and amines, 
in which the final ‘click’-products were isolated in moderate to high yields (Scheme 
1-10).126,127  
 
Scheme 1-10 In situ generation of both azide and alkyne coupling partners from an aldehyde 53 and and amine, 
and subsequent CuAAC to synthesise pyrene furnished triazoles. 
 
This is the first noted instance of both CuAAC coupling partners being generated in situ in 
the same reaction, and whilst the yields are not always exceptional, the group demonstrate 
scope of the chemistry with a good range of amine substrates (although a smaller set of 
aldehyde substrates was investigated) and extend the methodology to the synthesis of 
triazole linked sugars, demonstrating its potential utility in oligosaccharide synthesis.  
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1.10.4. The Use of Alkynes With and Without Protecting Groups 
Other reported one-pot CuAAC reactions have focused on developing a reaction using 
protected alkyne precursors straight into the reaction mixture. This avoids the extra steps 
of deprotection and isolation of any alkyne ‘click’ partners before the CuAAC reaction. This 
is particularly useful when, for example, one is using low molecular weight acetylenes to 
make small triazole containing products, or to conveniently allow control over reactivity 
when the compound contains more than one alkyne unit. 
An important study towards this methodology was reported in 2006, where Leigh and 
Aucagne demonstrated a methodology for a ‘click-click’ reaction of three components in 
one pot.128  The group took advantage of orthogonal reaction conditions and utilised 
molecules containing both TMS-protected and free acetylenes, ‘clicking’ one and then 
deprotecting in situ to release the second acetylene for CuAAC ligation, under mild 
conditions (Scheme 1-11). 
 
Scheme 1-11 Schematic of the one pot ‘click-click’ reaction methodology developed by Leigh and Aucagne. 
 
The group found that during initial optimisations, Cu(MeCN)4PF6 was compatible alongside 
AgBF4 for the orthogonal reactions. Upon applying these conditions to peptides, the solvent 
system of tBuOH/H2O required the use of more classical CuAAC conditions using CuSO4 and 
sodium ascorbate to generate Cu(I) in-situ. The reaction was very sluggish, and trying to 
solve this with higher catalytic loadings, and the use of heat/microwave conditions 
encouraged Cu(I) promoted desilylation. Gentle warming of the reaction proved to be a 
successful compromise.  
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However, many groups, noting the instability of TMS, moved to the alternative 
triisopropylsilyl (TIPS) protecting group. This gave greater control and stability, and yet was 
still compatible with their CuAAC conditions.129,130  This, combined with the report from 
Gramlich and co-workers, on their combined use of TIPS and TMS to synthesise 
oligonucleotides,131  prompted Aucagne and co-workers to investigate alternatives to TMS 
as alkyne protecting groups, and to develop a more robust methodology for successive 
iterative cycloadditions.132 The group settled on a combination of TES and TIPS, with their 
orthogonal deprotection conditions, and demonstrated three iterative ‘clicks’ on a single 
molecule.  
Despite being the most common alkyne protecting group, alternatives strategies to silyl 
protecting groups have also appeared. In 2011 two groups reported the one pot synthesis 
of triazoles using both aryl halides and protected alkynes, generating the azide in situ and 
the tandem CuAAC/deprotection of the respective protecting groups. Zysman-Colman et al. 
utilised the classic TMS protected alkynes and obtained moderate yields, and, in some 
cases, also observed the formation of an undesired 1,5-triazole product,133 [2] while 
interestingly Kolarovic et al. reported the first use of alkynoic acids to deliver acetylene 
groups for CuAAC, with the aim to circumvent the use of low molecular weight alkynes, 
which are sometimes desirable for producing terminal triazole moieties.134  The CuAAC 
proceeds alongside the transformation of the aryl iodide to the azide, under classical 
CuAAC conditions of Cu(II) with a reductant, and in-situ decarboxylation of the protecting 
group on the alkyne leaves the triazole product 56 (Scheme 1-12). This decarboxylation is 
presumed to be copper-catalysed,135 and this one-pot process furnished very high yields of 
products with a range of azides and alkynoic acids. Li and Flood also reported the use of 
                                                          
2
 Other groups have also reported similar reactions of note.  
212–214
 
Introduction 
 
 
58 
 
butyn-2-ol as an alternative protecting group cleaved readily under strong basic conditions, 
to allow sequential ‘click’ reactions in the synthesis of triazolophanes.136  
 
Scheme 1-12 One pot substitution-CuAAC-decarboxylation multicomponent sequence, as reported by Kolarovic 
et al. 
 
Nevertheless the silver-catalysed in-situ deprotection of TMS groups in tandem with a 
CuAAC reaction in one pot as shown in Scheme 1-11 still proved popular due to its evident 
simplicity and utility, and this methodology found uses in supramolecular chemistry,137  
synthetic peptide synthesis,138 convenient fluorescent labelling of biomolecules 139  and also 
in the construction of analogues of DNA.140  
1.10.5. Control via Reactivity Without Protecting Groups 
Perhaps the least studied method of iterative CuAAC reactions, controlling the reactivity to 
ensure sequential ‘click’ ligation of different moieties is not so popular due to its potential 
unpredictability and often very slow reaction times. These types of reactions however, are 
advantageous in that they remove the need for a protection/deprotection sequence 
altogether, and there are some notable examples in the literature to draw inspiration from. 
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Figure 1-24 Central molecules with two ‘clickable’ moieties for the formation of bistriazole products without the 
need for protecting or ‘masking’ groups. 
 
Bis-alkyne linker 57 (Figure 1-24) was synthesised by Girard et al. for the exact reason of 
circumventing protecting groups.141 The methodology relies on the conjugated alkyne being 
activated by the amide group, thus making this the more reactive alkyne of the two in the 
molecule. After first carrying out a neat AAC on the activated alkyne with no catalyst 
involved (or in acetone if solvent was required), the 1,4-triazole isomer was isolated from a 
crude mixture of regioisomers by a simple trituration. This was carried forward to a CuAAC 
reaction for the second inactivated alkyne to form iterative triazoles on the same molecule 
with moderate and excellent yields for each cycloaddition respectively.  
The drawbacks to this methodology are evident. The formation of a mixture of both 
isomers (in some cases intractable) during the first cycloaddition reaction does not identify 
this as a fully efficient iterative ‘click’ methodology. Furthermore, whilst exclusively 
affording the 1,4-regioisomer, the second copper-catalysed ‘click’ reaction is very slow, and 
in the case of many substrates it can take up to 48 h to complete. On a positive note, the 
catalyst used for the CuAAC was a solid-supported Cu(I) catalyst, and this provided a facile 
work-up at the end to afford the bis-triazole product in a simple fashion without any 
copper residues remaining from the reaction.  
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Strain-promoted azide-alkyne cycloaddition, or SPAAC, is a popular method to install 
triazoles in large biomolecules and other drug-like target molecules without the use of 
copper, avoiding metal residues. Despite copper being an essential element in the body, 
these catalytic residues can promote oxidative damage by the formation of reactive oxygen 
species, and SPAAC is now commonplace as a bioconjugation strategy in biological systems 
and some drug targets.142  The ring strain, as demonstrated by the cyclooctyne moiety in 
58, allows the AAC to proceed without the need for a thermal or catalytic push.143,144  Beal 
et al. took advantage of this when designing 58, and demonstrated a sequential 
SPAAC/CuAAC on this large molecule to selectively generate one triazole after another, and 
synthesised a bis-triazole compound capable of binding to bovine serum albumin.145 The 
group demonstrate that a range of biomolecules can be ligated to the framework, including 
biotin, peptides, disaccharides, and fluorescent tags. However, again the SPAAC is sluggish 
unless carried out at high concentrations, and synthesis of the cyclooctyne itself can be 
challenging and low yielding. 
As well as bis-alkynes, a procedure for iterative CuAAC reactions on a bis-azide compound 
has recently been reported.146 Utilising Cu(II)-chelation assisted CuAAC,147,148 Zhu and co-
workers designed various pyridine-containing bis-azides like 59, where Cu(II) chelates to 
the pyridine nitrogen and its adjacent azide, selectively forming that triazole first. Only 
upon addition of a reductant to increase the concentration of a Cu(I) species in-situ does 
the pendant azide participate in a CuAAC, thereby giving control and selectivity when 
performing iterative CuAAC ligations. The group found they obtained a greater yield of the 
bis-triazole product in one-pot than with stepwise iterations, making this an efficient 
iterative CuAAC procedure. There was also very little material loss, as the intermediate 
mono-‘click’ product is not isolated. The group also demonstrated that there was no loss of 
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reactivity when the reaction was performed in aqueous HEPES buffer at pH 7, thus 
demonstrating its potential application in bioconjugation strategies. 
 
Figure 1-25 Pyrene tagged DNA product reported by Ingale and Seela, using bis-azide 59 
 
Indeed, Ingale and Seela used 59 to synthesise cross-linked and fluorescent pyrene-tagged 
DNA (such as 61).149,150  The methodology allowed them to sequentially ligate two 
molecules to the bis-azide core in one pot in a desired controlled manner, after many 
previous attempts to do so with varying success.151–153 One serious drawback of this 
methodology is that the bis-azide core 59 used by both groups for their study is classed as a 
low-molecular weight azide, and the dangers of synthesis and handling of this compound 
(as previously discussed) require great care and attention. Zhu and co-workers also 
synthesised larger molecules whereby the pendant, non-chelating azide is attached to the 
pyridine by a longer alkyl linker, thereby increasing molecular weight and removing any 
inherent dangers associated with bis-azide manipulation.  
Finally, Kaliappan et al. reported a unique approach to iterative CuAAC reactions with a 
view to linking carbohydrates through triazoles.154  The group designed sugars with both an 
azide and alkyne moiety attached, as compound 60, and successively ‘clicked’ first the 
azide, and then the alkyne moiety without oligomerisation to furnish a bis-triazole sugar 
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using simple building blocks such as methyl propiolate, and small phenyl and benzyl azides. 
However, the yields of bis-triazole obtained were very low (23-46%) due to the instability of 
the central building block 60 both on standing and in solution, and the group isolated the 
CuAAC product of the two external azide and alkyne building blocks in higher yield than the 
desired bis-triazole, as well as other unknown by-products from the decomposition of the 
sugar. This particular report highlights the need for stable building blocks, high 
chemoselectivity and control over reaction partners in one-pot multi-component 
procedures like this one to ensure high yielding successful reactions.  
1.11. Concluding Remarks 
This chapter highlights only a selection of the wide variety of zinc-specific probes already 
reported. After highlighting precise cellular localisation as one of the key objectives for the 
design of novel fluorescent probes for zinc, we can see a number of groups have made 
efforts towards this aim. The probes presented are of a wide variety of structures with a 
variety of cellular compartments targeted, but their challenging and low yielding synthetic 
route detracts from the success of the sensors themselves. Modifications to the core 
structure are not available in a rapid, facile manner, and this prevents further studies to 
develop more structurally diverse biologically targeted sensors for zinc in different 
biological settings. 
‘Click’ chemistry, namely the CuAAC reaction, could readily provide a path to access these 
types of probes. Their utility in the synthesis of zinc-specific probes has already been 
realised in many examples presented here, with high yielding reactions and high molecular 
diversity of the ‘click’ components for each reaction. To maintain the ideal supramolecular 
structure set out for a probe we can envisage a method to incorporate sequential ‘click’ 
reactions into an existing core scaffold to append additional functionality. There are many 
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methods of iterative CuAAC ligation to draw experience from, and this methodology, and 
‘click’ chemistry in general, could be utilised to aid the rapid generation of a successful 
library of probes. 
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Chapter 2: Design and Development of a Novel Iterative Double-
‘Click’ Reaction 
 
2.1. Introduction and Aims 
Previous work by Watkinson and co-workers had utilised CuAAC chemistry towards Zn2+-
specific chemosensors. In 2009 the group synthesised probe 30 consisting of the metal 
chelating azamacrocycle, cyclam, linked to a naphthalimide fluorophore via a triazole linker 
(Scheme 2-1).72 
 
Scheme 2-1 Synthetic route to ‘Clickate’ probe 30. Conditions i) Ethylamine, 1,4-dioxane, 70 °C, 82%. ii) NaN3, 
NMP, rt 24 h, 50%. iii) CuSO4.5H2O, Na. ascorbate, THF/H2O, 82%. iv) TFA/ CH2Cl2 (1:5), 88%. 
The synthesis, as expected for ‘click’ chemistry, was simple and high-yielding, and the 
sensor showed 1:1 binding of the zinc ion to the sensor with a desirable ‘switch-on’ 
fluorescent response (6 fold increase), and also demonstrated an effective response over a 
broad pH range (pH 4-10). The probe also showed excellent selectivity for Zn2+ over all 
other first row transition metals. Probe 30 was also tested in vivo in murine thymocyte 
cells, and appeared to detect cellular levels of zinc in apoptotic cells without the addition of 
extracellular zinc. This work was a particularly novel modular approach to the design of a 
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sensor molecule and is one of the first instances reported where a triazole acts as an extra 
metal ligand on a probe of this type.  
The simple modular nature of the ‘click’ synthesis of probe 30 allowed the group to 
investigate an alternative yet similar ligand and investigate its effects on the efficacy of the 
sensor. Based on work by Kimura et al.,155 the group incorporated an alternative 
azamacrocyclic ligand, cyclen, to synthesise probe 68 in similarly high yields to 30.156 It also 
demonstrated a significant (approx. 5-fold) increase in fluorescence in response to zinc, 
across the same pH range, and displayed a broadly similar selectivity profile to probe 30, 
with a difference in fluorescence response to Cd2+. 
 
Scheme 2-2 Synthesis of cyclen ‘clickate’ analogue 68 
156
 
 
Both probes demonstrated efficacy in imaging in live organisms in vivo, as shown in Figure 
2-1. In vivo results in zebrafish showed localisation of the probes in the intestine, biliary 
system and the eye, suggesting potential application of these small molecule sensors as 
organ-level imaging agents for zinc in zebrafish models. 
This study clearly demonstrated how the simple modular construction of the sensor 
allowed the ready investigation of different novel zinc-selective probes. It showed how a 
small structural change to the ligand induced slight changes in metal binding behaviour and 
metal detection, whilst maintaining the overall efficacy as a zinc-selective probe. 
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Figure 2-1 Fluorescence microscopy images of Danio rerio (zebrafish) embryos incubated with sensors 21 and 
22. 
156
  These images indicate the probes localise in the eye and gut region of the embryo. Arrows indicate 
iridophores in the embryo, these are not illuminated due to the probe. 
 
We felt all the properties of probe 30 and 68 were promising, despite the UV-excitation and 
emission wavelength (λem 30 = 407nm, 68 = 420nm), and so we envisaged the next step was 
to develop this system further, as a targeted probe in vivo to aid the study of chelatable 
pools of zinc in a specific organ or at cellular organelles. We anticipated the sensor itself 
could be conjugated to a biomolecule marker that is known to bind to specific sites in 
cellulo, as demonstrated by many of the small molecule probes discussed in Chapter 1, 
thereby targeting the sensor to specific cellular locations. We planned to extend the 
synthetically simple, modular design of the previously synthesised fluorescent probes to 
create a library of easily tailored, targeted probes to overcome the complexities of existing 
targeted sensors that require challenging synthetic protocols for their preparation.  
This chapter will discuss in detail the design and optimisation of the synthetic route 
developed towards a number of novel sensors, drawing inspiration from literature 
precedent of sequential iterative CuAAC ligations in one-pot. It will describe the eventual 
success of utilising a simple in-situ azide formation to synthesise a range of three unit, bis-
triazole constructs with model substrates. 
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2.2. Synthetic Strategy and Target Molecules 
There was potential for different ligation strategies to be applied to the ‘clickate’ sensor 30. 
The naphthalimide based fluorophore has a viable point of conjugation, at the nitrogen 
atom at the imide position of the molecule, as well as a facile means of adding alternative 
metal binding units via ‘click’ chemistry (as shown with probe 68) to alter the binding 
capabilities of the probe (Figure 2-2). This would make the fluorophore component the 
core of these new probes. 
 
Figure 2-2 Potential points of modification highlighted on ‘Clickate’ probe 21 
 
We aimed to design a modular synthesis based on a central building block of a 
naphthalimide fluorophore, with various ‘clickable’ units of ligand and biological targeting 
group. Many of the targeted small molecule probes reported in the literature are limited by 
their challenging and low yielding syntheses, and this is even more evident for recombinant 
probes and those probes that utilise peptides. Whilst they are efficient and demonstrate 
excellent behaviour for imaging purposes, their use is limited by the expensive and difficult 
requirements for synthesis and purification, the need to tag the probes with large peptide 
chains, or the transgenic approaches required for gene delivery. As well as the numerous 
benefits previously described of one-pot multicomponent reactions, our main focus was to 
use it to provide a facile synthesis of a multicomponent molecule. We aimed to overcome 
all of these complexities with pre-functionalised building blocks, to allow tailored design 
and production of a successful targeted small molecule fluorescent probe capable of 
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detecting biological zinc. Triazoles themselves are specifically noted for their 
biocompatibility and inertness to metabolic conditions,157 making them an ideal 
conjugation approach for our desired purpose. A basic representation of our initial design 
of the possible ‘click’ pairs is shown in Figure 2-3.  
 
Figure 2-3 Schematic to demonstrate proposed synthetic routes to novel bis-triazole constructs using a clickable 
fluorescent central building block (in blue) 
 
Targeting groups and ligands can be readily functionalised with either an azide or alkyne 
group, which ‘clicks’ to a central building block chosen to match with the appropriate click 
partners, using synthetic equivalents of molecules with two ‘clickable’ moieties to 
synthesise novel three-unit constructs. It is important to note that only one loading of 
catalyst was envisioned, as both CuAAC steps could utilise the same catalyst, reducing 
reaction costs even further, removing purification steps and also reducing metal waste.  
2.3. Results and Discussion 
2.3.1. Design and Synthesis of Central Building Blocks 
The key to a successful synthetic route using these synthons was to retain control over the 
CuAAC taking place at any one time. The bromide in the 4-position of the naphthalimide 
was presented as a potential functional group to act as a masked ‘clickable’ functional 
group.158,159 By starting from the commercially available anhydride 62, this would allow 
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facile installation of one ‘click’ component upon formation of the imide, with the bromide 
subsequently transformed at a later stage to allow the sequential iterative clicks to take 
place. 
We took inspiration from the reports previously described on the in-situ substitution of 
halides to azides with a subsequent and one-pot CuAAC, particularly the work of Crowley et 
al. (Scheme 1-6)98,99 Unlike this method, the nucleophilic displacement of the bromide to 
the azide in the case of our naphthalimide core is catalyst free. The synthesis of the new 
central building blocks 69 and 70 (Figure 2-4) would hopefully allow us to perform a CuAAC 
at one end of the naphthalimide, to install a potential targeting group first, and then 
transform the bromide and ‘click’ a ligand at the other end without isolating any 
(potentially unstable) reaction intermediates, and maintaining the ability to control the 
iterative CuAAC reactions in constructing our three component molecule as desired in a 
high yield.  
 
Figure 2-4 Synthetic targets for new central building blocks 69 and 70 (derived from commercially available 
naphthalic anhydride 62) 
 
The synthesis of central building block 69 was a simple and readily scaleable one-step 
condensation between the anhydride 62 and propargylamine in 1,4-dioxane that is very 
high yielding at 96% (Scheme 2-3).  
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Scheme 2-3 One step syntheses of central building blocks 69 and 70 
 
Li and co-workers reported the installation of an azide at the anhydride position of the 
fluorophore in a similar manner to the installation of the alkyne in 69. The group 
incorporated 3-azido-propan-1-amine into naphthalenediimide structures to create a 
‘clickable’ unit (in this instance for the formation of [2] and [3]catenanes).160,161 This led us 
to the design of central building block 70, which we hoped would allow the sequential 
ligation of two different alkyne functionalised groups. We were able to synthesise the 
desired building block in high yield on a gram scale (Scheme 2-3).  
The cyclam and cyclen ligands from ‘clickate’ probes 30 and 68, and many other known 
zinc-binding ligands in the literature,22,72,156,162,163 are most commonly functionalised with an 
alkyne. The design of both fluorophores meant that the second CuAAC ligation for the 
metal binding unit would readily be able to incorporate these easily accessible alkyne-
functionalised compounds upon application to probe synthesis. 
2.3.2. Optimisation of Synthetic Route for One-pot Synthesis 
2.3.2.1. Initial Stepwise Iterations 
Initial investigations were applied to the central building block 69, using benzyl azide and 
phenylacetylene as model ‘template’ CuAAC partners for our actual desired building blocks. 
This allowed us to optimise the reaction using inexpensive and analytically simple 
substrates. First, we set out to identify each of the desired intermediates and to confirm a 
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stepwise synthesis of a model three unit construct (Scheme 2-4). For the first CuAAC with 
benzyl azide we used classical ‘click’ conditions of CuSO4 and a reductant in a THF/H2O 
mixture, as with the ‘clickate’ sensor 30 and its cyclen analogue. Triazole 71 was isolated 
after column chromatographic purification in good yield. The SNAr reaction was performed 
with 1.2 equivalents of sodium azide in N-methyl pyrrolidinone (NMP), with moderate yield 
of 72 after isolation, and the final CuAAC under the same conditions with phenylacetylene 
gave a yield after purification of 68% for the bistriazole three unit construct 73. 
 
Scheme 2-4 Initial stepwise iterations to obtain each intermediate and intended final product in the one-pot 
synthetic route, using classical CuAAC conditions. Conditions i) CuSO4.5H2O (10 mol%), Na. ascorbate, THF:H2O 
(7:3) 16 h, 76%. ii) NaN3, NMP, rt, 24 h, 41%. iii) as stage (i), 68%. 
 
It was evident from the outset that the major limitation on the implementation of this 
synthetic route into a one-pot procedure was the choice of solvent. Polar aprotic solvents 
such as DMF, DMSO and NMP are the most effective for the nucleophilic aromatic 
substitution (SNAr) of the aromatic bromide on the naphthalimide to the azide. This meant 
that for a one-pot route we were limited to the use of these solvents, thus ruling out 
THF/H2O and the classical ‘click’ conditions used in Scheme 2-4. Due to successful 
precedence within the group, we elected to use NMP as our solvent of choice.  
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We identified a literature procedure for the use of CuI as a CuAAC catalyst in NMP, and 
employment of this copper source in the first CuAAC formed 71 in good yield (Scheme 2-5).  
With an established procedure in hand for the synthesis of the azide intermediate, we 
moved on to optimise the final CuAAC. 
 
Scheme 2-5 CuAAC reaction between 69 and benzyl azide in NMP to synthesise 71 
 
2.3.2.2. CuAAC Catalyst Screening 
An initial test using ethyl-naphthalimide azide 64 as a model substrate for the reaction 
proved that the addition of CuI and phenylacetylene did not result in the desired triazole 
product 75 (Scheme 2-6), and it became clear a screen of copper salts was necessary to 
obtain conditions specific to the requirements of this reaction. 
 
Scheme 2-6 Failed CuAAC from model substrate 64 to form triazole 75 
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Entries 1 – 3 in Table 2-1 show the range of Cu(I) and (II) catalysts screened for a test 
CuAAC with azide 64 and phenylacetylene in NMP, including a reductant (sodium 
ascorbate) with the Cu(II) salts. The reactions were monitored at regular time intervals, and 
finally stopped at 72 h, after seeing no conversion to 75 in all cases.  
Whilst entry 1 demonstrates clearly that CuI on its own does not work in the designed 
system, it is commonplace to use a basic additive alongside CuI to accelerate the reaction 
and facilitate the CuAAC by aiding the formation of the active catalytic species in the 
cycle,64,65,164–168 with each reaction displaying a particular sensitivity and specificity to base 
and solvent used. This literature precedent for addition of a basic additive in the presence 
of NMP 169,170 led us to test some commonly used bases. Entries 4 – 6 show that all bases 
tested dramatically accelerated both the reaction time and increase the yield. The use of 
sodium acetate (NaOAc) as an inorganic base gave the highest yield at 98%, although the 
organic bases also displayed high yields, and so this was chosen as the basic additive. [3]  
 
 
 
 
 
 
 
                                                          
3
 It is important to note that the NaOAc base should be dried thoroughly before employment in the reaction. 
We found that any water present in the reaction had a marked effect on the yield of final product and we 
observed some formation of decomposition products by 
1
H NMR analysis when water was present. 
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Table 2-1 Catalyst and additive optimisations for CuAAC from model substrate 64 to form 75 
 
Entry  Cu source 
(10 mol%)  
Additive  Yield %a  
1  CuI  -  0 (72 h)  
2  Cu(I)L b  -  0 (72 h)  
3 Cu(II)L’ c  Na. ascorbate  0 (72 h)  
4  CuI  DIPEA  93   (3 h)  
5  CuI  NaOAc  98   (3 h)  
6  CuI  NEt3  95
   (3 h)  
 
(a) NMR yield; (b) L = PF6(MeCN)4, I, Br, (PPh3)3Br, (PPh3)3OAc ; (c) L’ = (ClO4)2.6H2O, (acac)2, (OTf)2 . 
We extended this model approach to optimising the one-pot SNAr-CuAAC reaction to test 
the ability of these reaction conditions, and from bromide 63 we obtained triazole 75 in 
moderate yield of 58%, and so these conditions using CuI and NaOAc were chosen for our 
one-pot, double-CuAAC investigation from our intended central building blocks.  
 
Scheme 2-7 Successful one-pot SNAr-CuAAC sequence from bromide 63 to form 75. 
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2.3.3. Stepwise Confirmation of New Conditions 
Having established suitable conditions for each individual step, the synthetic route was 
investigated in both a stepwise manner and in one-pot using central building block 69 and 
the ‘template’ CuAAC partners benzyl azide and phenylacetylene, as previously shown in 
Scheme 2-4.  
Scheme 2-8 Stepwise formation of bistriazole 73 from central building block 69 using the optimised conditions. 
Conditions i) CuI (10 mol%), NaOAc, NMP, rt, 1 h, 95%. ii) NaN3, NMP, rt, 24 h, 55%. iii) as stage (i), 4 h, 80%. 
It was clear that the reaction was efficient when carried out stepwise, as expected, with an 
overall yield of 41 % over three steps and purifications. The lowest yielding step is the SNAr 
to form the azide 72, and this was the main cause of such a low overall yield.  
2.3.3.1. Investigations into Formation of Azide 72 
After synthesising and isolating a large clean stock of bromide 71 we attempted to modify 
the reaction time in NMP, under the conditions developed. Heating the reactions promotes 
the complete conversion of bromide 71 to 72 in 4 h, but the yield of 72 formed is only 78% 
by 1H NMR analysis of the reaction mixture. The remainder is a clear decomposition 
product formed in-situ, which was identified to be aniline 76 (Spectrum 2-1). This was 
consistently the major decomposition product formed throughout this study and reaction 
optimisation, and whilst it is only a minor contaminant, due to the very high quantum yield 
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of  4-amino naphthalimide derivatives in organic solvents the impurity needed to be 
removed, even when present in very small quanitites, which proved difficult.   
 
Spectrum 2-1 
1
H NMR spectroscopic analysis of formation of azide 72 in NMP at 60
o
C. 
Decomposition product corresponds to aniline 76 (highlighted in green). 
At room temperature, analysis of the reaction mixture by 1H NMR spectroscopy showed it 
proceeded cleanly and completely. It appears the azide intermediate 72 is ultimately not 
stable however, as decomposition product 76 begins to appear after work-up, and more is 
isolated after column chromatography. Heating the reaction was therefore detrimental to 
the overall yield, and it was decided to keep our original solvent conditions at room 
temperature in NMP. Additionally, the instability of azide 72 on isolation gave credence to 
the idea that this would be a successful one-pot multicomponent reaction however; as the 
intermediate would not require isolation this would likely give high yields of our desired 
double-triazole product 73.   
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2.3.4. Preliminary One-pot Synthesis Attempt 
 
Scheme 2-9 Synthesis of bistriazole 73 using a one-pot procedure from central building block 69 
 
Upon applying our optimised conditions to a one-pot procedure, we found that whilst the 
first two stages of the reaction proceeded well, the final CuAAC was very slow (72 h) with a 
final yield of only 59% of 73 isolated after purification. This corresponded with the 1H NMR 
yield from an aliquot taken before work-up, and many decomposition products of 72 were 
isolated upon purification, along with a small amount of unreacted azide 72.  
Therefore in an attempt to optimise this final CuAAC step we synthesised and isolated a 
stock of azide 72 and set up a number of CuAAC reactions with phenylacetylene under the 
standard conditions we had optimised, screening a variety of additives to determine which 
were having a detrimental effect on the reaction (Table 2-2). 
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2.3.4.1. Investigation into Slow Reaction Time of 72 to Form 73 
Table 2-2 Effect of various additives on formation of double triazole 73 from azide 72 
 
Entry Additive Time (h) Product Yield % a 
1 0.05 eq. 76 48 73 98 
2 1 eq. NaBr 48 73 19 
3 0.2 eq. NaN3 48 73 83 
                                        (a) 
1
H NMR yields 
As the SNAr reaction to form azide 72 is not 100% efficient, we decided to include aniline 76 
as one of the additives. We found that 5 mol% of this had no effect on the reaction at all 
(entry 1), and neither did 0.2 equivalents of NaN3, the potential excess present from the 
addition of 1.2 equivalents to perform the SNAr (entry 3). However NaBr, an unavoidable 
by-product formed in stoichiometric amounts as a result of the SNAr reaction, has a 
significant effect on the yield of triazole formed, and even after 48 h there was only 19% 
formation of 73 and significant levels of decomposition of azide 72 were observed by 1H 
NMR analysis. To overcome this, rather than employ silver salts to scavenge the bromide 
ions, we decided to add a protic solvent to form a mixed solvent system for the final 
CuAAC, with a view to solvate the bromide ion instead. The solvent was to be added after 
the SNAr was complete, so it could have not have a detrimental effect on the azide 
formation. 
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2.3.4.2. Protic Solvent Screen 
Table 2-3 Effects of protic solvent on the formation of bistriazole 73 
Entry Starting Material Solvent Ratio (NMP:X)a Time (h) Product Yield % 
1 71 H2O 4:1 48 73 82
 b 
2 71 MeOH 4:1 48 73 86 b 
3 71 EtOH 4:1 48 73 88 b 
4 71 iPrOH 4:1 48 73 63 b 
5c 69 EtOH 9:1 48 73 48 
6c 69 EtOH 4:1 41 73 66 
7c 69 EtOH 1:1 41 73 85 
(a) Protic solvent added after completion of SNAr. (b) 
1
H NMR yields. (c) 69 to 71 1h, 1.2 equiv. BnN3, 71 to 72 24 
h, 1.4 equiv. PhCCH, 72 to 73 16 h. 
 
Initially, despite the previous decomposition observed in its presence, water was used as 
the protic solvent and was added as 1 part water to 4 parts NMP, so as not to drastically 
increase the volume of the reaction (Table 2-3, entry 1). After monitoring the reaction by 
1H NMR spectroscopy we were pleased to see a dramatic increase in yield of desired 
product 73 with no major decomposition observed. A switch to protic organic solvents for 
the same screen gave comparable results using MeOH and EtOH after 24 h (entries 2 and 
3), with iPrOH showing a lower yield of 63% in the same timeframe (entry 4). As EtOH gave 
a marginally higher yield, this was our final choice of protic solvent.  
A screen of the whole model one-pot multicomponent procedure as in Scheme 2-9 with 
different ratios of EtOH added for the final CuAAC (entries 5 – 7) showed that despite 
halving the concentration of the reaction mixture, the final CuAAC reaction completed in a 
faster time of 16 h, with an 85% isolated yield of bistriazole 73 when using a 1:1 ratio of 
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EtOH to NMP. As the ratio of EtOH:NMP got larger, the yield of 73 clearly diminished. Entry 
7 demonstrates our finalised conditions for a one-pot, double ‘click’ ligation procedure, as 
shown in Scheme 2-10. 
 
Scheme 2-10 Finalised one-pot, multicomponent procedure for the synthesis of bistriazole 73 from central 
building block 69, benzyl azide and phenyl acetylene 
 
Finally, whilst these reactions were carried out at 0.1 M, we also demonstrated this system 
gave similarly high yields at 0.2 M (86% NMR yield) and 0.3 M (85% NMR yield) as well, 
showing that the reaction is not limited by reaction concentration.  
2.3.5. Application of Optimised Synthesis to Building Block 70 
These optimised conditions (exemplified in Scheme 2-10) were then readily applied to 
central building block 70. After the three stepwise iterations of CuAAC, azide formation and 
a second CuAAC and three purifications, the overall yield of final product 79 obtained from 
70 was only 41%, but gratifyingly by following the designed one-pot protocol we obtained a 
final isolated yield of 79 of 72% (Scheme 2-11). During the stepwise iteration, it became 
apparent that the azide intermediate 78 formed after the SNAr had a poor level of stability. 
Immediately after column chromatography, azide 78 appeared to be unstable as both a 
solid and in solution, even if kept in an air-free atmosphere and in the dark. For this reason 
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we were unable to characterise it fully. This is also a potential reason behind the slightly 
diminished yield of bis-triazole 79 compared to 73, and more by-products are evident by 
analysis of the 1H NMR spectrum of the crude reaction mixture after work-up procedures. 
  
 
Scheme 2-11 Application of optimised multicomponent procedure to central building block 70 to form 
bistriazole 79, both stepwise and in one-pot. Conditions: i) CuI (10 mol%), NaOAc, NMP, rt, 1 h, 67%. Ii) NaN3, 
NMP, rt, 24 h, 76%. iii) as stage (i), 16 h, 81%. (a) EtOH (1:1 w/ NMP) added for final step when carried out in 
one pot. There was no second addition of copper source. 
 
2.4. Conclusion 
In conclusion, a novel one-pot three component iterative ‘click’ reaction to form double-
triazole containing compounds with a naphthalimide core was designed and optimised. We 
utilised a simple SNAr-CuAAC strategy to successfully design a novel ‘click’-chemistry based 
reaction sequence with high yields and high purity of final bis-triazole products 73 and 79 
(Scheme 2-12). Excitingly, we were also able to isolate both products straight from the 
reaction mixtures by simple precipitation and filtration, with greater than 99% purity by 1H 
NMR spectroscopy. The reaction was designed for future application in the synthesis of 
novel fluorescent bis-triazole constructs capable of acting as sensors for Zn2+ in an 
analogous manner to existing probes in our group, but with readily incorporated cell 
Design and Development of a Novel Iterative Double-‘Click’ Reaction 
 
 
82 
 
targeting moieties to induce localisation in a cellular environment. Our efforts towards this 
are described in Chapter 3. 
 
Scheme 2-12 A schematic representation of the final optimised multicomponent one-pot routes to synthesising 
bistriazole containing compounds from central building blocks 69 and 70, and isolated yields (0.1 M reaction 
concentration) 
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Chapter 3: Design and Development of Biologically-Targeted 
Zinc Sensors 
 
3.1. Introduction 
Having designed a successful iterative one-pot ligation procedure that is high yielding and 
synthetically simple, we decided to demonstrate its utility by synthesising sensors with 
biological targeting groups, rendering them capable of localisation in cellular 
compartments with an end goal of using them for visualisation of zinc in these locations. 
The building blocks required for constructing these types of sensors would be pre-
functionalised units, synthesised to incorporate either an azide or alkyne moiety to ligate 
them to the central building block core (Scheme 3-1). 
 
Scheme 3-1 Schematic representation of the synthesis of three-unit constructs for fluorescent sensing in 
cellular compartments 
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We chose to integrate metal binding units already demonstrated to be selective for Zn2+. 
Many recent examples of biologically targeted fluorescent probes are described in Chapter 
1, and it is interesting to note that in many cases these probes are merely simple 
modifications of existing sensors, with the additional functionality being easily applied via a 
synthetic handle on the probe. We aimed to take a similar approach when synthesising our 
biological targeted building blocks and took well-established targeting units from the 
literature to incorporate into our sensors.  
Unlike the established targeted probes already reported (see section 1.6), we aimed to 
overcome their difficult and low yielding synthetic procedures by utilising our iterative 
multicomponent procedure to give compounds with the desired functionality in high yields. 
This chapter will discuss the routes taken to synthesise both the ‘clickable’ building blocks 
and a small family of fluorescent sensors, in-vitro testing of each sensor’s fluorescent 
response to zinc, and also the successful in-cellulo testing of selected sensors in murine 
pancreatic islet cells. 
3.2. Results and Discussion 
3.2.1. Synthesis of Biological Targeting Groups 
Our first task was to synthesise the ‘clickable’ building blocks that would allow us to 
incorporate a biological targeting group into our novel three unit sensor construct. 
3.2.1.1. Azide-bearing Targeting Groups 
We began by synthesising potential targeting units functionalised with an azide moiety. 
This would allow us to use the central building block 69 with an alkyne unit as the site for 
the first CuAAC to install the targeting group.  
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The ability to monitor the efflux of zinc out of cells using an extra-cellularly anchored zinc-
specific probe was recently demonstrated by Li and co-workers in their development of the 
probe ZIMIR 22, through the attachment of a pair of dodecyl alkyl chains for interdigitating 
the cell membrane extracellularly.50 We envisaged that the incorporation of a didodecyl 
unit into our sensor motif would induce similar behaviour to ZIMIR.  
 
Scheme 3-2 Synthesis of didodecylamine unit 82. Conditions: i) Chloroacetyl chloride, NEt3, CH2Cl2, 24 h, 76%, ii) 
NaN3, DMF, 65 °C, 24 h, 98%. 
 
A ‘clickable’ didodecyl unit 82 was synthesised from commercially available didodecylamine 
80 in 2 steps using established protocols (Scheme 3-2). The amide 81 was formed using 
chloroacetyl chloride and triethylamine in anhydrous CH2Cl2 in good yield after purification. 
The azide formation reaction in DMF was very high yielding at 98%, and no further product 
purification was required.  
In light of the report of cholesterol conjugated probe 21 having efficacy in targeting the 
cellular membrane, we also decided to use cholesterol as a bioconjugate in our library, due 
to its ability to act as an alternative extracellular anchor. 49 Chloride 84 was synthesised in 
excellent yield from commercially available cholesterol, and azide 85 was synthesised in 
DMF in moderate yield after purification (Scheme 3-3). 
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Scheme 3-3 Synthesis of cholesterol azide 13. Conditions: i) Chloroacetyl chloride, NEt3, CH2Cl2, 24 h, 92%, ii) 
NaN3, DMF, 65 °C, 24 h, 65%. 
Another common and successful targeting group often incorporated into the framework of 
zinc specific sensors is the triphenylphosphonium cation, known to induce localisation of 
the organic molecule into the charged mitochondrial matrix. DQZn2 15 and SZn-Mito 16 are 
two such examples.40,41 We synthesised (4-azidobutyl)triphenylphosphonium bromide 89 in 
2 steps from commercially available dibromobutane 86 following literature procedures 
(Scheme 3-4).171 Following this, we carried out an ion exchange of the bromide for a 
tetrafluoroborate anion, to reduce the previously observed propensity of bromide anions 
to arrest the CuAAC one-pot process (see Chapter 2).  
 
Scheme 3-4 Synthesis of (4-azidobutyl)triphenylphosphonium tetrafluoroborate 89. Conditions i) PPh3, toluene, 
reflux 16 h, 68% ii) NaN3, EtOH/H2O (1:1), reflux 16 h, 73% iii) aq. NH4BF4, 96%. 
171
 
 
DQZn4 24 has a structurally identical core to DQZn2 15, but instead of a 
triphenylphosphonium cation it uses an N,N-dimethyl ethylamino moiety to instead target 
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intracellular lysosomal space.53 This molecule was the first reported lysosomal Zn2+ specific 
sensor, and so we also decided to append this unit to our fluorescent sensor to provide 
another targeting group option.  
 
Scheme 3-5 Synthesis of 2-azido-N-(2-(dimethylamino)ethyl)acetamide 92. Conditions i) Chloroacetyl chloride, 
EtOAc, 0 °C, 1 h, 89%  ii) NaN3, H2O, 60 °C, 48 h, 72%. 
Following a modified literature procedure 172 we obtained the hydrochloride salt 91 in 
excellent yield, and this it was taken forward to react with sodium azide in water to give 
the azide 92 in a good yield of 72% (Scheme 3-5).  
3.2.1.2. Alkyne-bearing Targeting Group 
For the central building block 70, which is designed to incorporate two alkyne units as the 
building blocks for the three unit constructs, we settled on the use of propargylated 
glycosides as a potential biological targeting unit.  
Sugars have been incorporated into zinc-specific ligands previously, as demonstrated by the 
quinoline-based probes synthesised by Mikata and co-workers,58 and there is a great 
precedent for ‘clickable’ glycosides as cell-targeting tools, particularly by the Scanlan 
research group.59,173 Not only would these act as targeting moieties, they could also 
potentially aid the solubility and cellular uptake of our sensors.60 Acetyl-protected 
propargylated glucose 94 was synthesised according to literature procedures from 
commercially available glucose penta-acetate 93 in moderate yield (Scheme 3-6).  
 
Scheme 3-6 Synthesis of propargylated glucose 15 
59
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3.2.2. Synthesis of Metal Binding Ligands 
The design of the central building blocks dictated that the second CuAAC iteration for the 
zinc specific ligand must be carried out with an alkyne-appended ‘click’ partner. This led us 
to the synthesis of propargylated ligands 95–97 (Figure 3-1), all of which were readily 
synthesised.  
 
Figure 3-1 Propargylated ligands chosen for this study 
 
All of the ligands shown in Figure 3-1 are known metal chelators. Cyclam acetylene 95 has 
been used by the Watkinson group in our studies towards zinc sensing.71–73 Di-2-
picolylamine (DPA, 96) and iminodiacetate (IDA, 97) are commonly used in many small 
molecule fluorescent sensors and whilst they also known to chelate to other metals such as 
copper and manganese, both of these ligands have been employed in sensors specific to 
the detection of Zn2+, and were chosen for this study for their varying binding affinities for 
zinc.22,50,163 This variety is to ensure that the probes synthesised are able to detect mobile 
zinc at a wide range of biologically relevant concentrations.174 These ligands were 
synthesised with appropriate protecting groups (when needed) for both ease of synthesis 
in the one-pot procedure, and to avoid unwanted binding of copper from the CuAAC. 
Following literature procedures,72 Boc-protected cyclam acetylene 65 was synthesised from 
commercially available starting material 98 in moderate yield after purification by column 
chromatography (Scheme 3-7). 
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Scheme 3-7 Synthesis of Boc-protected propargylated cyclam ligand 65. Conditions: i) Boc2O, NEt3, CH2Cl2, 16 h, 
49%, ii) Na2CO3, MeCN, reflux, 16 h, 69%.
72
 
Scheme 3-8 demonstrates the high-yielding one step synthesis of acetylene-functionalised 
DPA 96. The product was synthesised, after column chromatography using ethyl acetate 
with 5% triethylamine as the eluent, in excellent yield. This particular ligand is useful in the 
synthesis of sensors as it requires no extra protection-deprotection steps.  
 
Scheme 3-8 Synthesis of propargylated DPA ligand 96 
IDA 97 has also previously been synthesised by Varazo et al..162 Following their procedures 
we obtained the protected variant of the desired ligand 104 in a moderate yield after 
column chromatography.  
 
Scheme 3-9 Synthesis of protected IDA ligand 104. Conditions: i) SOCl2, EtOH, rt, 16 h, 33%. ii) K2CO3, MeCN, 
reflux, 16 h, 76%.
162
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3.2.3. Synthesis of Sensors Using One-pot Methodology 
With our selection of desired building blocks in hand, we began synthesising a small library 
of sensors, using our optimised one-pot procedure to ensure high yields, high purity and 
minimal loss of material.  
3.2.3.1. Didodecyl-Bearing Sensors 
 
Figure 3-2 Didodecyl-appended sensors with different metal binding units, designed to target the extracellular 
membrane of a cell. 
 
Sensors 105, 107 and 109 were synthesised from central building block 69, in order to 
demonstrate the modularity and flexibility of our synthesis with respect to the metal 
binding unit. Each was synthesised with the same extracellular targeting didodecylamine 
unit 82, but contained a different metal binding ligand (Figure 3-2). This was to 
demonstrate that our synthetic approach can allow for the tailored synthesis of a probe 
with the appropriate binding constant, to reflect the concentration of mobile zinc in the 
intended area of study. 
Following our optimised conditions, we were pleased to find the reaction proceeded 
extremely well for the synthesis of 105 from 69 on a 1 mmol scale, with an overall isolated 
yield of 82%, corresponding to an average of 95% yield for each step in the synthesis. This 
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and all of the one-pot iterative reactions noted in this study were monitored by 1H NMR 
spectroscopy to ensure and confirm completion of each step before proceeding to the next 
addition for the iterative procedure. The pure product was isolated from the reaction 
mixture by column chromatography using neutral alumina, following work-up with a 
saturated basic solution of EDTA to ensure all copper residues were removed. Sensor 105 
required no deprotection steps and the sensor was ready to use in the laboratory and in 
cellulo (Scheme 3-10).  
 
Scheme 3-10 One-pot synthesis of sensor 105 from central building block 69  
 
As with 105, 106 was readily synthesised on a 1 mmol scale using didodecylamine azide 82 
and protected IDA ligand 104 (Scheme 3-11). The protected sensor was isolated after 
column chromatography in good yield of 76%. Upon standing however, this compound 
appeared to show signs of degradation, both by 1H NMR spectroscopy and by TLC analysis. 
After stirring this degradation mixture in diethyl ether, we were pleased to find that sensor 
106 remained in solution, and the impurity was precipitated. Whilst this impurity was not 
identified, 1H NMR spectroscopic analysis showed there was no second triazole present as 
seen by the absence of ligand 104, and furthermore the chemical shifts did not match that 
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of what would be the corresponding azide intermediate. This was further confirmed by IR 
spectroscopy, where no characteristic azide band was observed.  
Deprotection of 106 to give the ready-to-use sensor 107 proved to be problematic. Basic 
hydrolysis of the ester using potassium hydroxide caused complete degradation of the 
sensor, whilst sodium hydroxide gave a slight degradation but mostly recovered 106, with 
very little of the desired product detectable. A third alternative, the use of lithium 
hydroxide in a THF/H2O mixture, gave conversion to clean product 107 after work up with 
citric acid, but in only a moderate yield of 53%.175  
 
Scheme 3-11 One-pot synthesis of protected sensor 106 from central building block 69, and subsequent 
deprotection to yield 107. 
 
Sensor 109, similar in structure to the original ‘clickate’ sensor 30, was also synthesised on 
a 1 mmol scale, in a good yield of 75% for the Boc-protected 108, using the targeting group 
82 and the protected cyclam alkyne ligand 65. Deprotection by stirring 108 in TFA/ CH2Cl2 
(1:5) followed by a basic work-up gave sensor 109 in excellent yield of 89% (Scheme 
3-12).72  
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Scheme 3-12 One-pot synthesis of protected sensor 108 from central building block 69, and subsequent 
deprotection to yield 109. 
 
3.2.3.2. Cyclam-appended Sensors 
 
Figure 3-3 Cyclam-appended sensors with different biological targeting units, designed to target different 
compartments of a cell. 
 
In a similar mix-and-match approach, sensors 110, 112 and 114 were synthesised from 
central building block 69, in order to demonstrate the modularity and flexibility of our 
synthesis, this time with respect to the biological targeting unit (Figure 3-3). We 
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hypothesised that as the majority of the molecules were identical in structure to the 
‘clickate’ sensor 30 that these probes would retain their zinc selectivity and sensitivity, but 
with the added bonus of specificity for a cellular location. 
The synthesis of sensor 110 presented many difficulties in its handling during the synthetic 
stages of the one-pot route. The well-known tendency of cholesterol to aid the formation 
of gels via van der Waals and hydrogen bonding 176 caused our reactions to stall. The 
gelation prevented efficient mixing, and further dilutions with NMP did not aid the process 
of stirring. Despite this, after rigorous purification, one attempt yielded 28% of sensor 110 
(Scheme 3-13). However, this result could not be consistently reproduced, and so synthesis 
of this sensor was abandoned due to lack of facile access to the desired product.  
 
Scheme 3-13 Synthesis of sensor 110 from central building block 69 
 
Sensor 111 was also synthesised on a 1 mmol scale, in a moderate yield of 66% for the Boc-
protected 111, using the targeting group 89 and the protected cyclam alkyne ligand 65 
(Scheme 3-14). The reaction and work up proceeded as expected but we found most of the 
crude material to be insoluble in chlorinated solvents CH2Cl2 and CHCl3, and also observed 
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streaking upon TLC analysis. A simple trituration of the crude material with EtOAc resulted 
in the extraction of the final sensor and some minor impurities, whilst the remaining solid 
from the trituration was found to be further impurities and degradation products. Column 
chromatography of the separated product mixture in CH2Cl2-MeOH gave the desired 
protected sensor 111. As with sensor 109, deprotection of the Boc groups with TFA gave 
the final sensor 112 in good yield. 
 
Scheme 3-14 One-pot synthesis of protected sensor 111 from central building block 69, and subsequent 
deprotection to yield 112. 
The ethylene-diamine appended protected sensor 113 was also isolated in a moderate 
yield of 68% following the one-pot procedure with central building block 69, azide 92 and 
cyclam alkyne 65 (Scheme 3-15). Loss of material was identified during column 
chromatography due to the polar nature of the compound, with significant streaking on 
TLC plates occurring in the various solvent systems investigated, so the yield of 113 was 
diminished. The deprotection in acidic conditions proceeded smoothly to desired sensor 
114 in moderate yield.   
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Scheme 3-15 One-pot synthesis of protected sensor 113 from central building block 69, and subsequent 
deprotection to yield 114. 
3.2.3.3. D-Glucose-bearing Sensor 
Sensor 116 was synthesised to demonstrate the ability of the methodology to incorporate 
alkyne-bearing targeting groups, with propargylated glycoside 94 designed for ligation to 
central building block 70 to showcase this. It was decided to utilise the propargylated DPA 
ligand 96 in the synthesis of this sensor to avoid any harsh deprotection conditions that 
could destroy the sugar moiety.  
During the azide formation step of the procedure, as expected, 1H NMR spectroscopic 
analysis of the reaction mixture showed the formation of an aniline intermediate in small 
quantities (~10%) as observed previously using this central building block 70 in optimisation 
studies (see Chapter 2.3.5). After completion of the reaction, upon work up a small amount 
of 116 was also identified in the reaction mixture. This, combined with the nature of the 
pyridine-based ligand made purification quite challenging, and we obtained 115 in a 
moderate yield of 61% following column chromatography on alumina in CH2Cl2-MeOH.  
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Scheme 3-16 One-pot synthesis of protected sensor 115 from central building block 70, and subsequent 
deprotection to yield 116. 
 
Deprotection of the acetyl groups on the glycoside was carried out according to a modified 
literature procedure using 30 mol% sodium methoxide (NaOMe).59 A longer reaction time 
of 18 h gave product 116 in 79% yield. The now-deprotected glycoside greatly increased 
the propensity of the compound to dissolve in water, and the obtained compound was not 
soluble in many organic solvents. Therefore sensor 116 was assumed to be a 30% Na-salt as 
it was obtained by simply evaporating the reaction solvent. 
3.2.4. In vitro Testing of Sensors 
With the synthesis of a small family of sensors complete, it was necessary to carry out 
testing in the laboratory to confirm that our novel three-unit constructs 105, 107, 109, 112, 
114 and 116 had the desired fluorescent properties for a zinc probe. All of the ligands 
incorporated into our constructs were all based on previously reported sensors that 
displayed a desirable selective switch-on response upon zinc binding and with a 1:1 binding 
stoichiometry;22,50,163 nonetheless we felt it was imperative to ensure each of our designed 
sensors still retained this behaviour even with the inclusion of an additional biological 
targeting unit in both aqueous and organic media. 
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3.2.4.1. Response to Zn2+ in Aqueous and Organic Media 
 
Figure 3-4 The switch on fluorescent response (F/F0) of each sensor to 1 (red) and 5 (purple) equivalents Zn
2+
 in 
MeCN and aqueous HEPES buffer 
As a first pass, to ensure full solubility of both free sensor, metal salt and metal bound 
sensor, we chose MeCN as the organic solvent to carry out our initial testing. The 
concentration of each sample was 100 μM of sensor, and the sensors were titrated with 1, 
and then 5 equivalents of zinc perchlorate hexahydrate, to demonstrate their response 
upon zinc-binding.  
All of the sensors had a broad absorption band at 347 nm (obtained from UV-Vis 
spectroscopy), so this was determined as the wavelength of excitation for each to monitor 
the fluorescent response. The emission wavelength of each probe was also very close to 
that of the original ‘clickate’ probe 30 and its cyclen analogue 68, with λem values between 
400 and 420 nm.  
As Figure 3-4 demonstrates, each of the sensors responded to 1 equivalent of zinc with the 
expected switch-on fluorescent enhancement of between 2- and 4.5- fold with no 
significant blue or red shift seen in any of the emission profiles, and very little or no 
enhancement with 5 equivalents of zinc added. 
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The exception appears to be sensor 112, which showed a small decrease in fluorescence 
upon addition of excess zinc (Figure 3-5). However, despite the slight quenching, this effect 
was not investigated further as overall there was still a 3-fold fluorescence enhancement, 
and so this probe still generates a desirable response.  
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Figure 3-5 Fluorescence emission profile of sensor 112 (100 μM) in response to Zn
2+
 in MeCN 
A key part of this study was to ascertain the sensors’ response in an aqueous environment, 
both for a direct comparison to our previously synthesised sensors 30 and 68, and also to 
obtain information about these targeted probes under biologically relevant conditions.  
With the exception of 105 and 107 (vide infra), the probes 109, 112, 114 and 116 
responded as expected in 0.1 mM aqueous HEPES buffer (pH 7.4) upon excitation at the 
same wavelength (λex = 347 nm), demonstrating a similar, or in some cases enhanced, 
fluorescent enhancement in response to Zn2+ to that seen in organic media. For solubility 
purposes, the samples in HEPES buffer required a total 1% volume of DMSO, as this is also 
the most common solvent used to load other organic dyes onto cellular media with little to 
no toxicity. 
No results in aqueous solution were obtained with sensor 107, the IDA and didodecyl 
appended sensor designed for targeting the extracellular membrane. Despite the addition 
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of DMSO to aid solubility, the sensor precipitates in aqueous media upon the addition of 
zinc, therefore we were not able to collect data on its behaviour in HEPES buffer.  
Overall these results demonstrate that the switch-on response of these sensors to zinc has 
not been affected by the inclusion of a biological targeting group. 
3.2.4.2. Investigations into Anomalous Behaviour of Sensor 105 in Aqueous Media 
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Figure 3-6 Fluorescence response of sensor 105 (100 M) with increasing amounts of Zn
2+
 in aqueous buffer 
(0.1 mM HEPES, pH 7.4, ambient temperature, λex = 347 nm). 
 
Figure 3-4 and Figure 3-6 demonstrates the anomalous behaviour of sensor 105 in HEPES 
buffered water, where the addition of 5 equivalents of zinc produced a greater fluorescent 
response than 1 equivalent.  We decided to further investigate these observations to 
ascertain a reason for it.  
Addition of further equivalents of zinc(II) perchlorate resulted in further significant 
increases in the fluorescence emission of the probe, up to a maximum value of a 35 fold 
enhancement with 15 equivalents of zinc added (100 μM). This was also combined with a 
large red shift in the emission value; at 1 equivalent with a 5 fold increase we observed a 23 
nm red shift, and at 15 equivalents with a 35 fold increase we observed a red shift of 31 nm 
(Figure 3-7). 
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Figure 3-7 a) Fluorescence emission of sensor 105 with increasing amounts of Zn
2+
. b) The red shift in emission 
value upon addition of 1 equiv. of Zn
2+
 to sensor 105 
 
Alongside these results from fluorescence studies, there was a strong visual difference in 
the appearance of the samples to the naked eye. It was clearly evident that the addition of 
zinc to the samples of sensor decreased the turbidity of the samples (see Figure 3-8(a)), 
and that this decrease in turbidity corresponded to the increased fluorescence output 
(Figure 3-8(b)). This effect was still visible even at lower concentrations of 50 μm and even 
10 μm, with titrations also demonstrating a continual increase in fluorescence emission up 
to 15 equivalents of Zn2+ and a red shift in emission wavelength, as demonstrated by Figure 
3-7(a). However, the effect was very slightly diminished upon reduction of sample 
concentration. 
 
Figure 3-8 a) Samples of sensor 105 in HEPES buffered water (pH 7.4) with (L-R) 0, 1, 5 and 15 equivalents of 
Zn2+. b) the same samples illuminated with a UV-wavelength lamp to demonstrate their fluorescent output. 
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These observations suggested that sensor 105 was acting in a surfactant-like manner, with 
its structure bearing a lipophilic aliphatic tail and a polar metal binding head group, and we 
therefore hypothesised that the emission behaviour could be attributed to aggregation 
effects in aqueous solution. A similar photophysical response was observed for ZIMIR 22 
but not realised or noted by the authors, suggesting similar behaviour, which could account 
for its large reported dynamic range. 
Dynamic light scattering (DLS) experiments were performed to confirm the presence of 
aggregates, at a sensor concentration of 30 μm in HEPES buffer (1% DMSO). Sensor 105 
demonstrated aggregation phenomena in aqueous solution, as shown by the large particle 
size observed in these samples. The aggregates were at their largest with no Zn2+ present 
(Z-average diameter 773 nm). In the presence of Zn2+ the particle size decreased greatly (15 
equiv. Zn2+ Z-average diameter 247 nm), coinciding with an increase in fluorescence 
emission. These aggregates remained even when the concentration of the samples was 
dropped to 10 μm, although this phenomenon was not observed in MeCN solution. 
Structurally similar samples to 105, containing 116 with a different biological targeting unit, 
showed no significant aggregation. This was demonstrated by the low degree of scattering 
and poor signal quality by DLS, demonstrating the difference small structural changes can 
have on the behaviour of these probes.  
To further examine the behaviour of probe 105 and its apparent solvent dependency we 
investigated the effect of solvent composition on its fluorescence emission in both the 
presence and absence of zinc (Figure 3-9).177 We found that in the absence of zinc, as the 
volume of HEPES buffered water in MeCN was varied, there was little difference in the 
fluorescence output, albeit a small drop as the percentage of HEPES buffered water 
increased above 50% v/v. In the presence of 5 equivalents of zinc however, we observed a 
steady increase in fluorescence emission up to 60% v/v HEPES buffered water in MeCN, and 
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then a significant drop in the emission value after this point. This drop coincides with the 
observed red shift in fluorescence emission wavelength. This shows that the behaviour of 
this sensor can be attributed to a combination of PET quenching and aggregation-induced 
quenching.  
 
Figure 3-9 HEPES/MeCN titration of aggregating sensor 105 demonstrating both the change in fluorescence 
emission and red the shift of the emission wavelength upon increasing the percentage of HEPES in MeCN. 
 
It was possible that the binding of other metal ions could possibly influence aggregation 
significantly leading to a loss of selective Zn2+ sensing behaviour. Given the important role 
that aggregation plays in the performance of sensor 105 in vitro, we validated the 
selectivity of 105 for zinc ions. Pleasingly, only Cd2+ and Hg2+ produced a fluorescent 
response, which is to be expected based on previous studies using this particular ligand, 
and is not biologically relevant as the presence and interference of cadmium and mercury 
in living cells is negligible.178 All other metal ions tested led either to no change in 
fluorescent output or quenching of the background fluorescence. 
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Figure 3-10 Fluorescence response of sensor 105 (100 μm) in HEPES buffered water (1% DMSO) to 5 equivalents 
of metal cations (as the perchlorate salt) 
 
3.2.5. Determination of Kd values for sensors 109, 112, 114 and 116 
179 
Dissociation constants (Kd) were determined by non-linear regression analysis of titrated 
samples of sensors 109, 112, 114 and 116. Sensor 105 could not be evaluated due to the 
aggregation observed in aqueous media, and nor could sensor 107 due to the 
aforementioned precipitation upon addition of zinc. In the case of probes 112 and 114 that 
target the lysosome and mitochondria respectively, titrations were also performed at the 
relevant pH of the organelle. 
 
 
Equation 3-1 Equation for a 1:1 binding model of ligand (L) and metal (M) 
 
 
    
     
      
     
           
  
  
 
  
  
      
  
  
 
  
  
 
 
 
   
  
 
   
  
Equation 3-2 Equation used to determine Kd values for sensors 109, 112, 114 and 116 where CM and CL 
concentrations of Zn
2+
 and probe respectively, F is the observed fluorescence, F(0) is the observed fluorescence 
of the probe alone (i.e. CM = 0).  Non-linear regression analysis was used to determine F(max)/F(0) and Kd.
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Equation 3-3 Equation to demonstrate more complex equilibria for species potentially formed between ligand 
(L) and metal (M) in solution 
 
Titrations were carried out in HEPES buffered aqueous solution, by measuring the 
fluorescent output upon the addition of Zn2+. Assuming our sensors follow a simple 1:1 
binding model (Equation 3-1), by using Equation 3-2, the Kd of the four sensors was 
evaluated from the data obtained. Although reasonable values of Kd were obtained when 
compared to those reported for structurally similar ligands,22,163 the goodness of fit to a 1:1 
binding model varied considerably, as demonstrated in Figure 3-11.  
 
Figure 3-11 Representative examples of non-linear fitting of fluorescence titration data using Equation 3-2 for a) 
sensor 109 and b) sensor 112, demonstrating the varied goodness of fit to the model. 
 
The values obtained for probes 109, 112, 114, and 116 are shown in Table 3-1. It is of note 
that the value obtained for sensor 109 is a lower Kd value than that of the analogous 
‘Clickate’ probe 30, but we obtained a better goodness of fit in our calculations than those 
for sensor 30.72 
We observed poor fitting of sensors 112 and 114, and similar issues have recently been 
identified by Vögtle and co-workers in their investigations of dendrimeric cyclam sensors 
for Zn2+.180 This assumes that instead of the simple, one species model as approximated for 
these systems, there exists instead a series of complex equilibria of species where multiple 
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ligands can bind to the metal ion (Equation 3-3). Lippard and McQuade also observed 
similar characteristics with their Zn2+-specific probes QZ2E 29 and QZ2A, and were unable 
to obtain accurate binding constants, due to the unexplored nature of a complex equilibria 
of species in solution.62 
Attempts to try and obtain further data on these probes by 1H NMR spectroscopic studies 
were unsuccessful. Whilst we can speculate that our probes behave similarly, this was not 
further investigated as it would require extensive study and calculation to ascertain the 
reasons behind the observed data.  This was considered to be a separate study outside the 
scope of this thesis, as the main focus remained the successful demonstration of function 
and utility of the synthesised sensors in biological milieu. 
Table 3-1 Values for Kd and F(max)/F(0) obtained by non-linear regression analysis of sensors 109, 112, 114 and 
116. 
Sensor Kd (calculated) F(max)/F(0) R
2 Kd Lit. 
value72,163 
109 2.96 x10-6 (pH7.4) 4.3 0.9926 4.3 x 10-8 M-1 
112 2.13 x10-7 (pH 7.4) 
1.85 x10-7 (pH 7.8) 
3.1 
3.3 
0.7438 
0.7150 
4.3 x 10-8 M-1 
114 9.80 x10-8 (pH 7.4) 
1.38 x10-7 (pH 5.8) 
11.5 
10.0 
0.9223 
0.9019 
4.3 x 10-8 M-1 
116 2.12 x10-7 (pH 7.4) 2.6 0.6482 1.2 × 10-8 M-1 
 
3.2.6. In-cellulo Testing 
3.2.6.1. Introduction and Background to Cell Testing Work 
The biological trafficking of zinc has been strongly linked to type 2 diabetes associated with 
the pancreas.181–183 The release of insulin from pancreatic β-cells is associated with the 
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concomitant release of zinc from Zn2+-containing granules, which allows the changes in the 
concentration of Zn2+ on the exterior of the plasma membrane to be used as a proxy for the 
release of insulin.  This approach has been refined in recent work by Li and co-workers 
through the development of ZIMIR 22, a selective sensor for Zn2+ that utilises two dodecyl 
chains as a targeting group (Figure 3-12).50 The group demonstrated ZIMIR anchors on the 
extracellular face of the plasma membrane, and can be used to monitor the response of 
the pancreatic cells in releasing zinc to various stimuli with high spatial resolution. 
 
Figure 3-12 ZIMIR, an extracellular-membrane probe for Zn
2+
 and 105 .  
As Figure 3-12 demonstrates, the structure and in vitro behaviour of sensor 105 bears 
remarkable similarities to ZIMIR in that both:  i) possess a surfactant-like structure, which in 
the case of ZIMIR has been shown to localize the sensor to the extracellular face of the 
plasma membrane;  ii) display a large increase in fluorescence output in the presence of 
excess Zn2+ (70-fold in the case of ZIMIR, 35 fold in the case of sensor 27); and  iii) 
demonstrate selectivity for Zn2+ over other biologically available divalent metal ions.  
Given the utility of ZIMIR 22 in monitoring the stimulated efflux of zinc, we decided to 
evaluate probe 105 in cellulo in collaboration with Prof. Guy Rutter and Dr David Hodson, 
based at Imperial College and who worked on ZIMIR, to see if it displayed similar 
membrane targeting behaviour in pancreatic islet cells. We also decided to screen a 
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selection of the other sensors we synthesised for this study to validate our hypothesis and 
visualise the targeting capabilities of both our intra- and extra-cellular targeted fluorescent 
probes. 
As predicted in our in-vitro testing, sensor 107 was not viable for cell studies due to its 
immediate precipitation in physiological buffer (HEPES-bicarbonate buffer (120 mM NaCl, 
4.8 mM KCl, 24 mM NaHCO3, 0.5 mM Na2HPO4, 5 mM HEPES, 2.5 mM CaCl2 and 1.2 mM 
MgCl2) saturated with 95% O2/5% CO2 and adjusted to pH 7.4). Probe 116 was also not 
tested in this context as the glucose unit appended as the targeting group on the probe 
could stimulate random and unwanted zinc secretions from these types of pancreatic islet 
cells. Importantly, all of the other probes tested retained their ‘switch-on’ response 
towards Zn2+ in the physiological buffer, and so were deemed viable for loading onto cells.  
3.2.6.2. Testing of Sensor 105 [4] 
Sensor 105 (30 μm) was incubated with pancreatic islet cells for 1 h, which were then 
washed under a steady flow of biological buffer for the remainder of the experiment to 
remove unbound sensor. In order to overcome the less favourable absorption/emission 
profile of sensor 105 compared with ZIMIR 22 (λex
 = 493 nm, λem
 = 518 nm vs λex
 = 347 nm, 
λem
 = 443 nm), the cells were imaged using 2-photon excitation (λex
 = 850 nm), to visualise 
the distribution of the probe within the first few islet layers. Two-photon microscopy is fast 
becoming the imaging tool of choice, particularly at a sub-cellular level, as it allows for 
deeper imaging in tissues and cells and sharper imaging compared with conventional 
fluorescence microscopy.184 The low energy excitation wavelengths are also advantageous 
in minimising photobleaching and cellular damage, something which was particularly key 
                                                          
4
 Isolation of murine pancreatic islet cells, and MIN6 cells for toxicity studies, and all microscopy 
work was carried out by Dr David Hodson. JP assisted with the loading of probes onto pancreatic 
islet cells and making of solutions used, as well as observation of the epifluorescence studies on all 
probes tested. 
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for us using UV-excitatable naphthalimide fluorophores in our sensors. Two-photon 
microscopy allowed us to overcome any limitations of UV-bleaching when imaging the islet 
cells and allowed for longer imaging times with little cell damage.  
After incubation and irrigation with buffer, the imaging showed sensor 105 remained 
clearly localised on the cell surface, appearing to stain the plasma membrane in a manner 
similar to ZIMIR with little or no internalisation of the probe over the time scale of the 
experiment. (Figure 3-13a) This clearly demonstrates that 105 targets the extracellular 
membrane with our chosen targeting group.  
We also investigated the response of 105 to changes in the extracellular concentration of 
Zn2+ using fluorescence microscopy. Trivially, addition of extracellular Zn2+ led to an 
increase in fluorescence, to confirm the presence and localisation of 105 as anchored on 
the extracellular face of the plasma membrane (Figure 3-13b). More interestingly, when KCl 
was administered, to cause membrane depolarisation and concomitant release of insulin 
and Zn2+ into the extracellular space, sensor 105 exhibited a strong fluorescence response 
(Figure 3-13c and d) in a manner similar to that previously observed with ZIMIR, and the 
epifluorescence images in Figure 3-13d clearly demonstrate the success and intensity of the 
‘switch-on’ response in-cellulo. Using glucose as a stimulus for the cell also gave a 
moderate response, but still a definite ‘switch-on’ visible by microscopy. Therefore these 
results suggest that not only does readily available sensor 105 successfully localise on the 
extracellular membrane, but it could also be used to map the release of insulin at the 
cellular level.  
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Figure 3-13 Fluorescence study of primary mouse islets of Langerhans incubated for 1 h with 105 (30 M). a) 
Two photon image (λex = 850 nm, λem = 400-550 nm, max z-projection 80-100 μm); Response of sensor 105 over 
time to exogenous b) 10 μM ZnCl2 and c) 20 mM KCl measured by epifluorescence microscopy. d) 
Epifluorescence images demonstrating the response to Zn
2+
 co-released with insulin from dense core secretory 
granules after stimulation with KCl (20 mM) 
 
Intriguingly, when the same experiment was attempted with sensor 109, despite the 
structurally similarity to sensor 105 (polar metal binding unit, lipophilic tail), no increased 
fluorescence response in the cell membrane was observed, which once again demonstrates 
the unpredictable behaviour of designed probes in biological settings, and highlights the 
need to be able to rapidly modify probe structures at any stage of a study. 
3.2.6.3. Testing of Probes 112 and 114 
We also investigated the in cellulo behaviour of probe 112, appended with a 
triphenylphosphonium ion for targeting mitochondrial space, in the same manner as probe 
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105. As Figure 3-14a clearly shows, the qualitative appearance of the two photon 
microscopy image is not only distinctly different to that of sensor 105 (Figure 3-13a), but 
demonstrates a stippled, internalised appearance commonly seen with mitochondrial 
stains. Epifluorescence imaging using cell stimuli (both exogenous ZnCl2 and KCl to fully 
depolarise the membrane) clearly demonstrate a lack of response of the probe to 
extracellular events (Figure 3-14c). To further confirm its internalisation into cell 
compartments, using pyrithione to compromise the cell membrane and additional ZnCl2 we 
were able to visualise a significant increase in fluorescence (Figure 3-14d). 
The two photon microscopy imaging of probe 114, appended with the ethylenediamine 
unit to localise the probe into lysosomal compartments, was also carried out. Figure 3-14b 
shows that whilst 114 also displayed an extranuclear localisation with a punctate 
appearance, consistent with its presence in or on intracellular organelles, the appearance 
of islets incubated with sensor 114 is qualitatively different to those incubated with 
mitochondria targeted probe 112, with 114 localised in larger bodies. In a similar manner, it 
also demonstrated no response to extracellular stimuli during epifluoresence imaging, and 
a significant ‘switch-on’ response upon administration of pyrithione and ZnCl2 to the islets. 
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Figure 3-14 Fluorescence study of primary mouse islets of Langerhans incubated for 1 h with 112 (30 M) and 
114 (300 M). Two photon image (λex = 850 nm, λem = 400-550 nm, max z-projection 80-100 μm) of a) 112 and 
b) 114. Response of sensor 112 over time to exogenous c) 10 μM ZnCl2 and 20 mM KCl, and d) 5 μm pyrithione 
co-administered with 100μm ZnCl2, measured by epifluorescence microscopy. 
 
3.2.6.4. Co-localisation and Cytotoxicity Studies of Probes 105, 112 and 114 
The selective and differential localisation of 112 and 114 in the cell was confirmed by co-
localisation with Mitotracker and Lysotracker respectively (Figure 3-15c). Both are 
commercially available dyes commonly used in cell staining for their respective organelles, 
and we observed efficient co-localisation, as demonstrated by the correlation co-efficients 
obtained. The very strong correlation of 112 and 114 with their respective stains is a clear 
indicator of successful localisation of our probes in the intended compartments of the cell. 
Finally, we were also able to show that none of the probes were cytotoxic as incubation of 
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mouse islets with probes 105, 112 and 114 does not significantly induce cell death 
(necrosis) compared to DMSO alone (Figure 3-15a and b).  
 
Figure 3-15 Cytotoxicity and co-localisation assays for probes 105, 112 and 114. a) Incubation of mouse islets 
with probes 105, 112 and 114 does not significantly induce cell death (necrosis) versus DMSO-alone (1:333) (NS, 
non-significant; P<0.54). b)  Representative images showing calcein and PI staining in islets treated with DMSO 
and probes 105, 112 and 114. Below is a positive control (Triton X-100; to permeabilise the membrane). c) 
Statistical analysis of probe localisation with Mitotracker and Lysotracker.  
 
3.3. Conclusions and Future Work 
These results clearly show that the one-pot iterative method can be used to synthesise 
fluorescent sensors efficiently and rapidly, by utilising biological targeting groups bearing 
either an azide or an alkyne with central building blocks 69 or 70 respectively, and metal 
binding ligands incorporating an alkyne moiety. All six successful sensors were isolated in 
good to excellent yields over three steps that correspond to an average of 85-92% for each 
chemical step. We anticipate that this approach will significantly accelerate the 
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development of probes for application in biological systems, as the units and the probes as 
a whole are accessible in a synthetically flexible and expedient manner.  
The importance of ease of synthesis in order to overcome the difficulties associated with 
their unpredictable behaviour in cellulo was inadvertently exemplified through the 
different responses of 105, 107 and 109, all of which were originally designed for staining 
the plasma membrane in biological systems.  
Testing of sensors 105, 112 and 114 bearing different targeting units in pancreatic islet cells 
demonstrated not only their differential localisation but also their divergent responses to 
extracellular stimuli, suggestive of applications in the study of Zn2+ trafficking in the 
subcellular space. In particular, sensor 105 successfully allowed us to monitor insulin 
release in vitro in living pancreatic islet cells, using Zn2+ as a proxy, in a manner analogous 
to ZIMIR 22 but with the advantage of being significantly less challenging to prepare and 
showing improved dynamic range in cellulo. This is suggestive of great potential for probes 
like ours in the high resolution imaging of insulin secretion, an important goal in the study 
of diabetes. We believe our modular synthetic approach will facilitate the future 
optimisation and application of targeted Zn2+ sensors for biology, allowing the manufacture 
of tailor-made probes, such as 105, with applicability for the study of Zn2+-signalling and 
insulin exocytosis.  
Often chemosensors that have been developed for sensing are very specific for the cation 
they intend to probe, and cannot be readily modified to sense other analytes. As a future 
application, our approach potentially allows us to expand the scope of cation sensing and 
incorporate other ligands with known specific affinity for other metals and incorporate 
those into our scaffolds to readily create other new sensors for toxic metals and other 
biologically relevant species. The same could also be said for expanding the scope of 
targeting group, to include small molecules to target synapses and neurotransmitters, or 
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even short peptide sequences known to interact with specific proteins or with specific cell 
types.  
It would also be of interest to investigate the behaviour of the glucose appended sensor 
116 in cellulo. It is known that cancerous cells overexpress lectins on their surface that 
partake in known interactions with carbohydrates, and the ability to target these lectins 
could allow for facile and specific imaging of cancerous cells,59 particularly those associated 
with prostate cancer, a disease that zinc is known to be implicated in. In a similar manner 
to the work carried out by Scanlan and co-workers,59 our methodology would allow for the 
rapid synthesis of a library of probes with mono and di-saccharides intended to target 
these cells for imaging purposes.  
The blue-emission characteristics of these probes can additionally allow for multicolour 
imaging of a cell when used alongside other alternative cell stains for different 
compartments, and collaborations are currently ongoing towards this aim. Ultimately, the 
ease of this synthetic route could help to overcome many barriers currently being faced by 
cell biologists in the field of imaging of cells and organelles in many disease states 
associated with zinc.  
 
 
 
 
  
 
116 
 
Chapter 4: Chapter 4 Header 
 
4.1. Introduction to Rotaxanes 
A rotaxane, specifically a [2]rotaxane, is an interlocked structure consisting of a ring shaped 
molecule, known as a macrocycle, threaded onto a dumbbell shaped molecule known as a 
thread. This type of structure allows the macrocycle to move freely across the thread 
without slipping off at the ends, as the ends of the thread act as stoppers to prevent this. 
The two components are not covalently linked, but their separation would require the 
breaking of a covalent bond in the structure. Rotaxanes with more than two components, 
for example with two macrocycles on one thread, are known as [3]rotaxanes; and so with n 
components, these types of supramolecular structures are [n]rotaxanes (Figure 4-1). 
 
Figure 4-1 Representation of a) a thread and its corresponding b) [2]rotaxane and c) [3]rotaxane 
4.2. Synthesis of Rotaxanes 
One of the first accounts of rotaxane formation in 1967 relied on the statistical probability 
that in the presence of a macrocycle, the joining of two half thread components would 
occur through the ring (Scheme 4-1). 185 Whilst this gave a 6% yield of the interlocked 
structure 119, the methodology was cumbersome and inefficient; clearly unreliable for a 
desired high-yielding synthesis.  
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Scheme 4-1 [2]Rotaxane 119 as synthesised by Harrison and Harrison in 1967. Conditions: i) Decane-1,10-diol, 
pyridine/DMF/toluene, 70 repetitions, followed by resin removal from macrocycle.  
 
The development of the ‘Passive Template’ methodology pioneered by Sauvage and co-
workers made the synthesis of interlocked molecules much easier.186 In this approach the 
components are pre-arranged by a template before formation of the final covalent bond to 
form the interlocked structure. In the case of [2]rotaxane formation, this commonly 
involves one of two methods: 187 
a) Stoppering or capping, the threading of a molecule through the macrocycle cavity and 
then stoppering either end of the thread; 
b) Clipping, the formation (closing) of a macrocycle from its precursor around the pre-
formed stoppered thread.  
 
Figure 4-2 Representation of the stoppering and clipping methods of forming [2]rotaxanes 
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This pre-arrangement can be mediated by templates such as hydrogen bonding, 
electrostatic interactions, halogen bonding, and can also be metal mediated. In these 
instances, the metal used merely acts as an aid to pre-arrangement of the components. Its 
inherent reactivity is ignored and unused for the subsequent covalent bond formation to 
yield the final interlocked product. 
4.3. Active Template Methodology of [2]Rotaxane Synthesis 
The active template methodology was first reported by the Leigh group, and this has greatly 
facilitated access to structures like rotaxanes, catenanes and other interlocked 
structures.187–189 This approach uses transition metal-catalysed reactions such as Pd-
catalysed Heck reactions, and the CuAAC reaction to both template the formation and 
catalyse the joining of the half-thread components together to successfully form rotaxanes 
(Figure 4-3). This offered many advantages to the passive template methods. These 
methods can provide shorter reaction times and an operationally-simple synthesis, only use 
sub-stoichiometric amounts of the metal which effectively acts as a traceless mediator of 
formation, and allow for higher molecular diversity not previously possible with passive 
template components due to a need for recognition sites for the template.  
 
Figure 4-3 Representation of the metal-mediated active template synthesis to form [2]rotaxanes. 
The first active template-CuAAC (AT-CuAAC) for the formation of [2]rotaxanes was reported 
in 2006 (Scheme 4-2)190 and since then has provided access to many novel rotaxanes, 
catenanes and molecular machines with varying properties and function. However, these 
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reactions employed large macrocycles, and therefore bulky half threads to form rotaxanes 
such as 120, limiting the architectures that could be accessed and their diversity.  
 
Scheme 4-2 AT-CuAAC synthesis from Leigh and co-workers to synthesise [2]rotaxane 120 
 
More recently, the Goldup group reported the use of small macrocycles with small half 
threads as stoppers, such as 122 and 123 to synthesise [2]rotaxanes with the highest 
yielding AT synthesis to date.191 As with all CuAAC reactions, this readily allows for the 
synthesis of supramolecular constructs with high molecular diversity, and the structures 
obtained can be easily modified to investigate and facilitate novel functions and 
applications.192 A particular highlight was the serendipitous isolation and characterisation of 
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an interlocked Cu(I) triazolide 124, sterically protected by the crowded nature of these 
small rotaxanes which was found to be very stable.193 This was the second time the 
triazolide intermediate had been observed, and the first time it was isolated from a direct 
CuAAC reaction, and is an example of how active template synthesis can help in the 
elucidation of key steps and intermediates in transition metal-catalysed reactions.  
 
Scheme 4-3 Synthesis of Cu-triazolide 124 by Goldup and co-workers 
 
4.4. Rotaxanes as Fluorescent Sensors 
There are many examples of luminescent rotaxanes in the literature. Their interesting 
features and properties come from the restricted motion of the components of the 
rotaxanes; the mechanical motions of a shuttling and pirouetting macrocycle can alter the 
photophysical properties of these molecules in relation to their non-interlocked 
components, and means these types of molecules can be used as chemosensors for 
recognition of binding events.  
 
Figure 4-4 Representation of pirouetting and shuttling of a macrocycle on a [2]rotaxane. 
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Perhaps the most popular use for rotaxanes as chemosensors are those used as anion 
detection systems. Generally these systems are synthesised by passive anion-templated 
methods, and working examples have been reported and summarised in excellent reviews 
by Beer and co-workers,194,195 and Ma et al..196 
 
Figure 4-5 Anion-sensing [2]rotaxanes 125–127, and [3]rotaxane 128. 
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Some interesting examples are shown in Figure 4-5, incorporating commonly available 
organic luminescent units that work effectively to aid selective sensing of the desired anion, 
such as naphthalenes,197 squaraines,198 naphthalimides 199 and additional lanthanide 
motifs.200  
In contrast, there are limited examples of rotaxanes which elicit a photophysical response 
based on cationic guest/host interactions. One of the earliest examples is from 1996, when 
Swager and co-workers presented a polyrotaxane polymer 129, in which the binding of Cu+ 
resulted in greater conductivity of the polymer and a red-shift of the UV-Vis absorption, 
rendering the polymer a successful Cu+ sensor in CH2Cl2. 
201 
 
 
Figure 4-6 Cu
+
 binding polyrotaxane synthesised by Swager and co-workers. 
 
Hiratani and co-workers synthesised a [1]rotaxane 130 stoppered by an anthracene group, 
in which the binding of Li+ in CH2Cl2/MeCN (9:1) selectively induced a conformational 
change in the position of the anthracene group to the macrocycle, resulting in a greater 
energy transfer from macrocycle to fluorophore and chelation enhanced fluorescence 
(CHEF). 202 The binding was monitored by fluorescence spectroscopy with a broad emission 
band centred around 420 nm (Figure 4-7).  
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Figure 4-7  Anthracene-appended [1]rotaxane 130 and its emission spectra in the presence of analytes tested. 
Image reproduced with permission from Journal of the American Chemical Society, 2004, 126, p 13568 - 13569. 
Copyright © 2004 American Chemical Society b) [3]rotaxane 131 and its binding mode with Cs
+
 
 
The same group also synthesised a [3]rotaxane 131 as shown in Figure 4-7, with anthracene 
groups again, this time as appended stoppers on the two-macrocycle system. 203 They 
observed when binding to Li+, two cations ions were incorporated into the [3]rotaxane, but 
in the case of Cs+ 1:1 binding with the [3]rotaxane was observed (figure 4-7). They proposed 
that the Cs+ ion encouraged a change in orientation of both macrocycles to form a sandwich 
complex with the cation, and confirm this by NOESY NMR spectroscopy and mass 
spectrometry. The addition of Cs+ and the conformational change also induced CHEF which 
was observed by fluorescence spectroscopy, with excitation at 285 nm. 
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Li et al. synthesised a fluorescent switchable [2]rotaxane 132 with two different recognition 
sites on the thread, an amide and an amine.204 The addition of acid and base causes the 
macrocycle to shuttle between the two stations, as did the addition of either Li+ or Zn2+. The 
fluorescence output of the anthracene moiety on the thread is dependent on the motion 
and station choice of the macrocycle. In the case of Li+, the fluorescence of the [2]rotaxane 
is weak as the macrocycle binds and sits at the amide station, so the amine is available to 
participate in PET quenching of the anthracene stopper (132[Li], Scheme 4-4). Binding of 
Zn2+ both displaces the Li+ ion and results in the shuttling of the macrocycle to the amine 
station (132[Zn]), resulting in enhanced fluorescence of anthracene by eliminating PET 
quenching (λex 132[Zn] 370nm, λem 132[Zn] max 422nm). 
 
Scheme 4-4 [2]Rotaxane 132 by Li et al. and its shuttling modes with Li and Zn. 
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More recently, Smith and co-workers reported the synthesis and testing of squaraine 
rotaxane endoperoxides such as 133, with sites for metal chelation and their response to 
metal cations.205 Whilst the rotaxanes are not selective for a particular metal, the binding of 
Co2+, Zn2+ and Ni2+ at the appended dipicolylamine binding sites on the thread induced 
quenching of the observed fluorescence of the rotaxane in MeCN (Figure 4-8, (a) and (b)).  
       
Figure 4-8 Squaraine endoperoxide rotaxane 133, and its a) absorption and b) emission spectra in the presence 
of Zn
2+
. Images reproduced with permission from Taylor & Francis.
205
 Copyright © 2012, Taylor & Francis. 
 
4.5. Aims for This Project 
Whilst each of these systems has interesting properties, it is of note that all of them suffer 
with difficult and low yielding syntheses. They also often require mixtures of solvent due to 
solubility issues of such large structures. Additionally, as AT-CuAAC methodology could 
allow for the incorporation of a fluorescent unit into related structures this could provide a 
facile route into novel mechanically chelating rotaxane ligands, perhaps with the ideal 
optical properties to act as sensors.  
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Previously, when reporting the investigation into smaller [2]rotaxanes, the Goldup group 
synthesised a novel fluorescent rotaxane 134 incorporating a naphthalimide unit as one of 
the half-threads to demonstrate the utility of the synthesis and the smaller macrocycles.191 
The naphthalimide was shown to act as an efficient bulky stopper which prevented de-
threading. 
 
Figure 4-9 Naphthalimide [2]rotaxane 134 synthesised by Goldup and co-workers. 
The incorporated bipyridine macrocycle is non fluorescent but is known to be able to act as 
a ligand for metal cations inside the rotaxane cavity, demonstrated in particular by the 
active template methodology used to synthesise the rotaxanes. We therefore anticipated 
that the rotaxane may be able to function as a sensor for metals via the unique movements 
of the macrocycle and perhaps a charge transfer mechanism from the macrocycle to the 
fluorophore during a signalling event. We aimed to investigate the capability of these 
systems for sensing metals, and ideally with Zn2+ in particular considering our previously 
demonstrated success in this field.72,156 We also wanted to utilise the modularity of the AT-
CuAAC to synthesise novel fluorescent rotaxanes with modified naphthalimide fluorophores 
to hopefully induce selectivity and a desirable ‘off-on’ response as a Zn2+ chemosensor, 
without perturbing the binding abilities of the macrocycle. 
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4.6. Preliminary Work 206 
Preliminary studies within our group focused on the photophysical properties of rotaxanes 
134 and 137 in MeCN (Scheme 4-5). The synthesis was found to be very straightforward, 
with both the macrocycle 136 and half thread components 64, 122 and 123 known in the 
literature. The alkyne-bearing fluorescent half thread 135 was synthesised in two steps in 
good yield, following a Sonogashira coupling of trimethylsilyl acetylene and bromo-
naphthalimide 63, and the subsequent removal of the TMS group with K2CO3. Using one 
equivalent of each respective half thread and macrocycle, 0.96 equivalents of Cu(I) and 
heating for 72 h in CH2Cl2 gave the desired rotaxane 134 and 137 in 99% and 91% yield 
respectively.  
 
Scheme 4-5 Synthesis of rotaxanes 134 and 137. Conditions: [Cu(MeCN)4]PF6 , CH2Cl2, reflux 72 h, 99% (134), 
91% (137). 
 
Rotaxane 134 displayed an absorption at 344 nm in MeCN. Interestingly we observed two 
fluorescence emissions at 430 and 553 nm. Monitoring the binding of Zn2+ to the rotaxane 
clearly demonstrated a quenching effect of the metal binding event on the observed 
fluorescence of the more intense second band (Figure 4-10, (a)). In contrast the thread on 
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its own demonstrates no binding of zinc by both fluorescence and UV, and only has a single 
observed emission (Figure 4-10, (b)).  
We thus tentatively attributed the second emission band to energy transfer between the 
aromatic groups on the macrocycle and the fluorophore upon excitation; i.e. exciplex 
formation. The metal binding in the macrocycle cavity presumably perturbs this interaction, 
causing a breakdown of the exciplex.207,208  
 
Figure 4-10 a) Fluorescence emission spectra of rotaxane 134 in MeCN titrated with increasing amounts of Zn
2+
. 
b) Emission spectra of the thread component only in the absence and presence of Zn
2+
. c) Emission spectra of 
rotaxane 134 in the presence of other metals, in MeCN. 
 
Unfortunately this observed quenching of emission was not unique to Zn2+, and we found 
that a range of biologically relevant metal ions induced the same quenching effect (Figure 
4-10 (c)), rendering this rotaxane ineffective as a chemosensor. 
In the case of rotaxane 137, despite the only difference in structure being the orientation of 
the triazole, the system displays a single emission. Upon excitation at 381 nm in MeCN, the 
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emission is centred at λmax 465nm. Interestingly, the emission increases at first, and is then 
quenched after the addition of 0.3 equivalents of Zn2+, with a hypsochromic shift to 455 nm 
in emission. Overall this corresponds to a ‘switch-off’ response to Zn2+ with a blue shift in 
emission. The thread demonstrates no significant response to Zn2+, again confirming the 
need for the interlocked structure form cation binding. As with rotaxane 134, this response 
is not limited to Zn2+ (Figure 4-11).  
 
Figure 4-11 a) Fluorescence emission spectra of rotaxane 137 in MeCN titrated with increasing amounts of Zn
2+
. 
b) Emission spectra of the thread component only in the absence and presence of Zn
2+
. c) Emission spectra of 
rotaxane 137 in the presence of other metals, in MeCN. 
 
4.7. Results and Discussion 
4.7.1. Designing Modified Fluorescent Rotaxanes 
The studies on rotaxanes 134 and 137 and their observed lack of selectivity led to a 
redesign in strategy. It is well known that the substitution at the 4-position of a 
naphthalimide fluorophore dictates the absorption and emission profile of these dyes, and 
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we felt we could utilise this to tune the optical output and aid the development of a cation-
selective rotaxane. 
 
 
Figure 4-12 Proposed points of modification on a [2]rotaxane that will both lengthen the thread and incorporate 
an additional stoppering moiety 
 
Figure 4-12 demonstrates our proposed points of modification. To incorporate an 
alternative substitution at the 4-position of the fluorescent half thread, an extra linker 
needed to be incorporated, thereby increasing the overall thread length. Recent work in 
the Goldup group has shown that in the case of more flexible threads, the ethyl-
naphthalimide fluorophore is unable to prevent the macrocycle escaping the interlocked 
system. For this reason we decided to replace the ethylamine group with a 2,2-diphenyl 
ethylamine group. 
4.7.2. Additional Stoppering of Rotaxanes 
To confirm the incorporation of a 2,2-diphenyl ethylamine group at the imide position did 
not greatly affect the behaviour of the rotaxane, we first synthesised rotaxane 140, an 
analogue of 137 with the additional stoppering group incorporated. 
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Scheme 4-6 Synthesis of half thread 139 incorporating the new 2,2-diphenyl ethylamine stopper. Conditions: i) 
EtOH, reflux 18 h, 97% ii) NaN3, NMP, rt 24 h, 59%.  
The fluorescent half thread was synthesised in an analogous manner to half thread 64. 
After refluxing the naphthalic anhydride with diphenyl ethylamine in EtOH, the bromide 
138 was obtained in quantitative yield. Stirring with NaN3 in NMP at room temperature for 
24 hours gave the azide half thread 139 in 59% yield after purification. Following a modified 
rotaxanation procedure,193 the corresponding rotaxane was obtained in 88% yield following 
purification by column chromatography. 
 
Scheme 4-7 Synthesis of rotaxane 140. Conditions: [Cu(MeCN)4]PF6  i(0.96 eq.), DIPEA (1 eq.), EtOH, rt, 16 h 
 
Fluorescence spectroscopy studies on rotaxane 140 indicated the behaviour in MeCN in 
response to Zn2+ was analogous to that of 134. The same dual band emission was observed, 
with the second more intense band being quenched upon addition up to 1 equivalent of 
Zn2+, and remaining at a plateau as increasing equivalents were added.  Similarly Rotaxane 
140 failed to display any selectivity for first row biologically relevant transition metals or 
Cd2+. 
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Figure 4-13 a) Fluorescence emission spectra of rotaxane 140 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Emission spectra of rotaxane 140 in the presence of other metals (5 equiv.) in MeCN. 
 
Satisfied that the addition of the diphenyl stopper did not affect the binding behaviour and 
fluorescent profile of the rotaxanes, we could now study the effects of additional 
modifications of the fluorescent half-thread on the behaviour and selectivity of these 
rotaxane scaffolds. 
4.7.3.  Incorporation of Heteroatoms into the Fluorescent Half Thread 
It is well known that the incorporation of heteroatoms, in particular at the 4-position of 
naphthalimide fluorophores, introduces an electron donation site, and so gives rise to 
highly emissive compounds. It was also hypothesised this extra potential co-cordination site 
for metals could help to induce selectivity, in the case of a 4-amino or 4-thio-naphthalimide. 
The desired half threads are demonstrated in Figure 4-14, incorporating an amine, amide 
and thio-ethanol derived group as shown. 
 
Figure 4-14 New half threads 141-143 designed to incorporate heteroatoms into the rotaxane thread. 
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4.7.4. Synthesis of Azide Half Threads 141-143 
The synthetic route to the amino- and thio-ethanol derived 141 and 143 was identical. 
Heating bromide 138 in DMSO for 16 h with 2-aminoethanol or 2-mercaptoethanol under 
basic conditions gave the alcohol intermediates in good yields. Following this, the alcohol 
was transformed to the azide-furnished half thread using diphenylphosphoryl azide in a 
Mitsunobu-type reaction. 
 
Scheme 4-8 Synthesis of half threads 141 and 143. Conditions: i) 2-aminoethanol or 2-thioethanol, Cu2O, K2CO3, 
DMSO, 80 °C, 16 h. ii) PPh3, DEAD, diphenylphosphoryl azide, 0 °C, 2 h. 
The amide-containing half thread 142 proved to be more challenging to synthesise. Starting 
from the 4-nitro naphthalic anhydride 146, formation of the imide with diphenyl 
ethylamine was trivial, but the subsequent reduction to the 4-amino naphthalimide 148 
was limited by the solubility of the nitro-compound 147. A reduction using palladium-on-
carbon in a 1:1 mixture of EtOAc/MeOH proved successful, with good yields of 148 
obtained without the need for purification. Amide formation using chloroacetyl chloride 
was quantitative, and subsequent displacement of the chloride with an azide using NaN3 
gave half thread 142 in 84% yield.  
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Scheme 4-9 Synthesis of half thread 142. Conditions: i) EtOH, reflux, 16 h, 86%.  ii) Pd/C (10 mol%), 
EtOAc/MeOH (1:1), rt, 4 h, 97%. iii) 2-chloroacetyl chloride, DMAP, THF, 0 °C to rt, 6 h, 98%. iv) NaN3, DMF, rt, 
24 h, 84%. 
4.7.5. Rotaxane Synthesis and Testing 
4.7.5.1. Amine-functionalised Rotaxane 
Using the same conditions as in Scheme 4-7 for the synthesis of rotaxane 140, amine-
containing rotaxane 150 was synthesised from half thread 141, 3,5-di-tert-butyl 
phenylacetylene and macrocycle 136 in 72% yield after purification (Scheme 4-9).   
 
Scheme 4-10 Synthesis of rotaxane 150. Conditions: [Cu(MeCN)4]PF6  i(0.96 eq.), DIPEA (1 eq.), EtOH, rt, 16 h 
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Figure 4-15 Partial 400 MHz 1H NMR spectra of a) macrocycle 136, b) thread 151 and c) rotaxane 150 in CDCl3. 
Assignments as indicated in Section 5.3 
 
Rotaxane 150 was identified as the most emissive of the rotaxanes synthesised with an 
intense yellow colour in solution, due to the electron donating nature of the 4-amino 
substitution pattern on the naphthalimide. A simple titration with zinc perchlorate showed 
the fluorescence was quenched upon addition of Zn2+. The emission spectrum 
demonstrates a small hypsochromic shift in emission wavelength, from 510 nm for the free 
rotaxane, to 500 nm when bound with Zn2+, indicating a binding interaction of the amine 
moiety. The UV absorption profile demonstrates a similar blue-shift from 440 nm to 420 
nm.  
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Figure 4-16 a) UV-Vis absorption spectra of samples of rotaxane 150 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Fluorescence mission spectra of samples of rotaxane 150 in MeCN titrated with increasing 
amounts of Zn
2+
. 
The emergence of 2 sharp bands at 314 nm and 322 nm, increasing with binding of Zn2+ to 
rotaxane 150 is clearly observed in the absorption profile (Figure 4-16), however, a UV-Vis 
spectroscopic titration of the macrocycle 136 on its own with Zn2+ shows the same emission 
bands, indicating the absorptions are due to the binding of metal to the bipyridine moiety. 
 
Figure 4-17 UV-Vis absorption spectra of samples of macrocycle 136 (100 μM) in MeCN in the absence (black) 
and presence (red) of 5 equiv. Zn
2+
. 
This binding can also be observed by 1H NMR spectroscopy. It is interesting to note that 
whilst the triazole peak in these interlocked systems is generally shifted significantly 
downfield due to hydrogen bonding effects with the bipyridine macrocycle, in this system 
the triazole peak is restored to its expected shift position in the aromatic region of the 
spectrum analogous to the thread (see Figure 4-15). We hypothesise this to be due to the 
macrocycle hydrogen bonding at the amine position on the thread. Upon addition of Zn2+ to 
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the rotaxane, the shift and broadening of the bipyridine macrocycle signals is clearly 
evident, as is the shift of the triazole peak to 5.7 ppm (Figure 4-18). This indicates shuttling 
of the macrocycle away from the amine position on the thread, thus potentially disrupting 
any previous interaction between the macrocycle and naphthalimide component.  
 
Figure 4-18 Partial 400 MHz 1H NMR spectra of a) rotaxane 150 in the presence of Zn
2+
 and b) rotaxane 150 in 
d-MeCN. Assignments as indicated in Section 5.3. 
These observed characteristics could account for the ‘on-off’ behaviour observed by 
fluorescence spectroscopy upon binding. We can hypothesise that in the free rotaxane, the 
proposed hydrogen bonding with the amine moiety on the thread could help to stabilise 
the excited state of the molecule, accounting for the brightness. Upon binding, the 
movement of the macrocycle destabilises the excited state, thus altering the optical output. 
The thread 151 on its own, as expected, displays no significant spectral changes to indicate 
any binding, thus affirming the need for the interlocked structure to display these changes 
in absorption and emission spectra. 
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Figure 4-19 a) UV-Vis absorption spectra of samples of thread 151 (100 μM) in MeCN in the presence and 
absence of Zn
2+
. b) 
 
Fluorescence mission spectra of samples of thread in MeCN in the presence and absence of 
Zn
2+
. 
Despite these properties, a screen of metals indicates rotaxane 150 also displays a lack of 
selectivity upon addition of 5 equivalents of each metal.  Group 1 and 2 alkali and alkali 
earth metals appear not to bind to the rotaxane scaffold as no response is obtained.  
Interestingly, both Mn2+ and Hg2+ displays a similar profile to 140, also perhaps indicating no 
binding.  All other first-row transition metals, and Cd2+ display the same quenching 
behaviour as Zn2+, but to differing extents (Figure 4-20).  
 
Figure 4-20 Fluorescence emission (F/F0) of samples of rotaxane 150 (100 μM) in the presence of 5 equiv. of 
different metals. 
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4.7.5.2. Amide-functionalised Rotaxane 
 
Scheme 4-11 Synthesis of rotaxane 152. Conditions: [Cu(MeCN)4]PF6  i(0.96 eq.), DIPEA (1 eq.), EtOH, rt, 16 h 
 
 
Figure 4-21 Partial 400 MHz 1H NMR spectra of a) macrocycle 136, b) thread 153 and c) rotaxane 152 in CDCl3. 
Assignments as indicated in Section 5.3. 
 
Amide functionalised rotaxane 152 was synthesised and tested in an analogous manner. 
152 was synthesised in 61% yield under the same conditions, using half thread 142. The 
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absorption spectra of a basic titration with increasing equivalents of Zn2+ displayed a 
decrease in a broad absorption band centred around 378 nm, and a concomitant increase 
in absorption at 350 nm, with an isosbestic point at 361 nm. The same absorption bands for 
the bipyridine binding are observed at 310 nm and 318 nm, indicating binding inside the 
rotaxane scaffold. 
When its fluorescence spectrum was measured, exciting the samples at the wavelength of 
the isosbestic point (361 nm), an interesting response was observed which was comparable 
to that of rotaxane 137, with an initial increase in emission, along with a blue shift, followed 
by an incremental decrease in emission and a further blue shift.  Overall, this contributes to 
a slight ‘switch-on’ response, with a significant blue shift of 20 nm from 450 nm (no Zn2+) to 
430 nm (5 equiv. Zn2+). Emission spectra obtained by exciting at the other notable 
wavelengths from the excitation spectra (351 nm and 378 nm) show similar characteristics 
(Figure 4-22). 
Chapter 4 Header 
 
 
141 
 
 
Figure 4-22 a) UV-Vis absorption spectra of samples of rotaxane 152 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Fluorescence mission spectra of samples of rotaxane 152 in MeCN titrated with increasing 
amounts of Zn
2+
 (λex 361 nm (isosbestic point)). c) as (b), λex 351 nm. d) as (b), λex 378 nm. 
Analysis of rotaxane 152 by 1H NMR spectroscopy in the absence and presence of Zn2+ in 
MeCN clearly demonstrates the binding of Zn2+ to the rotaxane, as observed by the 
broadening of the bipyridine macrocycle signals at 6.5 and 6.8 ppm. In a similar manner to 
rotaxane 150, the triazole signal in the free rotaxane is observed in the aromatic region, 
whilst the NH proton of the amide group is observed at 10.6 ppm. This indicates a potential 
hydrogen bonding interaction between the macrocycle and the amide station on the thread 
in the free rotaxane. Upon binding of zinc, the macrocycle appears to shuttle to the triazole 
station, restoring the amide signal to 9.9 ppm. The equivalent 1H NMR spectrum of the non-
interlocked thread component shows the triazole proton present at 7.95 ppm, and also the 
amide NH signal at ~9.5 ppm (Figure 4-21).  
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Figure 4-23 Partial 400 MHz 1H NMR spectra of a) rotaxane 152 in the presence of Zn
2+
 and b) rotaxane 152 in 
d-MeCN. Assignments as indicated in Section 5.3. 
The triazole proton also moves upfield to 6.1 ppm, as observed with the previous 
rotaxanes. We also see a shift of the α-CH2 on the thread between the amide and triazole 
from 4.9 to 4.6 ppm, indicating a change in interaction inside the interlocked molecule 
(Figure 4-23). Both absorption and emission spectra of the thread alone, which is more 
emissive than the interlocked component at the same concentration, demonstrate no 
changes in their spectra upon addition of Zn2+, indicating no metal binding.  
 
Figure 4-24 a) UV-Vis absorption spectra of samples of thread 153 (100 μM) in MeCN in the presence and 
absence of Zn
2+
. b) 
 
Fluorescence mission spectra of samples of thread in MeCN in the presence and absence of 
Zn
2+
. 
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The metal screen provided an interesting result as an approximately 3-fold switch-on 
response was observed for rotaxane 152 in the presence of both Cd2+ and V2+. Given that 
both atoms have very different ionic radii 209 it is quite clear that factors other than the size 
of cavity are influencing the selectivity of these structures.  
 
Figure 4-25 Fluorescence emission (F/F0) of samples of rotaxane 152 (100 μM) in the presence of 5 equiv. of 
different metals.  
  
4.7.5.3. Sulfur-functionalised Rotaxane 
 
Scheme 4-12 Synthesis of rotaxane 154. Conditions: [Cu(MeCN)4]PF6  i(0.96 eq.), DIPEA (1 eq.), EtOH, rt, 16 h 
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Figure 4-26 Partial 400 MHz 1H NMR spectra of a) macrocycle 136, b) thread 155 and c) rotaxane 154 in CDCl3. 
Assignments as indicated in Section 5.3. 
The sulfur-functionalised rotaxane 154 was synthesised in 86% yield following the same 
conditions as the previous rotaxanations. As observed with rotaxane 150, this rotaxane was 
also highly emissive, due to the sulfur lone pairs donating into the fluorophore.  
The absorption profile observed by UV-Visible spectroscopy revealed a slight increase and 
blue shift of the main absorption band centred at 380 nm upon addition of Zn2+, and also 
the previously observed bipyridine binding from the emergence of two strong bands at 312 
and 322 nm. A simple titration with Zn2+ in MeCN indicated this rotaxane has a highly 
desirable switch-on response to the metal. Upon excitation at 380 nm we observed a broad 
emission at 468 nm, which incrementally increased in output to a maximum emission at 1 
equivalent, blue-shifted by 18 nm to 450 nm.  
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Figure 4-27 a) UV-Vis absorption spectra of samples of rotaxane 154 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Fluorescence emission spectra of samples of rotaxane 154 in MeCN titrated with increasing 
amounts of Zn
2+ 
 
A 1H NMR titration of rotaxane 154 with Zn2+ in MeCN indicates that upon addition of Zn2+ 
the spectrum resolves into a single species at or above one equivalent of zinc, with both the 
free rotaxane and the Zn-bound product observed when titrated with 0.5 equivalents of the 
metal (Figure 4-28). This is another indicator of 1:1 binding stoichiometry. We clearly 
observe the binding through the same characteristic signals as previously observed. The 
broadening of bipyridine macrocycle signals is shown from two distinct doublets to a broad 
multiplet at approx. 6.5 ppm. A large downfield shift of the triazole proton signal from 9.3 
to 5.5 ppm is also observed, as is the shift of the ethylene CH2- proton signals upfield. This 
combined with the observed hypsochromic shift in fluorescence emission indicates a 
potential interaction of the bound metal with the sulfur heteroatom.  
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Figure 4-28 Partial 400 MHz 1H NMR spectra of a) rotaxane 154 in the presence of 1 equiv. Zn
2+
 , b) rotaxane 
152 in the presence of 0.5 equiv. Zn
2+
 and b) rotaxane 154 in d-MeCN. Assignments as indicated in Section 5.3 
To ensure the selectivity and behaviour was dependent on the interlocked structure the 
thread 155 was tested for its response to Zn2+. Both excitation and emission profiles for the 
thread show no change upon addition of 5 equivalents of zinc, indicating no binding. 
 
Figure 4-29 a) UV-Vis absorption spectra of samples of thread 155 (100 μM) in MeCN in the presence and 
absence of Zn
2+
. b) 
 
Fluorescence mission spectra of samples of thread in MeCN in the presence and absence of 
Zn
2+
. 
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As this rotaxane displayed such favourable characteristics for zinc binding we wanted to 
test its selectivity, and we were pleased to find rotaxane 154 was selective for Zn2+ over all 
metals tested, including Cd2+and Hg2+, with an approximate ~2 fold switch-on at maximum 
saturation (Figure 4-30, blue bars). It is notable that the sensor is selective for Zn2+ over 
Cd2+, as Zn2+ sensors often show a similar response to both metals due to their analogous 
co-ordination chemistry.  
 
Figure 4-30 Fluorescence emission (F/F0) of samples of rotaxane 154 (100 μM) in the presence of 5 equiv. of 
different metals (blue), and then 5 equiv. Zn
2+
 (red). 
An important feature of any potential Zn2+ probe is the ability to selectively function in the 
presence of other biologically relevant metal ions. A typical test for this carried out in vitro 
is a fluorescence recovery experiment, which we carried out in organic media, with a view 
to modifying these rotaxanes in future to function in aqueous media. In this experiment, 
five equivalents of a metal ion were added to a sample of the rotaxane, the fluorescence 
response measured, and then five equivalents of Zn2+ were added to the same sample and 
fluorescent output compared (Figure 4-30, red bars).  
We observed that almost all of the metals gave a recovery in fluorescence output upon 
addition of Zn2+ to the samples, apart from V, Ni and Cu. With the exception of V this is 
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consistent with the Irving-Williams series,209 whereby the stability constants are higher for 
those metals than Zn.   
 
4.7.6. Calculation of Binding Constants of Rotaxanes 150, 152 and 154 
We can quantify the interaction of zinc and rotaxane by calculating a binding constant (Kd) 
by monitoring the interaction by NMR, UV-Vis, or even fluorescence spectroscopy. After 
observing bands indicating binding of bipyridine in the UV-Visible absorption spectra for 
each rotaxane, we decided to use the absorbance spectra to calculate an approximate 
binding constant.  
By plotting the maxima of each absorbance measurement emission against the equivalents 
of Zn2+ added, we could obtain a visual representation of binding and use this data to 
extrapolate a Kd value for the ligand. The dissociation constant was determined by non-
linear regression analysis previously used for calculations in Chapter 3 (Equation 4-1).72 As 
the 1H NMR, UV-Vis and fluorescence spectroscopy titration data for each rotaxane 
indicated a 1:1 binding of Zn2+:rotaxane, we could confidently assume that the ligand 
follows a 1:1 binding model. 
 
    
     
      
     
           
  
  
 
  
  
      
  
  
 
  
  
 
 
 
   
  
 
   
  
Equation 4-1 Equation used to determine Kd value for rotaxanes, where CM and CL concentrations of Zn
2+
 and 
rotaxane respectively, F is the observed absorbance, F(0) is the observed absorbance of the rotaxane alone (ie 
CM = 0).  Non-linear regression analysis was used to determine F(max)/F(0) and Kd.
72,179
 
 
To begin with, a full titration was carried out of macrocycle 136 alone with Zn2+ to obtain a 
binding constant. Samples were made from 0 to 1 equivalents of Zn2+ in 0.1 equivalent 
increments, and further data points were obtained at excess amounts of Zn2+ to confirm the 
maximum response was achieved. The absorbance value at 319 nm (one of the π – π* 
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bands) was measured (F) and the relevant values inserted into Equation 4-1 to give a Kd 
value of 4.17 x 10-11 M with excellent ‘goodness of fit’, 
 
Figure 4-31 a) UV-Vis absorption spectra of samples of macrocycle 136 (100 μM) in MeCN titrated with 
increasing amounts of Zn
2+
. b) 
 
Non-linear fitting of data of data from (a) using Equation 4-1. 
A full titration of rotaxane 154 was also carried out. By applying the same formula to the 
UV-Vis titration data obtained for this zinc-selective rotaxane, we obtain an ambiguous Kd 
value of ~1.14 x 10-17 M, also with an excellent goodness-of-fit. The ambiguous value merely 
indicates that the values obtained are outside the limits of calculation using this 
methodology. 179 
 
Figure 4-32 a) UV-Vis absorption spectra of samples of rotaxane 154 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Non-linear fitting of data of data from (a) using Equation 4-1. 
In a similar manner, Kd values were obtained for both rotaxanes 150 and 152 using the 
same absorption band, and we obtained a similar ambiguous value for rotaxane 150, with 
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an estimated Kd of ~5.33 x 10
-17 M. Titration of rotaxane 152 gave a poorer fit with a value 
of 3.09 x 10-7 M. This variation can be accounted for by experimental error; titration by UV-
Vis spectroscopy is very sensitive to concentration of sensor and analyte, dilution and many 
other effects. A small loss of accuracy can lead to a large deviation in results. 
 
Figure 4-33 a) UV-Vis absorption spectra of samples of rotaxane 150 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Non-linear fitting of data of data from (a) using Equation 4-1. 
 
Figure 4-34 a) UV-Vis absorption spectra of samples of rotaxane 152 (100 μM) in MeCN titrated with increasing 
amounts of Zn
2+
. b) 
 
Non-linear fitting of data of data from (a) using Equation 4-1. 
Whilst all of the molecules are utilising the same binding motif (bipyridine), there are some 
factors that govern the binding to each ligand that could account for the difference in 
behaviour. For example, the macrocycle is less sterically restricted than the rotaxane. Both 
of the oxygen atoms from its ether linkages can participate in binding the metal inside the 
cavity. The rotaxanes have more severe steric restrictions due to the presence of the thread 
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in the macrocycle, and also will likely have a different co-ordination motif consisting of a 
different number of solvent molecules, and number of ether linkages participating in 
binding the metal.  Attempts to obtain X-Ray crystallographic data of these rotaxanes with 
Zn2+ bound have been unsuccessful to date, but a solid state structure would help to clarify 
how these rotaxanes bind metal guests in solution.  
4.8. Conclusions and Future Work 
In conclusion, we were able to exploit the metal-binding abilities of a bipyridine macrocycle 
to develop novel, fluorescent mechanically interlocked structures with different responses 
to metals. We have demonstrated that the AT-CuAAC is an effective route to simple and 
facile modifications of ligand design, and shown that even small changes in molecular 
structure can account for very different results. 
The study allowed for the discovery of a’switch-on’ sulfur- containing fluorescent rotaxane 
154 in the presence of Zn2+, in MeCN. As a chemosensor in organic media, it has an 
estimated Kd value appropriate for potential biological study, and although it retains its 
selectivity in the presence of several other first row transition metals, the binding of Cu2+, 
Ni2+ and V2+ quenches the fluorescence in a non-recoverable manner. This suggests that 
whilst this system has the optimal energy levels and conformations to produce a desirable 
optical response, this scaffold would perhaps need further adjustments to overcome its 
selectivity problems, which could possibly come from modification to the macrocycle 
component. 
A synthetic ‘trial-and-error’ study like this one provides no insight into the exact 
mechanisms working to give each rotaxane its unique optical response. To complete the 
study we would need to carry out extensive computational studies on these structures and 
obtain more information about the relative orbital energies and the processes governing 
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the fluorescence output. This in turn could allow for a more precise design process for 
selective [2]rotaxanes with desirable optical properties, including more bathochromically-
shifted emissions (with biological applications in mind), which are more desirable than 
those in the UV-range. 
We have seen through previous work and our own studies with designing biological sensors 
that their behaviour in cellulo can be highly unpredictable. With the ‘clickate’ sensor 
previously designed by the Watkinson group 72 they also observed a lack of recovery of 
fluorescence upon sequential addition of Cu2+ and then Zn2+, and the probe was still utilised 
successfully in both cells and organisms. 
To this end, despite the lack of recovery in the presence of some cations, there is still some 
merit in ascertaining the behaviour of a rotaxane scaffold as a novel in cellulo sensor. This 
too would require modification of the ligand scaffold primarily to make it water-soluble. 
Efforts towards this are currently being realised in the laboratory through the synthesis of 
water soluble macrocycles, and also particularly by appending water soluble di-carboxylic 
acid groups that act as both a stopper to avoid de-threading and to increase the solubility 
of these rotaxanes in aqueous media (156, Figure 4-35). We have already shown that 
modification to the stoppering element of the rotaxane has no significant effect on their 
photophysical behaviour, as exemplified by rotaxanes 134 and 140, and we anticipate this 
approach to work in a similar manner in this instance. 
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Figure 4-35 Potential structure of a hypothetical water-soluble rotaxane based on successful Zn
2+ 
sensor 
rotaxane 152 
The AT-CuAAC approach will not only make this a facile modular way to access and fine-
tune these types of structures, but also allow for the generation of a novel class of optical 
probes suitable for selective cation-imaging purposes for specific cells and even disease 
models. 
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Chapter 5: Experimental Section 
 
5.1. General Experimental Information 
All commercially available reagents, unless otherwise stated, and solvents for column 
chromatography were used as supplied without further purification. EDTA refers to 
ethylenediaminetetraacetic acid.  EtOH was stored over 4 Å-molecular sieves. Et3N was 
stored over KOH under a N2 atmosphere. Reaction solvents were supplied dry from an 
MBRAUN MB SPS-800 solvent purification system. Petrol refers to the fraction of petroleum 
ether boiling in the range 40-60 °C. All glassware and needles were oven dried and cooled 
under an inert atmosphere prior to experimental use. 
Infrared spectra were recorded in the range 4000-600 cm-1, obtained directly from the 
compound as a solid or neat liquid on a Bruker Tensor 37 FTIR spectrometer. 1H and 13C 
NMR spectra were recorded on a Bruker AV400 or AVIII 400 NMR spectrometer. Chemical 
shifts were reported in δ (ppm) and referenced to residual solvent. Multiplicities of signals 
are reported using standard abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, 
quint = quintet, m = multiplet, br = broad, and coupling constants measured in Hertz (Hz) 
and reported to 1 d.p.. Low resolution mass spectrometry was carried out by the mass 
spectrometry service at the University of Southampton using either a MaXis (Bruker 
Daltonics, Bremen, Germany) mass spectrometer equipped with a Time of Flight (TOF) 
analyser or solariX (Bruker Daltonics, Bremen, Germany). High resolution electrospray 
ionisation mass spectrometry was carried out by the EPSRC National Mass Spectrometry 
Service, University of Wales, Swansea on a Thermofisher LTQ Orbitrap XL. Melting points 
were measured on a Stuart SMP3 melting point apparatus and are uncorrected. 
Flash column chromatography, unless stated otherwise was performed using VWR silica gel 
60 (220-240 mesh), and TLC was carried out using pre-coated aluminium backed plates with  
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Merck Kieselgel 60 F254. The plates were visualised under a UV lamp (254 nm), or by 
staining with basified aqueous KMnO4 solution followed by gentle heating.  
Fluorescence spectroscopic/spectrophotometric studies for characterisation were 
performed using a Jobin Yvon Horiba Fluorormax®-3 machine, in a 1 cm path length cell 
without an incident ray filter. Solutions of deprotected sensors 105, 107, 109, 112, 114 and 
116 were prepared from a stock solution in DMSO such that each 3 mL testing sample 
contained 1% DMSO. All aqueous testing was carried out using HEPES buffered water (0.1 
mM, pH 7.4) at ambient temperature. Testing of all sensors and rotaxanes in MeCN was 
carried out using HPLC grade MeCN (VWR) which was used without any further purification. 
Dynamic light scattering (DLS) measurements to determine average aggregate size of 
solutions of sensors were obtained on a Malvern Zetasizer Nano ZS instrument equipped 
with a 633 nm laser. The measurement angle was 173 degrees. Samples were prepared as 
for the fluorescence measurements. 
The following compounds were all prepared following previously reported literature 
procedures. All spectroscopic data obtained matched those previously reported; 63, 64 and 
65,72 87 and 88,171 91,172 94,59 96,210 103,162 123 and 136,191 and 3-azido-1-aminopropane.211 
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5.2. General Procedures 
5.2.1. General Procedure A: One-pot Synthesis of a Sensor from Building Block 69 
 
Acetylene 69 (314 mg, 1.0 mmol), an azide (1.0 mmol), CuI (19.0 mg, 10 mol%) and NaOAc 
(8.2 mg, 10 mol%) were combined in a sealed CEM microwave vial which was wrapped in 
foil and purged with N2. Anhydrous NMP was added, and the reaction was stirred at r.t. for 
1 h. Upon complete consumption of 69 (determined by 1H NMR spectroscopy), NaN3 (78 
mg, 1.2 mmol) was added in a single portion to the reaction vial, which was resealed and 
the reaction stirred for a further 24 h. Upon completion of azide formation (determined by 
1H NMR spectroscopy), an acetylene (1 mmol) and EtOH (1:1 w/ NMP) were added to the 
reaction vial, and the final mixture was stirred for a further 16 h, at which point the reaction 
was complete (determined by 1H NMR spectroscopy). 
5.2.2. General Procedure B: One-pot Synthesis of a Sensor from Building Block 70 
 
Azide 70 (359 mg, 1.0 mmol), an acetylene (1.0 mmol), CuI (19.0 mg, 10 mol%) and NaOAc 
(8.2 mg, 10 mol%) were combined in a sealed CEM microwave vial which was wrapped in 
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foil and purged with N2. Anhydrous NMP was added, and the reaction was stirred at r.t. for 
1 h. Upon complete consumption of 70 (determined by 1H NMR spectroscopy), NaN3 (78 
mg, 1.2 mmol) was added in a single portion to the reaction vial, which was resealed and 
the reaction stirred for a further 24 h. Upon completion of azide formation (determined by 
1H NMR spectroscopy), an acetylene (1 mmol) and EtOH (1:1 w/ NMP) were added to the 
reaction vial, and the final mixture was stirred for a further 16 h, at which point the reaction 
was complete (determined by 1H NMR spectroscopy). 
5.2.3. General Procedure C: Rotaxane Synthesis 
 
The macrocycle 136 (1 eq.), azide (1 eq.), alkyne 123 (1 eq.), [Cu(MeCN)4]PF6 (0.96 eq.) and 
DIPEA (1 eq.) were weighed dry into a sealed flask and purged with N2. EtOH was added to 
make a 0.02 M solution (wrt. macrocycle), and the mixture stirred at r.t. for 16 h. The 
solvent was evaporated, and the resulting residue diluted with CH2Cl2 and washed with 16% 
aqueous EDTA tetrasodium-saturated ammonia solution. The organic layer was retained 
and the aqueous layer extracted twice further with CH2Cl2. The organic extracts were 
combined, dried over MgSO4, filtered and dried in vacuo. The crude mixture was purified by 
flash column chromatography (1:1 Petrol/ CH2Cl2 to 10% MeCN/1:1 Petrol- CH2Cl2) to yield 
the desired [2]rotaxane. 
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5.3. Experimental Data 
6-Bromo-2-(prop-2-yn-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (69): 
 
Following a modified literature procedure,72 4-bromo-1,8-naphthalic anhydride (1.0 g, 4.1 
mmol) was dissolved in 1,4-dioxane (30 mL). One portion of propargyl amine (0.26 mL, 4.1 
mmol) was added to the solution. This was stirred at r.t. for 1 h, and then heated at 70 °C 
for 2 h. After cooling the reaction mixture to r.t., a further portion of propargyl amine (0.05 
mL, 0.8 mmol) was added, and the reaction left to stir at 70 °C overnight. After cooling to 
r.t, the reaction mixture was slowly poured into iced water (120 mL). The resulting 
precipitate was collected by suction filtration and dried in vacuo to give bromide 69 as a 
brown solid (1.1 g, 96%).  1H NMR (400 MHz, CDCl3) δH 8.70 (d, J = 7.3, 1H, Hc), 8.60 (d, J = 
8.5, 1H, He), 8.46 (d, J = 7.9 , 1H, Hg), 8.06 (d, J = 7.9 , 1H, Hf), 7.87 (dd, J = 8.4, 7.4 , 1H, Hd ), 
4.95 (d, J = 2.4 , 2H, Hb), 2.20 (t, J = 2.4 , 1H, Ha); 
13C NMR (101 MHz, CDCl3) δC 162.9, 162.9, 
133.8, 132.5, 131.7, 131.2, 130.9, 130.8, 129.1, 128.2, 122.8, 121.9, 78.3, 70.7, 29.6;  IR ( 
max/cm
-1) 3391, 3257, 2923, 2106, 1700, 1659, 778; M.p. (°C) 177-179; HRMS (EI) calcd for 
C15H8
79BrNO2 [M + H]
+ 313.9811, found: 313.9809. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 
357 (8379), 343 (10173), 328 (6896).  
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2-(3-Azidopropyl)-6-bromo-1H-benzo[de]isoquinoline-1,3(2H)-dione (70): 
 
4-Bromo-1,8-naphthalic anhydride (0.25 g, 0.91 mmol) was dissolved in EtOH (30 mL). 3-
azido-1-aminopropane (0.46 g, 4.6 mmol) was added to the solution and the reaction left to 
stir at reflux overnight. After slow cooling to r.t, the resulting precipitate was collected by 
suction filtration and purified by flash column chromatography (4:1 CH2Cl2/EtOAc) to give 
bromide 70 as a brown solid (0.26 g, 79%). 1H NMR  (400 MHz, CDCl3) H 8.67 (d, J = 7.2, 1H, 
Hd), 8.59 (d, J = 8.5, 1H, Hf), 8.42 (d, J = 7.8, 1H, Hg), 8.05 (d, J = 7.8, 1H, Hh), 7.86 (m, 1H, He), 
4.28 (t, J = 7.0, 2H, Hc), 3.44 (t, J = 6.8, 2H, Ha), 2.04 (app. quint, J = 6.8, 2H, Hb). 
13C NMR 
(101 MHz, CDCl3)  C  163.8, 163.8, 133.6, 132.4, 131.5, 131.3, 130.8, 130.6, 129.2, 128.3, 
123.1, 122.2, 49.6, 38.2, 27.7. M.p. (°C) 92-93. HRMS (EI) calcd for C15H11
79BrN4O2 [M + H]
+ 
359.0138, found 359.0141. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 357 (11646), 343 
(13675), 327 (9214).  
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2-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)-6-bromo-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(71): 
 
Acetylene 69 (1.0 g, 3.2 mmol), benzyl azide (0.43 g, 3.2 mmol), and CuI (60 mg, 10 mol%) 
were combined in a sealed CEM microwave vial which was purged with N2. Anhydrous NMP 
(16 mL) was added, and the reaction stirred at r.t. for 1 h. The reaction mixture was diluted 
with a saturated solution of EDTA in 17.5% aqueous NH3 (30 mL) and stirred for 5 min.  The 
resulting precipitate was collected by suction filtration and purified by flash column 
chromatography (4:1 to 1:1 CH2Cl2/EtOAc) to yield triazole 71 as a pale yellow powder (1.35 
g, 95%). 1H NMR  (400 MHz, CDCl3) H 8.64 (d, J = 7.3, 1H, Hg), 8.55 (d, J = 8.5, 1H, Hi), 8.40 
(d, J = 7.8, 1H, Hj), 8.02 (d, J = 7.8, 1H, Hk), 7.82 (dd, J = 8.5, 7.3, 1H, Hh), 7.56 (s, 1H, He), 
7.37-7.29 (m, 4H, Hb and Hc), 7.26-7.22 (m, 1H, Ha), 5.46 (s, 4H, Hd and Hf); 
13C NMR (101 
MHz, CDCl3)  C 207.1, 163.5, 163.4, 134.7, 133.6, 132.5, 131.6, 131.2, 130.8, 130.8, 129.2, 
128.8, 128.3, 128.2, 123.3, 123.1, 122.2, 54.3, 35.5, 31.1; IR: ( max/cm
-1) 3133, 1700, 1653, 
1586, 1337, 1049, 959, 779. M.p. (°C) 128-131. HRMS (EI) calcd for C22H16
79BrN4O2 [M + H]
+ 
447.0451, found: 447.0450. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 358 (3459), 343 (4066), 
328 (2753). 
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2-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)-6-azido-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(72): 
 
Bromo-triazole 71 (1.4 g, 3.2 mmol), and NaN3 (0.25 g, 3.80 mmol) were combined in a 
sealed CEM microwave vial which was purged with N2 and wrapped in foil. Anhydrous NMP 
(16 mL) was added, and the reaction stirred at r.t. for 24 h. The reaction mixture was 
diluted with water (30 mL) and stirred for 5 min.  The resulting precipitate was collected by 
suction filtration and purified by flash column chromatography (1:1 Petrol/EtOAc) to yield 
azide 72 as a yellow powder (0.72 g, 55%). 1H NMR (400 MHz, CDCl3) H 8.64 (d, J = 7.2, 1H, 
Hg), 8.59 (d, J = 8.1, 1H, Hj), 8.44 (d, J = 8.4, 1H, Hi), 7.73 (dd, J = 7.4, 8.4, 1H, Hh), 7.55 (s, 1H, 
He), 7.46 (d, J = 8.0, 1H, Hk),  7.35-7.31 (m, 3H, Ha and Hb), 7.26-7.22 (m, 2H, Hc). 5.47 (s, 4H, 
Hd and Hf). 
13C NMR (101 MHz, CDCl3)  C 174.6, 163.8, 163.3, 143.8, 134.7, 132.6, 132.2, 
129.3, 129.2, 129.1, 128.8, 128.3, 126.9, 124.5, 123.3, 122.5, 118.8, 114.8, 54.2, 35.4.  IR: ( 
max/cm
-1) 3142, 2923, 2120, 1655, 1579, 1325, 1233, 1046, 780. M.p. (°C) 160-162. HRMS 
(EI) calcd for C22H16N7O2 [M + H]
+ 410.1360, found: 410.1358. UV: max(CH2Cl2)/nm ( / mol
-
1cm-1dm3) 384 (9103), 367 (11295), 344 (7235). 
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2-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)-6-(4-phenyl-1H-1,2,3-triazol-1-yl)-1H-
benzo[de]isoquinoline-1,3(2H)-dione (73): 
 
Triazole-azide 72 (0.050 g, 0.12 mmol), phenylacetylene (0.014 mL, 0.12 mmol), CuI (2.3 
mg, 10 mol%) and NaOAc (1.1 mg, 10 mol%) were combined in a sealed CEM microwave 
vial which was purged with N2. Anhydrous NMP (0.61 mL) was added, and the reaction 
stirred at r.t.  for 16 h. The reaction mixture was diluted with a saturated solution of EDTA 
in 17.5% aqueous NH3 (5 mL) and stirred for 5 min.  The resulting precipitate was collected 
by suction filtration and purified by flash column chromatography (100% CH2Cl2 to 1:1 
CH2Cl2/EtOAc) to yield bis-triazole 73 as a pale yellow powder (0.051 g, 81%). 
1H NMR  (400 
MHz, CDCl3) H 8.75-8.68 (m, 2H, Hg and Hj), 8.33 (d, J = 8.5, 1H, Hi), 8.25 (s, 1H, Hl), 7.96 (d, J 
= 7.4, 2H, Hm), 7.88 (d, J = 7.8, 1H, Hk), 7.86-7.82 (m, 1H, Hh), 7.59 (s, 1H, He), 7.52-7.48 (m, 
2H, Hn), 7.43-7.40 (m, 1H, Ho), 7.36-7.31 (m, 3H, Ha and Hb), 7.27-7.23 (m, 2H, Hc), 5.51 (s, 
2H, Hf), 5.49 (s, 2H, Hd). 
13C NMR (101 MHz, CDCl3)  C 163.5, 162.9, 148.7, 143.7, 138.5, 
134.7, 132.7, 131.1, 129.9, 129.7, 129.4, 129.3, 129.2, 129.0, 128.8, 128.7, 128.3, 126.7, 
126.1, 123.9, 123.6, 123.3, 123.0, 121.9, 54.3, 35.6. IR: ( max/cm
-1) 3128, 3066, 1705, 1658, 
1584, 1401, 1121, 1023, 953, 850, 781, 761, 718. M.p. (°C) >230. HRMS (EI) calcd for 
C30H22N7O2 [M + H]
+ 512.1829, found: 512.1829. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 
(9099). 
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6-Bromo-2-(3-(4-phenyl-1H-1,2,3-triazol-1-yl)propyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(77): 
 
Azide 70 (0.20 g, 0.56 mmol), phenylacetylene (0.062 mL, 0.56 mmol), and CuI (10 mg, 10 
mol%) were combined in a sealed CEM microwave vial which was purged with N2. 
Anhydrous NMP (2.8 mL) was added, and the reaction stirred at r.t. for 1 h. The reaction 
mixture was diluted with a saturated solution of EDTA in 17.5% aqueous NH3 and stirred for 
5 min.  The resulting precipitate was collected by suction filtration and purified by flash 
column chromatography (4:1 to 1:1 CH2Cl2/EtOAc) to yield triazole 77 as a pale yellow 
powder (0.17 g, 67%). 1H NMR  (400 MHz, CDCl3) H 8.65 (d, J = 7.3, 1H, Hh), 8.56 (d, J = 8.5, 
1H, Hj), 8.40 (d, J = 7.9, 1H, Hk), 8.02 (d, J = 7.9, 1H, Hl), 7.94 (s, 1H, Hd), 7.83 (dd, J = 8.3, 7.4, 
1H, Hi), 7.75 (m, 2H, Hc), 7.42-7.36 (m, 2H, Hb), 7.34-7.28 (m, 1H, Ha), 4.54 (t, J = 6.9, 2H, Hg), 
4.33 (t, J = 6.6, 2H, He), 2.48 (app. quint, J = 6.8, 2H, Hf). 
13C NMR (101 MHz, CDCl3)  C 163.9, 
163.9, 147.8, 133.7, 132.4, 131.6, 131.3, 130.8, 130.7, 129.1, 128.9, 128.3, 128.2, 125.7, 
122.9, 122.0, 120.0, 48.6, 37.9, 28.8; IR: ( max/cm
-1) 3142, 3061, 1698. 1659, 1586, 1568, 
1460, 1345, 1225, 1055, 970, 918, 810, 767, 696. M.p. (°C) 200-202. HRMS (EI) calcd for 
C23H17
79BrN4O2 [M + H]
+ 461.0608, found 461.0604. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 
358 (20486), 343 (23859), 327 (15782). 
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6-Azido-2-(3-(4-phenyl-1H-1,2,3-triazol-1-yl)propyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(78): 
 
Bromo-triazole 77 (50 mg, 0.11 mmol), and NaN3 (9.0 mg, 1.2 equiv., 0.13 mmol) were 
combined in a sealed CEM microwave vial which was purged with N2 and wrapped in foil. 
Anhydrous NMP (0.54 mL) was added, and the reaction stirred at r.t. for 24 h. The reaction 
mixture was diluted with H2O (5 mL) and stirred for 5 min.  The resulting precipitate was 
collected by suction filtration and purified by flash column chromatography (1:1 
Petrol/EtOAc) to yield azide 78 as a yellow powder (35 mg, 76%). 1H NMR  (400 MHz, CDCl3) 
H 8.63 (d, J = 7.3, 1H, Hh), 8.56 (d, J = 8.0, 1H, Hk), 8.44 (d, J = 8.4, 1H, Hj), 7.96 (s, 1H, Hd), 
7.77-7.71 (m, 2H, Hi and Hl), 7.45-7.35 (m, 4H, Hb and Hc), 7.34-7.28 (m, 1H, Ha), 4.54 (t, J = 
7.0, 2H, Hg), 4.33 (t, J = 6.6, 2H, He), 2.48 (app. quint, J = 6.8, 2H, Hf). Due to the instability of 
78 we were unable to obtain further characterisation data and it as used in subsequent 
reactions immediately. 
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6-(4-Phenyl-1H-1,2,3-triazol-1-yl)-2-(3-(4-phenyl-1H-1,2,3-triazol-1-yl)propyl)-1H-
benzo[de]isoquinoline-1,3(2H)-dione (79): 
 
Triazole-azide 78 (64 mg, 0.15 mmol), phenylacetylene (0.02 mL, 0.15 mmol), CuI (2.8 mg, 
10 mol%) and NaOAc (1.2 mg, 10 mol%) were combined in a sealed CEM microwave vial 
which was purged with N2. Anhydrous NMP (0.76 mL) was added, and the reaction stirred 
at r.t.  for 16 h. The reaction mixture was diluted with a saturated solution of EDTA in 17.5% 
aqueous NH3 (10 mL) and stirred for 5 min.  The resulting precipitate was collected by 
suction filtration and purified by flash column chromatography (100% CH2Cl2 to 1:1 
CH2Cl2/EtOAc) to yield bis-triazole 79 as a pale yellow powder (64 mg, 81%). 
1H NMR  (400 
MHz, CDCl3) H 8.72 (d, J = 7.8, 1H, Hk), 8.71 (d, J = 7.2, 1H, Hh), 8.32 (d, J = 8.5, 1H, Hj), 8.21 
(s, 1H, Hm), 7.97 (d, J = 7.3, 2H, Hn), 7.94 (s, 1H, Hd), 7.89-7.81 (m, 2H, Hi and Hl), 7.73 (d, J = 
7.3, 2H, Hb), 7.55-7.49 (m, 2H, Ho), 7.47-7.35 (m, 3H, Hc and Hp), 7.34-7.28 (m, 1H, Ha), 4.57 
(t, J = 6.8, 2H, Hg), 4.38 (t, J = 6.6, 2H, He), 2.53 (app. quint, J = 6.6, 2H, Hf). 
13C NMR (101 
MHz, CDCl3)  C 158.9, 158.9, 132.7, 131.1, 130.0, 129.7, 129.3, 129.1, 128.9, 128.8, 128.2, 
126.2, 125.7, 123.6, 121.9, 120.0, 48.6, 38.2, 28.7. IR: ( max/cm
-1) 3126, 3064, 2923, 2112, 
1698, 1654, 1583, 1517, 1465, 1432, 1400, 1348, 1232, 1188, 1152, 1057, 976, 898, 783. 
M.p. (°C) 185-188. HRMS (EI) calcd for C31H23N7O2 [M + H]
+ 526.1986, found 526.1979. UV: 
max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 345 (30104). 
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One-pot: 2-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)-6-(4-phenyl-1H-1,2,3-triazol-1-yl)-1H-
benzo[de]isoquinoline-1,3(2H)-dione (73): 
 
General procedure A was employed with 69 (0.31 g, 1.0 mmol), benzyl azide (0.13 g, 1.0 
mmol) in NMP (3.33 mL), followed by phenylacetylene (0.11 mL, 1.0 mmol) and EtOH (3.33 
mL). The crude product was obtained obtained via precipitation with a saturated solution of 
EDTA in 17.5% aqueous NH3 (20 mL) and purified by flash column chromatography (100% 
CH2Cl2 to CH2Cl2/EtOAc 1:1) to yield bis-triazole 73 as a pale yellow powder (0.43 g, 85%). All 
spectroscopic data in accordance with double triazole 73 vide supra. 
One-pot: 6-(4-Phenyl-1H-1,2,3-triazol-1-yl)-2-(3-(4-phenyl-1H-1,2,3-triazol-1-yl)propyl)-1H-
benzo[de]isoquinoline-1,3(2H)-dione (79): 
 
General procedure B was employed with 70 (0.36 g, 1.0 mmol), phenylacetylene (0.11 mL, 
1.0 mmol) in NMP (3.33 mL), followed by a second portion of phenylacetylene (0.11 mL, 1.0 
mmol) and EtOH (3.33 mL). The crude product was obtained obtained via precipitation with 
a saturated solution of EDTA in 17.5% aqueous NH3 (20 mL) and purified by flash column 
chromatography (100% CH2Cl2 to CH2Cl2/EtOAc 1:1) to yield bis-triazole 79 a pale yellow 
powder (0.37 g, 72%). All spectroscopic data in accordance with double triazole 79 vide 
supra. 
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2-Chloro-N,N-didodecylacetamide (81):  
 
A solution of didodecylamine (2.00 g, 5.65 mmol) and NEt3 (1.97 mL, 14.1 mmol) in dry 
CH2Cl2 (100 mL) was added in a slow dropwise manner to a solution of chloroacetyl chloride 
(0.54 mL, 6.79 mmol) in anhydrous CH2Cl2 (50 mL) at 0
 °C under N2. When the addition was 
complete, the red solution was warmed to r.t. and stirred for 24 h. The solution was filtered 
and the solid washed with chloroform (30 mL). The filtrate was further diluted with 
chloroform and washed with H2O (2 x 200 mL), Na2CO3 solution (1 M, 2 x 200 mL), HCl 
solution (1 M, 2 x 200 mL) and brine (2 x 200 mL). The organic phase was dried over MgSO4 
and the solvent was removed in vacuo. The crude oil was purified by flash column 
chromatography (4:1 CH2Cl2/EtOAc) to yield chloride 81 as a clear oil (1.86 g, 76%). 
1H NMR  
(400 MHz, CDCl3) H 4.05 (s, 2H, Ha), 3.36-3.22 (m, 4H, Hb), 1.65-1.47 (m, 4H, Hc), 1.36-1.17 
(m, 36H, alkyl-H), 0.92-0.84 (m, 6H, Hd). 
13C NMR (101 MHz, CDCl3)  C 166.2, 48.4, 46.3, 
41.5, 32.0, 29.8, 29.7, 29.7, 29.6, 29.5, 29.5, 29.4, 29.4, 29.3, 27.5, 27.1, 27.0, 22.8, 14.3. IR: 
( max/cm
-1) 2921, 2852, 1653, 1458, 1376, 1302, 1122, 925, 790. HRMS (EI) calcd for 
C26H52ClNO [M + H]
+ 430.3810, found 430.3810.  
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2-Azido-N,N-didodecylacetamide (82):  
 
Chloride 81 (1.86 g, 4.31 mmol) and NaN3 (1.68 g, 25 mmol) were combined in a flask 
purged with N2, dissolved in dry DMF (60 mL) and stirred for 24 h at 65 °C. After cooling to 
r.t, the reaction mixture was slowly poured into icy H2O (200 mL). The resulting precipitate 
was extracted with EtOAc (3 x 100 mL), the organic extracts combined and washed with 
saturated NaHCO3 solution (2 x 200 mL), brine (2 x 200 mL) and H2O (2 x 100 mL). The 
organic phase was dried over MgSO4 and the solvent was removed in vacuo to give azide 82 
as a viscous yellow oil (1.90 g, 98%). 1H NMR (400 MHz, CDCl3) H 3.87 (s, 2H, Ha), 3.31 (t, J = 
7.6, 2H, Hb), 3.11 (t, J = 7.6, 2H, Hc), 1.58-1.48 (m, 4H, Hd), 1.35-1.20 (m, 36H, alkyl-H), 0.91-
0.84 (m, 6H, He). 
13C NMR (101 MHz, CDCl3)  C 166.9, 50.4, 47.6, 46.6, 32.0, 29.7, 29.7, 29.7, 
29.7, 29.6, 29.6, 29.5, 29.5, 29.4, 29.4, 29.2, 27.8, 27.1, 26.9, 22.8, 14.2. IR: ( max/cm
-1) 
2921, 2852, 2103, 1654, 1458, 1425, 1376, 1273, 720. HRMS (EI) calcd for C26H53N4O [M + 
H]+ 437.4214, found 437.4215.  
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Cholesterol 2-chloroacetate (84): 
 
A solution of chloroacetyl chloride (0.25 mL, 3.10 mmol) in anhydrous CH2CL2 (25 mL) was 
added dropwise to a solution of cholesterol (1.00 g, 2.58 g) and NEt3 (0.54 mL, 3.88 mmol) 
in anhydrous CH2CL2 (50 mL) at 0 oC under N2. When the addition was complete, the 
solution was warmed to r.t. and stirred for 24 h. The reaction mixture was washed with 
aqueous HCl solution (1M, 2 x 100 mL). The organic phase was dried over MgSO4 and the 
solvent was removed in vacuo. The crude solid was purified by flash column 
chromatography (Petrol/CH2CL2 1:1) to yield chloride 84 as a white powder (1.10 g, 92%). 
1H NMR (400 MHz, CDCl3) H 5.39 (d, J = 4.4, 1H, Hd), 4.75-4.65 (m, 1H, Hb), 4.03 (s, 2H, Ha), 
2.35 (d, J = 7.8, 2H, Hc), 2.05-0.80 (m, 38H, Cholesterol-H), 0.67 (s, 3H, He). 
13C NMR (101 
MHz, CDCl3)  C 166.8, 139.3, 123.3, 76.3, 56.8, 56.3, 50.1, 42.4, 41.3, 39.9, 39.7, 38.0, 37.0, 
36.7, 36.3, 35.9, 32.1, 32.0, 28.3, 28.1, 27.7, 24.4, 23.9, 22.9, 22.7, 21.2, 19.4, 18.8, 12.0. IR: 
( max/cm
-1) 2936, 2859, 1750, 1463, 1411, 1311, 1191, 1006, 803, 786, 691. M.p. (oC) 157-
159. UV: max(CH2CL2)/nm ( / mol
-1cm-1dm3) 275 (43). 
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Cholesterol 2-azido acetate (85): 
 
Chloride 84 (1.00 g, 2.15 mmol) and NaN3 (0.84 g, 12.9 mmol) were combined in a flask 
purged with N2, dissolved in anhydrous DMF (60 mL), heated to 65 
oC and stirred for 24 h. 
After cooling to r.t, the reaction mixture was slowly poured into iced water (200 mL). The 
resulting precipitate was extracted with EtOAc (3 x 200 mL), the organic extracts combined 
and washed with saturated NaHCO3 solution (2 x 100 mL), brine (2 x 100 mL) and H2O (2 x 
100 mL). The organic phase was dried over MgSO4 and the solvent was removed in vacuo. 
The crude oil was purified by flash column chromatography (100% CH2CL2) to give azide 85 
as a cream powder (0.68 g, 65%). 1H NMR (400 MHz, CDCl3) H 5.39 (d, J = 4.4, 1H, Hd), 4.76-
4.68 (m, 1H, Hb), 3.83 (s, 2H, Ha), 2.36 (d, J = 7.8, 2H, Hc), 2.07-0.79 (m, 38H, Cholesterol-H), 
0.67 (s, 3H, He). 
13C NMR (101 MHz, CDCl3)  C167.8, 139.3, 123.3, 76.1, 56.8, 56.3, 50.7, 
50.2, 42.5, 39.8, 39.6, 38.1, 37.0, 36.7, 36.3, 35.9, 32.0, 32.0, 28.3, 28.2, 27.8, 24.4, 23.9, 
22.9, 22.7, 21.2, 19.4, 18.8, 12.0. IR: ( max/cm
-1) 2934, 2866, 2105, 1741, 1465, 1438, 1363, 
1209, 1002, 924, 801. M.p. (oC) 122-123. HRMS (EI) calcd for C29H48N3O2 [M + H]
+ 470.3741, 
found 470.3731. UV: max(CH2CL2)/nm ( / mol
-1cm-1dm3) 275 (84) . 
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 (4-Azidobutyl)triphenylphosphonium tetrafluoroborate (89): 
 
(4-Azidobutyl)triphenylphosphonium bromide 88 (2.27 g, 5.15 mmol) was dissolved in 
CH2Cl2 (40 mL). This solution was thoroughly washed with a saturated aqueous solution of 
ammonium tetrafluoroborate (50 mL). The organic phase was dried over MgSO4 and the 
solvent was removed in vacuo to yield tetrafluoroborate 89 as a white solid (2.18 g, 95%). 
1H NMR (400 MHz, CDCl3) H 7.86-7.65 (m, 15H, He), 3.46-3.28 (m, 4H, Ha and Hd), 1.96-1.85 
(m, 2H, Hb), 1.78-1.63 (m, 2H, Hc). 
13C NMR (101 MHz, CDCl3)  C 135.0 (JC-P = 2.9), 133.2 (JC-P 
= 9.9), 130.4 (JC-P = 12.7), 117.9 (JC-P = 86.4),  50.1, 28.8 (JC-P = 16.9), 21.2 (JC-P = 52.0), 19.5 (JC-
P = 3.9). IR: ( max/cm
-1) 2943, 2923, 2877, 2098, 1588, 1486, 1438, 1342, 1276, 1239, 1025, 
749, 722, 689. M.p. (°C) 115-118. HRMS (EI) calcd for C22H23N3P1 [M – BF4]
+ 360.1624, found 
360.1627.   
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2-Azido-N-(2-diethylamino-ethyl)acetamide (92): 
 
2-Chloro-N-(2-diethylamino-ethyl)acetamide hydrochloride 91 (0.83 g, 2.50 mmol) was 
dissolved in H2O (12.5 mL), NaN3 (1.61 g, 15.0 mmol) was added to the flask, and the 
reaction mixture stirred for 48 h at 65 °C. After cooling, the solution was adjusted to pH 10 
using aqueous NaHCO3 (1.0 M), and extracted with EtOAc (3 x 20 mL). The remaining 
aqueous layer was adjusted to pH 14 with aqueous NaOH (1.0 M), and extracted with EtOAc 
(3 x 20 mL). All organic extracts were combined, dried over MgSO4 and the solvent was 
removed in vacuo (400 mbar – volatile product) to give azide 92 as a pale yellow oil (0.31 g, 
72%). 1H NMR (400 MHz, CDCl3) H 6.82 (br s, 1H, Hd), 3.96 (s, 2H, He), 3.34 (q, J = 5.9, 2H, 
Hc), 2.42 (t, J = 6.0, 2H, Hb), 2.23 (s, 6H, Ha). 
13C NMR (101 MHz, CDCl3)  C 166.8, 57.8, 52.8, 
45.3, 36.9. IR: ( max/cm
-1) 3292 (b), 3079, 2978, 2948, 2872, 2783, 2101, 1658, 1541, 1461, 
1252, 1189, 1166, 1040, 906, 849, 776, 645. HRMS (EI) calcd for C6H13N5O [M + H]
+ 
172.1193, found 172.1191.  
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Diethyl 2,2'-(prop-2-yn-1-ylazanediyl)diacetate (104): 
 
Diethyl iminodiacetate 103 (1.00 g, 5.28 mmol) was dissolved in MeCN (30 mL). K2CO3 (1.46 
g, 10.5 mmol) was added, and propargyl bromide (0.94 mL, 6.34 mmol) was added slowly to 
the stirring reaction mixture and refluxed for 16 h. After cooling, the suspension was 
filtered, and the solvent removed in vacuo. The crude oil was purified by flash column 
chromatography (2:8 EtOAc/Petrol) to yield alkyne 104 as a colourless oil (0.71 g, 58%). 1H 
NMR (400 MHz, CDCl3) H 4.17 (q, J = 7.1, 4H, Hd), 3.66 (d, J = 2.3, 2H, Hb), 3.54 (s, 4H, Hc), 
2.25 (t, J = 2.4, 1H, Ha), 1.27 (t, J = 7.1, 6H, He). 
13C NMR (101 MHz, CDCl3)  C 170.5, 78.4, 
73.8, 60.8, 54.4, 43.4, 14.3.IR: ( max/cm
-1) 3278, 2978, 2870, 2105, 1733, 1444, 1372, 1190, 
1027, 990. HRMS (EI) calcd for C11H18N1O4 [M + H]
+ 228.1230, found 228.1224.  
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2-(4-((6-(4-((bis(Pyridin-2-ylmethyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-1,3-dioxo-1H-
benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-yl)-N,N-didodecylacetamide (105): 
 
 
General procedure A was employed with 69 (314 mg, 1.00 mmol), azide 82 (0.48 g, 1.0 
mmol) in NMP (3.33 mL), followed by propargyl dipicolylamine 96 (0.29 g, 1.1 mmol) and 
EtOH (3.33 mL). Crude product obtained after dilution of the reaction mixture with CH2Cl2 
(10 mL), and washing the organic mixture with a saturated solution of EDTA in 17.5% 
aqueous NH3 (3 x 15 mL). The organic phase was dried over MgSO4, concentrated in vacuo 
and purified by flash column chromatography on alumina (99:1 CH2Cl2/MeOH) to yield 
sensor 105 as a brown oil (0.78 g, 82%). 1H NMR (400 MHz, CDCl3) H 8.68 (d, J = 7.8, 1H, 
Hh), 8.67 (d, J = 7.1, 1H, Hg), 8.55-8.51 (m, 2H, Hr), 8.25 (d, J = 8.5, 1H, Hj), 8.15 (s, 1H, Hl), 
7.91 (s, 1H, He), 7.82-7.75 (m, 2H, Hi and Hk), 7.66 (app. td, J = 7.7, 1.6, 2H, Hp), 7.62-7.57 (m, 
2H, Ho), 7.18-7.12 (m, 2H, Hq), 5.52 (s, 2H, Hf), 5.14 (s, 2H, Hd), 4.06 (s, 2H, Hm), 3.94 (s, 4H, 
Hn), 3.31-3.23 (m, 4H, Hc), 1.64-1.43 (m, 4H, Hb), 1.34-1.12 (m, 36H, alkyl-H), 0.85 (app. t, 
6H, Ha). 
13C NMR (101 MHz, CDCl3)  C 164.3, 163.4, 162.9, 159.1, 149.3, 145.2, 143.4, 138.5, 
136.6, 132.5, 131.1, 129.9, 129.3, 128.5, 126.5, 125.7, 125.3, 123.7, 123.5, 122.9, 122.3, 
59.9, 50.8, 48.6, 47.9, 46.8, 35.5, 31.9, 29.7, 29.7, 29.6, 29.6, 29.5, 29.4, 29.3, 29.2, 27.6, 
27.1, 26.9, 22.8, 14.2. IR: ( max/cm
-1) 2922, 2852, 1703, 1661, 1587, 1467, 1430, 1369, 
1233, 1040, 995, 783. HRMS (EI) calcd for C56H76N11O3 [M + H]
+ 950.6127, found 950.6117. 
UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 (20365) 
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Diethyl 2,2'-(((1-(2-((1-(2-(didodecylamino)-2-oxoethyl)-1H-1,2,3-triazol-4-yl)methyl)-1,3-
dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-1H-1,2,3-triazol-4-
yl)methyl)azanediyl)diacetate (106): 
 
General procedure A was employed with 69 (314 mg, 1.00 mmol), azide 82 (0.48 g, 1.0 
mmol) in NMP (3.33 mL), followed by acetylene 104 (0.59 g, 1.1 mmol) and EtOH (3.33 mL). 
Crude product obtained after dilution of the reaction mixture with CH2Cl2 (10 mL), and 
washing the organic mixture with a saturated solution of EDTA in 17.5% aqueous NH3 (3 x 
15 mL). The organic phase was dried over MgSO4, concentrated in vacuo and purified by 
flash column chromatography (4:1 CH2Cl2/EtOAc to EtOAc to 4:1 EtOAc/MeOH) to yield 106 
as an orange foam (0.72 g, 76%). 1H NMR (400 MHz, CDCl3) H 8.70 (d, J = 7.8, 1H, Hj), 8.69 
(d, J = 7.2, 1H, Hg), 8.28 (d, J = 8.6, 1H, Hi), 8.13 (s, 1H, Hl), 7.91 (s, 1H, He), 7.92-7.78 (m, 2H, 
Hh and Hk), 5.54 (s, 2H, Hf), 5.15 (s, 2H, Hd), 4.23 (s, 2H, Hm), 4.18 (q, J = 7.1, Ho), 3.69 (s, 4H, 
Hn), 3.33-3.22 (m, 4H, Hc), 1.65-1.41 (m, 4H, Hb), 1.35-1.14 (m, 42H, Hp (6H) and alkyl-H 
(36H)), 0.90-0.80 (m, 6H, Ha). 
13C NMR (101 MHz, CDCl3)  C 171.2, 164.3, 163.4, 162.9, 
146.4, 143.5, 138.5, 132.6, 131.1, 129.9, 129.3, 128.6, 126.5, 125.7, 125.4, 123.9, 123.6, 
122.9, 65.9, 60.8, 55.1, 50.9, 49.3, 48.0, 46.9, 35.6, 32.0, 29.8, 29.7, 29.7, 29.6, 29.4, 29.4, 
29.3, 27.6, 27.1, 26.9, 22.8, 15.4, 14.4, 14.2. IR: ( max/cm
-1) 3145, 2921, 2852, 1739, 1704, 
1659, 1585, 1465, 1369, 1232, 1184, 1026, 949, 783. M.p. (°C) 48-51. HRMS (EI) calcd for 
C52H78N9O7 [M + H]
+ 940.6019, found 940.6010. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 
(18804) . 
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2,2'-(((1-(2-((1-(2-(Didodecylamino)-2-oxoethyl)-1H-1,2,3-triazol-4-yl)methyl)-1,3-dioxo-2,3-
dihydro-1H-benzo[de]isoquinolin-6-yl)-1H-1,2,3-triazol-4-yl)methyl)azanediyl)diacetic acid  
(107): 
 
To a stirred solution of 106 (28 mg, 0.030 mmol) in THF (0.15 mL) was added an aqueous 
solution of LiOH (2 equiv., 0.15 mL). The reaction mixture was stirred for 18 h at r.t., and 
the solvent removed in vacuo. The residue was re-suspended in CHCl3 (5 mL), washed with 
aqueous citric acid solution (5% w/v, 5 mL), the organic phase dried over MgSO4 and the 
solvent removed in vacuo to yield deprotected sensor 107 as an orange residue (14.0 mg, 
53%). 1H NMR (400 MHz, MeOD) H 8.72-8.66 (m, 2H, Hg and Hj), 8.50 (s, 1H, Hl), 8.24 (d, J = 
5.6, 1H, Hi), 7.98 (s, 1H, He), 7.96 (d, J = 5.2, 1H, Hk), 7.91-7.86 (m, 1H, Hh), 5.49 (s, 2H, Hf), 
5.34 (s, 2H, Hd), 4.35 (s, 2H, Hm), 3.73 (s, 4H, Hn), 3.39-3.11 (m, 2H, Hc – obscured by solvent 
peak), 1.68-1.46 (m, 4H, Hb), 1.37-1.13 (m, 36H, alkyl-H), 0.89-0.84 (m, 6H, Ha). 
13C NMR 
(101 MHz, MeOD) C 166.5, 164.5, 164.0, 156.7, 144.3, 140.3, 133.1, 132.2, 131.8, 131.4, 
131.0, 130.6, 130.6, 130.1, 129.6, 128.4, 128.3, 127.6, 127.1, 125.0, 124.9, 123.8, 121.2, 
51.8, 49.6, 47.7, 35.9, 32.8, 30.5, 30.4, 30.4, 30.2, 30.1, 29.6, 28.3, 27.7, 27.6, 23.5, 14.4. IR: 
( max/cm
-1) 3357 (broad), 2923, 2854, 1705, 1661, 1588, 1465, 1423, 1377, 1235, 1120, 
1052, 952, 785. HRMS (EI) calcd for C48H69N9O7 [M + H]
+ 884.5393, found 884.5391. UV: 
max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 (9173) 
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Tri-tert-butyl 11-((1-(2-((1-(2-(didodecylamino)-2-oxoethyl)-1H-1,2,3-triazol-4-yl)methyl)-1,3-
dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-1,4,8,11-
tetraazacyclotetradecane-1,4,8-tricarboxylate (108): 
 
General procedure A was employed with 69 (314 mg, 1.00 mmol), azide 82 in NMP (3.33 
mL), followed by cyclam acetylene 65 (0.59 g, 1.1 mmol) and EtOH (3.33 mL). Crude product 
was obtained by dilution of the reaction mixture with CH2Cl2 (10 mL), and washing the 
organic mixture with a saturated solution of EDTA in 17.5% aqueous NH3 (3 x 15 mL). The 
organic phase was dried over MgSO4, concentrated in vacuo and purified by flash column 
chromatography (4:1 CH2Cl2/EtOAC to EtOAc to 4:1 EtOAc/MeOH) to yield 108 as a brown 
oil (0.93 g, 75%). 1H NMR (400 MHz, CDCl3) H 8.67-8.59 (m, 2H, Hg and Hj), 8.20 (app. br s, 
1H, Hi), 7.98-7.72 (m, 4H, He and Hh, Hl and Hk), 5.47 (s, 2H, Hf), 5.09 (s, 2H, Hd), 3.89 (br s, 
2H, Hm), 3.50-3.08 (m, 16H, Hc and Cyclam-H (12H)), 2.70-2.62 (m, 2H, Ho), 2.54-2.48 (m, 2H, 
Hn), 1.92-1.78 (m, 2H, Hq), 1.76-1.66 (m, 2H, Hp), 1.60-0.93 (m, 67H, Hb (4H), 
tBu (27H) and 
alkyl-H (36H)), 0.86-0.72 (m, 6H, Ha). 
13C NMR (101 MHz, CDCl3) C 164.2, 163.4, 162.8, 
155.9, 155.6, 143.4, 138.4, 132.5, 131.1, 129.8, 129.2, 128.7, 126.5, 125.3, 123.7, 123.5, 
122.9, 79.7, 50.8, 47.9, 46.8, 35.5, 31.9, 29.7, 29.6, 29.6, 29.5, 29.4, 29.3, 29.2, 28.6, 28.5, 
27.6, 27.0, 26.9, 22.7, 14.2. IR: ( max/cm
-1) 2927, 2855, 1691, 1588, 1466, 1414, 1365, 1236, 
1166, 782. HRMS (EI)  calcd for C29H48N3O2 [M + H]
+ 1251.8149, found 1251.8577. UV: 
max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 (25178). 
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2-(4-((6-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1,3-dioxo-
1H-benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-yl)-N,N-didodecylacetamide 
(109): 
 
Compound 108 (50 mg, 0.040 mmol) was dissolved in a solution of TFA (20%) in CH2Cl2 (1 
mL), and for 6 h at r.t. The reaction mixture was concentrated in vacuo, re-suspended in 
CHCl3 (5 mL) and washed with aqueous NaOH (1 M, 5 mL). The organic phase was dried 
over MgSO4 and the solvent was removed in vacuo to yield deprotected sensor 109 as a 
yellow residue (34.0 mg, 89%). 1H NMR (400 MHz, CDCl3) H 8.72-8.64 (m, 2H, Hg and Hj), 
8.30 (d, J = 8.5, 1H, Hi), 8.15 (s, 1H, Hl), 7.90 (s, 1H, He), 7.85 (d, J = 7.8, 1H, Hk), 7.83-7.78 (m, 
1H, Hh), 5.52 (s, 2H, Hf), 5.14 (s, 2H, Hd), 3.98 (s, 2H, Hm), 3.33-3.20 (m, 4H, Hc), 2.84-2.62 (m, 
12H, cyclam-H), 2.00-1.87 (m, 2H, Ho), 1.70-1.42 (m, 6H, Hn, Hq, Hp), 1.36-1.12 (m, 40H, Hb 
(4H), and alkyl-H (36H)), 0.90-0.82 (m, 6H, Ha). 
13C NMR (101 MHz, CDCl3) C  164.3, 163.4, 
162.9, 145.8, 143.5, 138.6, 132.5, 131.1, 129.9, 129.3, 128.6, 126.5, 125.3, 125.2, 123.8, 
123.6, 123.0, 55.2, 53.8, 51.0, 50.9, 50.0, 49.4, 48.8, 48.2, 48.0, 47.8, 47.4, 46.9, 35.6, 32.0, 
29.7, 29.7, 29.7, 29.6, 29.4, 29.3, 29.2, 28.8, 27.6, 27.1, 26.9, 26.3, 22.8, 14.2.  IR: ( max/cm
-
1) 2927, 2850, 1695, 1578, 1460, 1403, 1368, 1244, 1156, 807, 782. HRMS (EI) calcd for 
C54H86N12O3 [M + H]
+  951.7019, found 951.7022. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 
345 (8389) 
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Tri-tert-butyl 11-((1-(2-((1-(2-cholesterol)-2-oxoethyl)-1H-1,2,3-triazol-4-yl)methyl)-1,3-dioxo-
2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-1,4,8,11-
tetraazacyclotetradecane-1,4,8-tricarboxylate (110): 
 
Sensor 13 was prepared according to General Procedure A albeit at 0.05 M reaction 
concentration, using central building block 69 (0.31 g, 1.0 mmol), azide 85 and cyclam 
acetylene 65. Reaction times for each stage take longer due to dilution; 6 h, 48 h and 24 h 
respectively. The crude product was obtained obtained via precipitation with a saturated 
solution of EDTA in 17.5% aqueous NH3 (20 mL) and purified by flash column 
chromatography (1:1 Petrol:EtOAc) to yield protected sensor 110 as a yellow foam (0.36 g, 
28%).  1H NMR (400 MHz, CDCl3) H 8.70-8.58 (m, 2H, Hg and Hj), 8.24 (bs, 1H, Hl), 7.92-7.62 
(m, 4H, He and Hh, Hi and Hk), 5.51 (s, 2H, Hm), 5.34-5.29 (m, 1H, Ha), 5.08 (s, 2H, Hf), 4.62 (m, 
1H, Hc), 3.93 (bs, 2H, Hd), 3.50-3.15 (m, 12H, Cyclam-H), 2.74-2.68 (m, 2H, Ho), 2.60-2.52 (m, 
2H, Hn), 2.27 (d, J = 7.8, 2H, Hb), 2.27-0.75 (m, 71H, Cholesterol-H (40H), tBu (27H), cyclam 
(4H)), 0.64 (s, 3H, Hp). 
13C NMR (101 MHz, CDCl3)  C 165.6, 163.4, 162.8, 143.6, 139.0, 
138.4, 132.5, 131.1, 129.9, 129.2, 128.7, 126.4, 125.1, 123.6, 123.3, 122.7, 79.7, 76.5, 56.7, 
56.2, 51.1, 50.0, 42.3, 39.7, 39.5, 37.9, 36.8, 36.5, 36.2, 35.8, 35.3, 31.9, 31.8, 28.5, 28.5, 
28.2, 28.0, 27.6, 24.3, 23.9, 22.9, 22.6, 21.1, 19.3, 18.8, 11.9.IR: ( max/cm
-1) 2934 (broad), 
1751, 1677, 1588, 1465, 1410, 1365, 1232, 1159, 732. M.p. (oC) 122-125. HRMS (EI) calcd 
for C72H106N11O10 [M + H]
+ 1284.8119, found 1284.8101. UV: max(CH2Cl2)/nm ( / mol
-1cm-
1dm3) 344 (74038).  
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 (4-(4-((1,3-Dioxo-6-(4-((4,8,11-tris(tert-butoxycarbonyl)-1,4,8,11-tetraazacyclotetradecan-1-
yl)methyl)-1H-1,2,3-triazol-1-yl)-1H-benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-
yl)butyl)triphenylphosphonium (111): 
 
General procedure A was employed with 69 (314 mg, 1.00 mmol), azide 89 (0.45 g, 1.0 
mmol) in NMP (5 mL), followed by cyclam acetylene 65 (0.59 g, 1.1 mmol) and EtOH (5 mL).  
Crude product obtained by dilution of the reaction mixture with CH2Cl2 (10 mL), and 
washing the organic mixture with a saturated solution of EDTA in 17.5% aqueous NH3 (3 x 
15 mL). The organic phase was dried over MgSO4, concentrated in vacuo and triturated with 
EtOAc (3 x 30 mL). The resulting suspension was filtered, the filtrate concentrated in vacuo 
and purified by flash column chromatography (CH2Cl2/MeOH 99:1 to 9:1) to yield 111 as a 
yellow foam (0.84 g, 66%). 1H NMR (400 MHz, CDCl3) H 8.65-8.61 (m, 2H, Hg and Hj), 8.26-
8.21 (m, 1H, Hi), 8.02 (br s, 1H, Hl), 7.88-7.83 (m, 1H, Hk), 7.80 (dd, J = 7.4, 8.4, 1H, Hh), 7.75 
(s, 1H, He), 7.75-7.59 (m, 15H, 3 x Ph), 5.41 (s, 2H, Hf), 4.38 (t, J = 6.5, 2H, Hd), 3.93 (br s, 2H, 
Hm), 3.45-3.25 (m, 14H, cyclam-H (12H) and Hc), 2.74-2.68 (m, 2H, Ho), 2.55 (t, J = 5.5, 2H, 
Hn), 2.16 (quint, J = 6.7, 2H, Hb), 1.93-1.86 (m, 2H, Hq), 1.80-1.72 (m, 2H, Hp), 1.63-1.51 (m, 
2H, Ha), 1.48-1.30 (m, 27H, 3 x Boc). 
13C NMR (101 MHz, CDCl3) C 163.5, 163.0, 155.7, 
143.6, 138.6, 135.3, 135.3, 133.6, 133.5, 132.6, 131.2, 130.7, 130.6, 129.3, 128.7, 123.7, 
123.7, 122.9, 118.4, 117.5, 79.8, 48.8, 35.7, 30.0, 29.8, 28.7, 28.6, 21.5, 21.0, 19.4, 19.3 
(overlapping signals). IR: ( max/cm
-1) 2981, 2930, 1684, 1664, 1588, 1478, 1441, 1411, 1364, 
1237, 1157, 1111, 1050, 1049, 882. HRMS (EI) calcd for C29H48N3O2 [M – BF4]
+ 1174.6002, 
found 1174.5983. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 (3139) 
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 (4-(4-((6-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1,3-dioxo-
1H-benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-yl)butyl)triphenylphosphonium 
trifluoroacetate (112): 
 
Compound 111 (20 mg, 0.016 mmol) was dissolved in a solution of TFA (20%) in CH2Cl2 (1 
mL), and for 6 h at r.t. The reaction mixture was concentrated in vacuo, re-suspended in 
CHCl3 (5 mL) and washed with aqueous NaOH (1 M, 5 mL). The organic phase was dried 
over MgSO4 and the solvent was removed in vacuo to yield deprotected sensor 112 as a 
yellow residue (12.0 mg, 74%) 1H NMR (400 MHz, CDCl3) H 8.71-8.64 (m, 2H, Hg and Hj), 
8.30 (dd, J = 8.6, 0.9, 1H, Hi), 8.16 (s, 1H, Hl), 7.87 (d, J = 7.8, 1H, Hk), 7.83-7.58 (m, 16H, Hh 
and 3 x Ph), 7.80 (s, 1H, He), 5.46 (s, 2H, Hf), 4.47 (t, J = 6.3, 2H, Hd), 3.98 (s, 2H, Hm), 3.64-
3.55 (m, 2H, Hc), 2.87-2.64 (m, 16H, cyclam-H (12H) and Hn + Ho), 2.22 (app. quint, J = 6.6, 
2H, Hb), 1.99-1.90 (m, 2H, Hq), 1.74-1.65 (m, 2H, Hp), 1.63-1.52 (m, 2H, Ha).  
13C NMR (101 
MHz, CDCl3) C 163.5, 163.1, 145.6, 143.6, 138.7, 138.2, 135.2, 135.2, 133.7, 133.7, 132.6, 
131.2, 130.7, 130.6, 129.4, 128.7, 127.2, 126.7, 125.4, 123.8, 123.7, 123.0, 118.5, 117.9, 
53.9, 50.9, 49.4, 48.8, 48.7, 47.7, 44.0, 35.8, 29.8, 29.8, 21.2, 19.4. 19F NMR (376MHz, CDCl3) 
F -75.0. 
31P NMR (162 MHz, CDCl3) P 24.3. IR: ( max/cm
-1) 3509 (b), 2966, 2943, 1663, 
1585, 1482, 1443, 1419, 1363, 1325, 1232, 1167, 1108, 1030, 863, 802. HRMS (EI) calcd for 
[M – anion]+ 874.4429, found 874.4425. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 345 (10549) 
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tri-tert-Butyl 11-((1-(2-((1-(2-((2-(dimethylamino)ethyl)amino)-2-oxoethyl)-1H-1,2,3-triazol-4-
yl)methyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-
1,4,8,11-tetraazacyclotetradecane-1,4,8-tricarboxylate (113): 
 
General procedure A was employed with 69 (314 mg, 1.0 mmol), azide 92 (0.17 g, 1.0 
mmol) in NMP (5 mL), followed by cyclam acetylene 65 (0.59 g, 1.1 mmol) and EtOH (5 mL). 
The crude product was obtained by dilution of the reaction mixture with CH2Cl2 (10 mL), 
and washing the organic mixture with a saturated solution of EDTA in 17.5% aqueous NH3 
(3 x 15 mL). The organic phase was dried over MgSO4, concentrated in vacuo and purified 
by flash column chromatography on alumina (EtOAC to 9:1 EtOAc/MeOH) to yield 113 as a 
brown oil (0.67 g, 68%). 1H NMR (400 MHz, CDCl3) 8.75-8.69 (m, 2H, Hh and Hk), 8.34-8,26 
(m, 1H,Hj), 7.98-7.82 (m, 4H, Hf, Hi, Hl and Hm), 6.49 (br s, 1H, Hd), 5.56 (s, 2H, Hg), 4.99 (s, 
2H, He), 3.96 (br s, 2H, Hn), 3.49-3.25 (m, 12H, cyclam-H), 3.29 (q, J = 5.8, 2H, Hc), 2.70 (t, J = 
5.2, 2H, Hp), 2.58 (t, J = 5.8, 2H, Ho), 2.35 (t, J = 6.0, 2H, Hb), 2.15 (s, 6H, Ha (2 x CH3), 1.95-
1.70 (m, 4H, Hp + Hq), 1.49-1.35 (m, 27H, 3 x 
tBu). H 
13C NMR (101 MHz, CDCl3) C 164.9, 
163.5, 163.0, 143.9, 132.7, 131.2, 130.2, 130.1, 130.0, 129.4, 128.8, 126.6, 124.9, 123.7, 
123.7, 122.9, 79.8, 57.4, 53.2, 49.6, 45.1, 37.2, 35.5, 30.8, 28.7, 28.6, 17.8 (overlapping 
signals). IR: ( max/cm
-1) 3409, 2966, 2919, 2850, 1691, 1688, 1593, 1476, 1420, 1369, 1260, 
1165, 1096, 1017, 864, 801. HRMS (EI) calcd for C49H71N13O9 [M + H]
+ 986.5570, found 
986.5562. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 344 (43812). 
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2-(4-((6-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1,3-dioxo-
1H-benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(2-
(dimethylamino)ethyl)acetamide (114): 
 
 
 
 
 
 
 
 
Compound 113 (20.0 mg, 0.016 mmol) was dissolved in a solution of TFA (20%) in CH2Cl2 (1 
mL), and for 6 h at r.t.. The reaction mixture was concentrated in vacuo, re-suspended in 
CHCl3 (5 mL) and washed with aqueous NaOH (1 M, 5 mL). The organic phase was dried 
over MgSO4 and the solvent was removed in vacuo to yield deprotected sensor 114 as a 
yellow residue (8.9 mg, 63%) 1H NMR (400 MHz, CDCl3) H 8.72-8.66 (m, 2H, Hh + Hk), 8.31 
(d, J = 6.5, 1H, Hj), 8.15 (s, 1H, Hm), 7.87 (d, J = 7.8, 1H, Hl), 7.84 (s, 1H, Hm), 7.81 (dd, J = 7.4, 
8.5, 1H, Hi and Hl), 6.57 (br s, 1H, Hd), 5.53 (s, 2H, Hg), 4.99 (s, 2H, He), 3.98 (s, 2H, Hn), 3.28 
(q, J = 5.7, 2H, Hc), 2.85-2.60 (m, 16H, Ho and Hp and cyclam-H), 2.33 (t, J = 6.0, 2H, Hb), 2.13 
(s, 6H, Ha (2 x CH3)), 1.96-1.89 (m, 2H, Hr), 1.70-1.62 (m, 2H, Hq). 
13C NMR (101 MHz, CD3CN) 
C 168.4, 164.4, 163.8, 160.9, 160.7, 160.5, 144.1, 138.8, 132.9, 131.6, 130.4, 129.6, 129.6, 
127.1, 127.0, 126.6, 124.9, 118.3, 116.0, 58.5, 55.5, 52.9, 50.7, 49.0, 47.9, 47.7, 45.9, 45.5, 
44.1, 36.1, 35.7, 31.0, 24.7, 23.4, 18.2. IR: ( max/cm
-1). UV: max(CH2Cl2)/nm ( / mol
-1cm-
1dm3) 345 (11800) 
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 (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-((1-(3-(6-(4-((bis(pyridin-2-ylmethyl)amino)methyl)-
1H-1,2,3-triazol-1-yl)-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)-1H-1,2,3-triazol-4-
yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (115): 
 
General procedure B was employed with 70 (359 mg, 1.00 mmol), propargyl-glucose 94 
(0.36 g, 1.0 mmol) in NMP (3.33 mL), followed by propargyl dipicolylamine 96 (0.26 g, 1.1 
mmol) and EtOH (3.33 mL). Crude product obtained by dilution of the reaction mixture with 
CH2Cl2 (10 mL), and washing the organic mixture with a saturated solution of EDTA in 17.5% 
aqueous NH3 (3 x 15 mL). The organic phase was dried over MgSO4, concentrated in vacuo 
and purified by flash column chromatography on alumina  (gradient from 99:1 to 90:10 
CH2Cl2/MeOH) to yield 115 as a yellow foam (0.58 g, 61%). 
1H NMR (400 MHz, CDCl3) H 
8.75-8.70 (m, 2H, Hl + Ho), 8.58-8.54 (m, 2H, Hw), 8.32 (dd, J = 8.6, 1.0, 1H, Hn), 8.19 (s, 1H, 
Hq), 7.88-7.82 (m, 2H, Hm + Hp), 7.76 (s, 1H, Hh), 7.69 (td, J = 7.7, 1.8, 2H, Hu), 7.63-7.59 (m, 
2H, Ht), 7.20-7.16 (m, 2H, Hv), 5.22 (t, J = 9.5, 1H, Hd), 5.10 (t, J = 9.5, 1H, Hc), 5.03 (dd, J = 
9.5, 8.0, 1H, He), 4.94 (d, J = 12.7, 1H, one of Hg), 4.84 (d, J = 12.7, 1H, one of Hg), (4.69 (d, J 
= 7.9, 1H, Hf), 4.56-4.48 (m, 2H, Hk), 4.33-4.24 (m, 3H, Hi and one of Ha), 4.17 (dd, J = 12.2, 
2.2, 1H, one of Ha), 4.08 (s, 2H, Hr), 3.96 (s, 4H, Hs), 3.80-3.74 (m, 1H, Hb), 2.43 (app. quint, J 
= 6.5, 2H, Hj), 2.09 (s, 3H, Ac), 2.02 (s, 3H, Ac), 2.00 (s, 3H, Ac), 1.99 (s, 3H, Ac). 
13C NMR (101 
MHz, CDCl3) C 170.8, 170.3, 169.5, 163.9, 163.4, 159.1, 149.3, 145.1, 144.1, 138.8, 136.7, 
132.6, 131.2, 130.3, 129.3, 128.7, 126.6, 125.8, 123.6, 123.6, 123.5, 123.3, 122.7, 122.4, 
99.6, 72.9, 72.0, 71.4, 68.6, 62.9, 62.0, 59.9, 53,5, 48.6, 48.4, 37.9, 29.0, 20.9, 20.8, 20.7 
(overlapping signals). IR: ( max/cm
-1) 3454 (weak), 3138, 3006, 2958, 1753, 1704, 1660, 
1588, 1435, 1361, 1218, 1038, 995, 905, 785, 755. HRMS (EI) calcd for C47H48N10O12 [M + H]
+ 
945.3526, found 945.3517. UV: max(CH2Cl2)/nm ( / mol-1cm-1dm3) 344 (16280)  
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6-(4-((bis(pyridin-2-ylmethyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-2-(3-(4-((((2R,3R,4S,5S,6R)-
3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-1,2,3-triazol-1-
yl)propyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (116): 
 
 
Following a modified literature procedure, sensor 115 (25 mg, 0.026 mmol) was dissolved in 
MeOH (0.5 mL) and NaOMe (0.3 eq) was added to the solution. The reaction mixture was 
stirred for 4 h, and evaporated to dryness in vacuo to yield deprotected sensor 116 as a 
yellow residue (16.0 mg, 79%). 1H NMR (400 MHz, MeOD) H 8.84-8.77 (m, 2H, Hl + Ho), 8.60 
(s, 1H, Hq), 8.58-8.55 (m, 2H, Hw), 8.33 (d, J = 8.6, 1H, Hn), 8.17 (s, 1H, Hh), 8.07 (d, J = 7.8, 
1H, Hp), 8.04-7.98 (m, 1H, Hm), 7.90 (td, J = 7.7, 1.6, 2H, Hu), 7.86-7.81 (m, 2H, Ht), 7.41-7.35 
(m, 2H, Hm), 5.01 (d, J = 12.5, 1H, one of Hg), 4.86-4.82 (m, 1H, one of Hg – obscured by 
solvent peak, identified by cross peak on COSY), 4.66 (t, J = 6.8, 2H, Hk), 4.48 (d, J = 7.7, 1H, 
Hf), 4.39 (t, J = 7.0, 2H, Hi), 4.16 (s, 2H, Hr), 4.06 (s, 4H, Hs), 4.00 (dd, J = 12.1, 1.6, 1H, one of 
Ha), 3.80 (dd, J = 11.8, 5.3, 1H, one of Ha), 3.50-3.40 (m, 3H, Hc and Hd and He – obscured by 
solvent peak, identified by cross peak on COSY), 3.34 (dd, J = 9.0, 7.8, 1H, Hb), 2.54 (quint, J 
= 7.0, 2H, Hj). 
13C NMR (101 MHz, CDCl3) C 159.8, 149.3, 145.3, 139.4, 138.5, 133.2, 131.8, 
130.1, 127.5, 125.2, 124.8, 123.7, 120.7, 103.1, 95.6, 77.7, 77.6, 74.7, 71.4, 62.7, 62.6, 60.5, 
49.8, 49.6, 38.7. IR: ( max/cm
-1) 3378 (broad), 2929, 2831, 1699, 1659, 1623, 1592, 1476, 
1434, 1394, 1352, 1268, 1233, 1103, 1082, 1046, 996, 842. HRMS (EI) calcd for C39H40N10O8 
[M + H]+ 777.3103, found 777.3104. UV: max(CH2Cl2)/nm ( / mol
-1cm-1dm3) 345 (13126). 
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6-bromo-2-(2,2-diphenylethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (138) 
 
4-bromo-1,8-naphthalic anhydride (1.5 g, 5.4 mmol) was dissolved in EtOH (45 mL). 
Diphenyl ethylamine (1.3 g, 6.5 mmol) was added to the solution and refluxed at 80 °C for 
18 h. After cooling the reaction mixture to r.t., and then on ice, the resulting precipitate 
was collected by suction filtration and dried in vacuo to give bromide 138 as a light brown 
solid (2.4 g, 97%). 1H NMR (400 MHz, CDCl3) H 8.56 (dd, J = 7.4, 0.8, 1H, Hf) 8.52 (dd, J = 8.4, 
0.8, 1H, Hh), 8.32 (d, J = 7.8, 1H, Hi), 7.99 (d, J = 7.8, 1H, Hj), 7.79 (dd, J = 8.4, 7.4, 1H, Hg), 
7.38-7.32 (m, 4H, Hc), 7.28-7.20 (m, 4H, Hb), 7.17-7.12 (m, 2H, Hc), 4.88-4.78 (m, 3H, Hd and 
He). 
13C NMR (101 MHz, CDCl3) C  163.6, 163.6, 141.6, 133.2, 132.0, 131.2, 131.0, 130.5, 
128.9, 128.5, 128.4, 128.0 126.7, 122.9, 122.0, 48.7, 44.6. IR: ( max/cm
-1) 3120, 1704, 1650, 
1570, 1320, 1009, 960, 740. M.p. (°C) 136-140. LRMS (ES+) 456. UV: max(MeCN)/nm ( / 
mol-1cm-1dm3) 341 (11395). 
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6-azido-2-(2,2-diphenylethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (139) 
 
Bromide 138 (0.82 g, 1.8 mmol) was stirred with NaN3 (0.23 g, 3.6 mmol) in NMP (20 mL) at 
r.t. for 24 h. After reducing the volume to ~5 mL in vacuo, the reaction was diluted with 
EtOAc (30 mL) and washed with brine (3 x 30 mL). The organic layer was dried with MgSO4, 
filtered and concentrated in vacuo. The crude product was purified by flash column 
chromatography (8:2 Petrol/EtOAc) to yield azide 139 as a brown solid (0.45 g, 59%).  1H 
NMR (400 MHz, CDCl3) H 8.54 (dd, J = 7.3, 0.9, 1H, Hf), 8.49 (d, J = 8.0, 1H, Hi), 8.39 (dd, J = 
8.4, 0.9, 1H, Hh), 7.69 (dd, J = 8.2, 7.5, 1H, Hg), 7.42 (d, J = 8.0, 1H, Hj), 7.38-7.33 (m, 4H, Hc), 
7.27-7.20 (m, 4H, Hb), 7.17-7.11 (m, 2H, Ha), 4.87-4.78 (m, 3H, Hd and He). 
13C NMR (101 
MHz, CDCl3) C 
13C NMR (101 MHz, CDCl3) δ 164.9, 164.4, 158.9, 158.7, 155.6, 151.4, 142.3, 
137.8, 130.6, 129.1, 128.7, 128.3, 126.5, 123.5, 122.3, 122.3, 122.2, 121.2, 120.1, 115.0, 
73.1, 70.9, 66.7, 49.0, 44.2, 42.6, 35.0, 31.5, 24.8. IR: ( max/cm
-1) 3140, 2923, 2110, 1650, 
1560, 1290, 1233, 1046. M.p. (°C) 162-165. HRMS (EI) calcd for C26H18N4O2 [M + Na]
+ 
491.1133, found 491.1121. UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 364 (3937). 
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Rotaxane 140 
 
General procedure C was employed with macrocyle 136 (0.20 g, 0.41 mmol) acetylene 123 
(0.09 g, 0.41 mmol), azide 139 (0.19 g, 0.41 mmol), [Cu(MeCN)4]PF6 (0.15 g, 0.40 mmol), 
and DIPEA (72 μL, 0.41 mmol) in EtOH (20 mL). Purification as noted gave rotaxane 150 as a 
light brown foam (0.41 g, 88%). 1H NMR (400 MHz, CDCl3) H 10.30 (s, 1H, Hk), 8.43 (dd, J = 
7.3, 1.0, 1H, Hf), 8.21 (dd, J = 8.5, 1.0, 1H, Hh), 8.13 (d, J = 7.9, 1H, Hi), 7.84 (d, J = 1.8, 2H, Hl), 
7.52 (dd, J = 8.5, 7.3, 1H, Hg), 7.46-7.36 (m, 7H, Hh, HB and Hc), 7.31 (t, J = 1.8,1H, Hm), 7.29-
7.23 (m, 6H, two of HA/HC and Hb), 7.20-7.14 (m, 4H, two of HA/HC and Ha), 6.71 (d, J = 8.5, 
4H, HF), 6.56 (d, J = 8.5, 4H, HG), 4.88-4.82 (m, 3H, Hd and He), 4.57 (d, J = 12.1, 2H, two of 
HE), 4.47 (ap. t, J = 6.6, 4H, HH), 4.16 (d, J = 12.1, 2H, two of HE), 3.97 (d, J = 12.3, 2H, two of 
HD), 3.90 (d, J = 12.3, 2H, two of HD), 2.40-2.30 (m, 2H, two of HI), 2.25-2.13 (m, 2H, two of 
HI), 1.32 (s, 18H, 2 x 
tBu). 13C NMR (101 MHz, CDCl3) C 
13C NMR (101 MHz, CDCl3) δ 164.9, 
164.4, 158.9, 158.7, 155.6, 151.4, 142.3, 137.8, 130.6, 129.1, 128.7, 128.3, 126.5, 122.2, 
121.2, 120.1, 115.0, 49.0, 44.2, 42.5, 35.0, 31.5, 24.8. IR: ( max/cm
-1) 2965, 2902, 2840, 
2347, 1713, 1679, 1598, 1253, 1079, 990. M.p. (°C) 45-50. HRMS (EI) calcd for C72H70N6O6 [M 
+ H]+ 1115.5430, found 1115.5429. UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 345 (9874). 
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2-(2,2-diphenylethyl)-6-((2-hydroxyethyl)amino)-1H-benzo[de]isoquinoline-1,3(2H)-dione 
(144) 
 
To a solution of bromide 138 (0.3 g, 0.64 mmol)  in DMSO (10 mL) was added Cu2O (1.8 mg, 
0.013 mmol) , K2CO3 (18.0 mg, 0.13 mmol) and ethanolamine (0.39 mL, 6.4 mmol), and was 
heated at 90oc overnight. The reaction mixture was diluted with brine (40 mL), and the 
aqueous portion extracted with EtOAc (2 x 40 mL). The organic phase was dried with 
MgSO4, filtered and concentrated in vacuo. The resulting oil was purified by flash column 
chromatography (CH2Cl2 to 7:3 CH2Cl2/EtOAc) to give alcohol 144 as an orange foam (0.27 g, 
96%).  1H NMR (400 MHz, CDCl3) H 8.21 (d, J = 7.2, 1H, Hf), 8.14 (d, J = 8.4, 1H, Hi), 7.56 (d, J 
= 8.4, 1H, Hh), 7.35-7.30 (m, 4H, Hc), 7.27 (ap. t, J = 7.8, 1H, Hg), 7.20-7.14 (m, 4H, Hb), 7.09-
7.03 (m, 2H, Ha), 6.44 (d, J = 8.4, 1H, Hj), 5.43 (bs, 1H, -NH-), 4.83-4.78 (m, 1H, Hd), 4.75-4.69 
(m, 2H, He), 3.94 (t, J = 4.9, 2H, Hl), 3.41 (t (broad), J = 4.4, 2H, Hk).
13C NMR (101 MHz, CDCl3) 
C 164.7, 164.4, 149.4, 142.2, 134.3, 131.2, 129.5, 128.7, 128.5, 126.7, 125.8, 124.7, 122.7, 
120.1, 110.2, 104.4, 60.6, 49.1, 45.6, 44.5. IR: ( max/cm
-1) 3505, 2950, 2350, 1699, 1635, 
1589, 1380, 1340, 1180. M.p. (°C) 43-45. LRMS (ES+) 437 [M + H+]. UV: max(MeCN)/nm ( / 
mol-1cm-1dm3) 432 (2347). 
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6-((2-azidoethyl)amino)-2-(2,2-diphenylethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (141) 
 
Alcohol 144 (0.13 g, 0.29 mmol) and triphenylphosphine (0.23 g, 0.87 mmol) were 
combined in a sealed flask which was purged with N2. Anhydrous THF (15 mL) was added, 
and the stirring solution was cooled to 0 °C. DEAD (0.14 mL, 0.87 mmol) was added to the 
reaction, followed by diphenyl phosphoryl azide (0.20 mL, 0.87 mmol), and stirred for 15 
mins. The reaction was then stirred at rt for 2 h, and then concentrated in vacuo. The 
resulting oil was purified by flash column chromatography (1:1 Petrol/ CH2Cl2 to CH2Cl2 to 
7:3 CH2Cl2/EtOAc) to give azide 141 as an orange solid (0.085 g, 61%). 
1H NMR (400 MHz, 
CDCl3) H 8.50 (d, J = 7.2, 1H, Hf), 8.40 (d, J = 8.3, 1H, Hi), 8.05 (d, J = 8.4, 1H, Hh), 7.61 (ap. t, 
J = 7.4, 1H, Hg), 7.42-7.34 (m, 4H, Hc), 7.28-7.20 (m, 4H, Hb), 7.16-7.11 (m, 2H, Ha), 6.70 (d, J 
= 8.4, 1H, Hj), 5.39 (br s, 1H, -NH-), 4.89-4.80 (m, 3H, Hd and He), 3.73 (t, J = 5.1, 2H, Hl), 
3.65-3.57 (m, 2H, Hk). 
13C NMR (101 MHz, CDCl3) C 164.5, 164.0, 148.4, 142.0, 140.8, 134.0, 
131.3, 128.5, 128.3, 126.5, 125.7, 125.1, 123.2, 120.5, 104.5, 49.9, 48.8, 44.3, 42.6. IR: ( 
max/cm
-1) 3350, 2954, 2101, 1695, 1658, 1580, 1347, 1235, 1120, 1052, 952. M.p. (°C) 90-95. 
LRMS (ES+) 462 [M + H+], 484 [M + Na]. UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 410 (3856). 
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2-(2,2-diphenylethyl)-6-((2-hydroxyethyl)thio)-1H-benzo[de]isoquinoline-1,3(2H)-dione (145) 
 
To a solution of bromide 138 (0.3 g, 0.64 mmol)  in DMSO (10 mL) was added Cu2O (1.8 mg, 
0.013 mmol) , K2CO3 (18.0 mg, 0.13 mmol) and 2-thioethanol (0.46 mL, 6.4 mmol), and was 
heated at 90oc overnight. The reaction mixture was diluted with brine (40 mL), and the 
aqueous portion extracted with EtOAc (2 x 40 mL). The organic phase was dried with 
MgSO4, filtered and concentrated in vacuo. The resulting oil was purified by flash column 
chromatography (CH2Cl2 to 8:2 CH2Cl2/EtOAc) to give alcohol 145 as an yellow foam (0.24 g, 
82%). 1H NMR (400 MHz, CDCl3) H 8.50-8.44 (m, 2H, Hf and Hh), 8.31 (d, J = 7.8, 1H, Hi), 7.63 
(dd, J = 8.3, 7.5, 1H, Hg), 7.54 (d, J = 7.9, 1H, Hj), 7.37-7.31 (m, 4H, Hc), 7.24-7.18 (m, 4H, Hb) 
7.15-7.09 (m, 2H, Ha), 4.83-4.79 (m, 3H, Hd and He), 3.94-3.86 (m, 2H, Hl), 3.31 (t, J = 6.2, 2H, 
Hk). 
13C NMR (101 MHz, CDCl3) C 163.9, 163.9, 143.5, 141.7, 131.6, 130.6, 130.01, 129.8, 
128.5, 128.4, 128.3, 128.2, 126.8, 126.6, 123.9, 122.9, 119.6, 60.4, 48.8, 44.5, 35.5. IR: ( 
max/cm
-1) 3505, 2940, 2346, 1695, 1640, 1559, 1352, 1245, 973. . M.p. (°C) 39-41. LRMS (ES+) 
454 [M + H+], 476 [M + Na]. UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 389 (5331). 
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6-((2-azidoethyl)thio)-2-(2,2-diphenylethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (143)  
 
Alcohol 145 (0.13 g, 0.28 mmol) and triphenylphosphine (0.22 g, 0.83 mmol) were 
combined in a sealed flask which was purged with N2. Anhydrous THF (12 mL) was added, 
and the stirring solution was cooled to 0 °C. DEAD (0.13 mL, 0.83 mmol) was added to the 
reaction, followed by diphenyl phosphoryl azide (0.19 mL, 0.83 mmol), and stirred for 15 
mins. The reaction was then stirred at r.t. for 2 h, and then concentrated in vacuo. The 
resulting oil was purified by flash column chromatography (1:1 Petrol/ CH2Cl2 to CH2Cl2 to 
8:2 CH2CL2/EtOAc) to give azide 143 as an orange foam (0.095 g, 72%).  1H NMR (400 MHz, 
CDCl3) H 8.57-8.49 (m, 2H, Hf and Hh), 8.39 (d, J = 7.8, 1H, Hi), 7.71 (dd, J = 7.5, 8.2, 1H, Hg), 
7.57 (d, J = 7.8, 1H, Hj), 7.40-7.31 (m, 4H, Hc), 7.27-7.18 (m, 4H, Hb), 7.16-7.10 (m, 2H, Ha), 
4.85-4.80 (m, 3H, Hd and He), 3.58 (t, J = 6.7, 2H, Hl), 3.30 (t, J = 6.7, 2H, Hk).
13C NMR (101 
MHz, CDCl3) C 163.9, 163.9, 142.6, 141.8, 131.8, 130.7, 130.3, 130.1, 129.8, 129.7, 128.6, 
128.5, 127.1, 126.7, 124.7, 124.5, 123.1, 120.4, 120.3, 120.2, 49.8, 48.8, 44.6, 32.3. IR: ( 
max/cm
-1) 3505, 2950, 2351, 2101, 1705, 1669, 1590, 1379, 1345, 1228. M.p. (°C) 45-48. 
HRMS (EI) calcd for C28H22N4O2S [M +Na]
+ 501.1356, found 501.1358.UV: max(MeCN)/nm ( 
/ mol-1cm-1dm3) 381 (6093). 
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2-(2,2-diphenylethyl)-6-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione (147) 
 
4-nitro-1,8-naphthalic anhydride (0.5 g, 2.1 mmol) was dissolved in EtOH (15 mL). Diphenyl 
ethylamine (0.49 g, 2.5 mmol) was added to the solution and refluxed at 80 °C for 18 h. 
After cooling the reaction mixture to r.t., the solvent was removed in vacuo and purified by 
flash column chromatography (1:1 Petrol/ CH2Cl2) to give nitro-compound 147 as a yellow 
foam (0.75 g, 86%). 1H NMR (400 MHz, CDCl3) H 8.79 (dd, J = 8.7, 1.0, 1H, Hh), 8.64 (dd, J = 
7.3, 1.0, 1H, Hf), 8.58 (d, J = 8.0, 1H, Hj), 8.34 (d, J = 8.0, 1H, Hi), 7.93 (dd, J = 8.7, 7.4, 1H, Hg), 
7.37-7.32 (m, 4H, Hc), 7.27-7.21 (m, 4H, Hb), 7.18-7.13 (m, 2H, Ha), 4.89-4.85 (m, 2H, He), 
4.82-4.71 (m, 1H, Hd). 
13C NMR (101 MHz, CDCl3) C 163.3, 162.4, 149.5, 141.3, 132.4, 129.9, 
129.7, 129.3, 128.9, 128.4, 128.4, 126.8, 126.7, 123.8, 123.6, 122.8, 48.5, 44.8, 34.1, 22.3, 
14.1. IR: ( max/cm
-1) 3405, 2905, 1692, 1620, 1577, 1520, 1375, 1313, 1226, 1181, 989. M.p. 
(°C) 40-43. LRMS (ES+) 423 [M +H+]. UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 347 (10978). 
 
 
 
 
 
 
 
 
 
 
 
Experimental Section 
 
 
233 
 
 
 
 
Experimental Section 
 
 
234 
 
2-(2,2-diphenylethyl)-6-amino-1H-benzo[de]isoquinoline-1,3(2H)-dione (148) 
 
Nitro-compound 147 (0.36 g, 0.95 mmol) was hydrogenated in MeOH/EtOAc (1:1, 20 mL) at 
r.t. under a hydrogen atmosphere, using a Pd/C catalyst (5%wt, 0.20g, 0.095 mmol, ). The 
reaction was monitored by TLC until all starting material had been consumed (~4 h). The 
reaction mixture was filtered through Celite, washed with MeOH/EtOAc (1:1), and the 
solvent evaporated in vacuo to yield aniline 148 as a yellow solid (0.36 g, 97%). 1H NMR 
(400 MHz, DMSO-d6) H 8.57 (d, J = 8.0, 1H, Hh), 8.34 (d, J = 6.8, 1H, Hf), 8.12 (d, J = 8.4, 1H, 
Hi), 7.60 (dd, J = 7.7, 8.0, 1H, Hg), 7.42 (br s, 1H, -NH2-), 7.35-7.30 (m, 4H, Hc), 7.26-7.20 (m, 
4H, Hb), 7.16-7.11 (m, 2H, Ha), 7.80 (d, J = 8.4, 1H, Hj), 4.73-4.69 (m, 3H, Hd and He).
13C NMR 
(101 MHz, DMSO-d6) C 163.8, 162.9, 152.6, 142.2, 133.9, 130.9, 129.6, 129.3, 128.2, 128.0, 
126.4, 123.9, 121.6, 119.2, 108.1, 107.3, 48.4, 43.3. IR: ( max/cm
-1) 3505, 3349, 3225, 2358, 
1648, 1592, 1375, 1246, 1017. 982. M.p. (°C) 95-96. LRMS (ES+) 393 [M +H+]. UV: 
max(MeCN)/nm ( / mol
-1cm-1dm3) 428 (3226). 
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2-chloro-N-(2-(2,2-diphenylethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-
yl)acetamide (149) 
 
Aniline 148 (0.36 g, 0.92 mmol)  and DMAP (56 mg, 0.46 mmol) were combined in a sealed 
flask which was purged with N2. Anhydrous THF (15 mL) was added, and the stirring 
solution was cooled to 0 °C. A solution of 2-chloroacetyl chloride (0.12 mL, 1.4 mmol) in 
anhydrous THF (10 mL) was added to the cold stirring solution dropwise over 20 min. The 
solution was then stirred at r.t. for 6 h. The reaction mixture was diluted with H2O (30 mL) 
and stirred vigorously, then extracted with EtOAc (3 x 30 mL). The combined organic phase 
was washed with brine (30 mL) and saturated aqueous NaHCO3 (2 x 30 mL), dried using 
MgSO4, filtered and concentrated in vacuo to yield amide 149 without further purification 
as a yellow solid (0.42 g, 98%).1H NMR (400 MHz, CDCl3) H 9.08 (s, 1H, -NH-), 8.56-8.50 (m, 
2H, Hf and Hi), 8.40 (d, J = 8.1, 1H, Hj), 8.13 (dd, J = 8.5, 0.7, 1H, Hh), 7.76 (dd, J = 8.4, 7.4, 1H, 
Hg), 7.38-7.33 (m, 4H, Hc), 7.26-7.20 (m, 4H, Hb), 7.17-7.11 (m, 2H, Ha), 4.88-4.80 (m, 3H, Hd 
and He), 4.37 (s, 2H, Hk).
13C NMR (101 MHz, CDCl3) C 164.2, 163.9, 163., 141.66, 137.0, 
132.1, 131.3, 128.7, 128.5, 128.4, 127.18, 126.6, 125.7, 123.8, 123.3, 119.5, 119.1, 48.7, 
44.5, 43.4, 30.9. IR: ( max/cm
-1) 3465, 3202, 2965, 2345, 1729, 1690, 1594, 1565, 1293, 
1203, 1101, 979.. M.p. (°C) 139-144. LRMS (ES+) 469 [M +H+], 491 [M + Na].. UV: 
max(MeCN)/nm ( / mol
-1cm-1dm3) 360 (10571). 
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2-azido-N-(2-(2,2-diphenylethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-
yl)acetamide (142) 
 
Chloride 149 (0.4 g, 0.85 mmol) and NaN3 (0.11 g, 1.71 mmol) were dissolved in DMF (60 
mL) and stirred at r.t. for 24 h. The mixture was diluted with brine (100 mL) and the 
aqueous layer was extracted with EtOAc (3 x 100 mL). The organic phases were combined 
and washed with saturated aqueous NaHCO3 (150 mL), dried with MgSO4, filtered and 
concentrated in vacuo. The resulting residue was purified by flash column chromatography 
(9:1 CH2Cl2/EtOAc) to give azide 142 as a brown solid (0.34 g, 84%). 
1H NMR (400 MHz, 
CDCl3) H 8.87 (s, 1H, -NH-), 8.54-8.47 (m, 2H, Hf and Hi), 8.41 (d, J = 8.2, 1H, Hj), 8.13 (d, J = 
8.4, 1H, Hh), 7.76 (ap. t, J = 7.8, 1H, Hg), 7.39-7.32 (m, 4H, Hc), 7.27-7.20 (m, 4H, Hb), 7.17-
7.10 (m, 2H, Ha), 4.87-4.80 (m, 3H, Hd and He), 4.35 (s, 2H, Hk). 
13C NMR (101 MHz, CDCl3) C 
164.8, 163.9, 163.4, 141.6, 137.1, 132.1, 131.3, 128.7, 128.5, 128.4, 127.0, 126.6, 125.7, 123.6, 123.3, 
119.2, 118.9, 53.2, 48.7, 44.5. IR: ( max/cm
-1) 3460, 3207, 2966, 2339, 2105, 1730, 1696, 1588, 
1306, 1212, 1089 M.p. (°C) 146-149. HRMS (EI) calcd for C28H21N5O3 [M + H]
+ 476.1717, 
found 476.1710.UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 361 (10925). 
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Rotaxane 150 
 
General procedure C was employed with macrocyle 136 (0.20 g, 0.41 mmol) acetylene 123 
(0.09 g, 0.41 mmol), azide 141 (0.17 g, 0.41 mmol), [Cu(MeCN)4]PF6 (0.15 g, 0.40 mmol), 
and DIPEA (72 μL, 0.41 mmol) in EtOH (20 mL). Purification as noted gave rotaxane 140 as 
an orange residue (0.35  g, 72%). 1H NMR (400 MHz, CDCl3) H 8.21-8.13 (m, 2H, Hi and Hf), 
7.49-7.43 (m, 3H, Hh and HB), 7.40-7.36 (m, 2H, Hn), 7.28-7.20 (m, 6H, Hc and two of HA/HC), 
7.08-7.01 (m, 7H, Hb, Ho and two of HA/HC), 6.96-6.91 (m, 2H, Ha), 6.89 (dd, J = 8.3, 7.5, 1H, 
Hg), 6.63 (d, J = 8.5, 4H, HF), 6.40 (d, J = 8.5, 4H, HG), 5.58 (d, J = 8.6, 1H, Hj), 4.79-4.73 (m, 
1H, Hd), 4.70-4.61 (m, 2H, He), 4.36 (d, J = 11.8, 2H, two of HE), 4.11 (d, J = 12.0, 2H, two of 
HD), 4.02 (d, J = 11.8, 2H, two of HE), 3.90 (d, J = 12.0, 2H, two of HD), 3.89-3.83 (m, 4H, HH), 
3.42-3.35 (m, 2H, Hl), 1.98-1.73 (m, 6H, Hk and HI), 1.17 (s, 18H, 2 x 
tBu).13C NMR (101 MHz, 
CDCl3) C 
13C NMR (101 MHz, CDCl3) δ 159.0, 158.8, 155.8, 151.6, 148.5, 142.4, 137.9, 134.4, 
130.7, 130.2, 130.0, 129.3, 128.9, 128.8, 128.4, 126.6, 123.6, 122.5, 122.5, 122.4, 121.4, 
120.7, 120.6, 120.3, 115.2, 109.3, 104.7, 73.2, 71.0, 66.9, 49.2, 47.1, 44.3, 42.7, 35.2, 31.7, 
24.9. IR: ( max/cm
-1) 2965, 2902, 2840, 2347, 1703, 1660, 1579, 1203, 1191, 1006, 979.. 
HRMS (EI) calcd for C74H74N7O6 [M + H]
+ 1158.5852, found 1158.5860. UV: max(MeCN)/nm 
( / mol-1cm-1dm3) 436 (15720). 
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Rotaxane 152 
 
General procedure C was employed with macrocyle 136 (0.20 g, 0.41 mmol) acetylene 123 
(0.09 g, 0.41 mmol), azide 142 (0.20 g, 0.41 mmol), [Cu(MeCN)4]PF6 (0.15 g, 0.40 mmol), 
and DIPEA (72 μL, 0.41 mmol) in EtOH (20 mL). Purification as noted gave rotaxane 152 as a 
yellow residue (0.29 g, 60%). 1H NMR (400 MHz, CDCl3) H 10.59 (s, 1H, -NH-), 8.59 (dd, J = 
8.6, 0.8, 1H, Hf), 8.46 (d, J = 8.3, 1H, Hi), 8.35 (dd, J = 7.3, 0.8, 1H, Hh), 7.86 (d, J = 8.4, 1H, Hj), 
7.81-7.77 (m, 4H, Hm and HB), 7.65 (d, J = 7.7, 2H, two of HA/HC), 7.58 (s, 1H, Hl), 7.52 (d, J = 
7.7, 2H, two of HA/HC), 7.46 (t, J = 1.8, 1H, Hn), 7.43-7.40 (m, 4H, Hc), 7.29-7.24 (m, 4H, Hb), 
7.18-7.14 (m, 2H, Ha), 7.09 (dd, J = 8.5, 7.3, 1H, Hg), 6.85 (d, J = 8.6, 4H, HF), 6.54 (d, J = 8.6, 
4H, HG), 4.92-4.84 (m, 5H, Hd, He and Hk), 4.59 (d, J = 11.8, 2H, two of HE), 4.33 (d, J = 11.8, 
2H, two of HE), 4.31 (d, J = 12.8, 2H, two of HD), 4.07 (d, J = 12.8, 2H, two of HD), 4.06-4.03 
(m, 4H, HH), 2.11-1.93 (m, 4H, HI), 1.44 (s, 18H,2 x 
tBu) 13C NMR (101 MHz, CDCl3) C  164.5, 
163.9, 163.1, 159.4, 159.2, 155.3, 151.4, 148.3, 141.9, 141.7, 139.7, 138.1, 132.4, 130.7, 
130.3, 129.8, 128.6, 128.5, 128.3, 128.1, 126.5, 125.1, 122.8, 122.5, 122.2, 122.1, 121.7, 
121.4, 120.1, 117.4, 117.0, 115.2, 73.1, 70.3, 66.4, 52.3, 48.9, 44.3, 35.0, 31.5, 31.3, 24.6. IR: 
( max/cm
-1) 3207, 2966, 2857, 2339, 1730, 1696, 1588, 1306, 1212, 1093, 983. HRMS (EI) 
calcd for C74H72N7O7 [M + H]
+ 1172.5644, found 1172.5648. UV: max(MeCN)/nm ( / mol
-
1cm-1dm3) 380 (11905). 
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Thread 153 
 
Azide 142 (44 mg, 0.093 mmol), alkyne 123 (20 mg, 0.093 mmol) and [Cu(MeCN)4]PF6 (8.7 
mg, 0.023 mmol) were weighed dry into a sealed flask and purged with N2. CH2Cl2 (1 mL) 
was added, followed by DIPEA (1 drop) and the mixture stirred at r.t. for 4 h. The solvent 
was diluted with CH2Cl2 (4 mL) and washed with 16% aqueous EDTA tetrasodium-saturated 
ammonia solution (5 mL). The organic layer was retained and the aqueous layer extracted 
twice further with CH2Cl2. The organic extracts were combined, dried over MgSO4, filtered 
and dried in vacuo. The crude mixture was purified by flash column chromatography (1:1 
Petrol/CH2CL2 to 10% MeCN/1:1 Petrol-CH2CL2) to yield the product 153 as a yellow 
residue (57 mg, 89%). 1H NMR (400 MHz, CDCl3) H  9.56 (br s, 1H, -NH-), 8.53-8.46 (m, 2H, 
Hf and Hi), 8.41 (d, J = 8.2, 1H, Hj), 8.12 (d, J = 8.4, 1H, Hh), 8.05 (s, 1H, Hl), 7.73 (ap. t, J = 8.0, 
1H, Hg), 7.69 (d, J = 1.7, 2H, Hm), 7.47 (t, J = 1.7, 1H, Hn), 7.37-7.30 (m, 4H, Hc), 7.25-7.18 (m, 
4H, Hb), 7.16-7.09 (m, 2H, Ha), 5.43 (s, 2H, Hk), 4.87-4.79 (m, 3H, Hd and He), 1.37 (s, 18H, 2 x 
tBu) 13C NMR (101 MHz, CDCl3) C 163.9, 163. 5, 160.8, 151.7, 150.8, 149.9, 141.6, 137.4, 
131.9, 131.3, 128.7, 128.5, 128.33, 127.3, 126.6, 126.3, 123.6, 123.2, 123.0, 121.9, 120.3, 
119.2, 118.8, 54.0, 48.7, 44.5, 34.9, 31. 4, 31.2, 30.9, 22.3, 14.0. IR: ( max/cm
-1) 3202, 2956, 
2851, 2347, 1740, 1689, 1591, 1313, 1201, 1012. HRMS (EI) calcd for C44H43N5O3 [M + H]
+ 
690.3439, found 690.3436  UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 361 (14285). 
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Rotaxane 154 
 
General procedure C was employed with macrocyle 136 (0.25 g, 0.52 mmol) acetylene 123 
(0.11 g, 0. 52 mmol), azide 143 (0.25 g, 0. 52 mmol), [Cu(MeCN)4]PF6 (0.18 g, 0.50 mmol), 
and DIPEA (90 μL, 0. 52 mmol) in EtOH (25 mL). Purification as noted gave rotaxane 154 as a 
pale yellow foam (0.52 g, 86%).  1H NMR (400 MHz, CDCl3) H 9.41 (s, 1H, Hm), 8.43 (d, J = 
7.2, 1H, Hf), 8.33 (d, J = 8.3, 1H, Hh), 7.76 (d, J = 7.8, 1H, Hi), 7.67-7.61 (m, 3H, Hg and HB), 
7.61-7.59 (m, 2H, two of HC/HA), 7.47-7.42 (m, 4H, Hn and two of HC/HA), 7.41-7.37 (m, 4H, 
Hc), 7.27 (t, J = 1.6, 1H, Ho), 7.27-7.22 (m, 4H, Hb), 7.17-7.11 (m, 2H, Ha), 6.90 (d, J = 7.8, 1H, 
Hj), 6.82 (d, J = 8.5, 4H, HF), 6.71 (d, J = 8.5, 4H, HG), 4.87-4.83 (m, 3H, Hd and He), 4.62 (d, J = 
11.8, 2H, two of HE), 4.58-4.50 (m, 2H, two of HH), 4.21 (d, J = 11.8, 2H, two of HE), 4.14-4.07 
(m, 2H, two of HH), 4.09 (d, J = 12.2, 2H, two of HD), 4.01 (d, J = 12.2, 2H, two of HD), 3.18-
3.12 (m, 2H, Hl), 2.38-2.23 (m, 2H, Hk), 2.30-2.19 (m, 2H, two of HI), 2.06-1.94 (m, 2H, two of 
HI), 1.85 (s, 18H, 2 x 
tBu). 13C NMR (101 MHz, CDCl3) C  164.0, 163.8, 159.0, 158.7, 155.6, 
151.1, 147.5, 142.7, 141.7, 137.4, 131.3, 130.6, 130.5, 129.7, 129.5, 128.8, 128.5, 128.4, 
127.9, 126.6, 126.5, 125.3, 125.3, 125.2, 122.8, 122.6, 121.7, 121.6, 120.7, 120.1, 120.0, 
120.0, 119.8, 119.2, 114.9, 72.9, 70.8, 66.4, 48.8, 47.5, 44.4, 34.8, 31.5, 31.3, 29.4, 24.7. IR: 
( max/cm
-1) 2970, 2901, 2839, 2353, 1711, 1656, 1569, 1202, 1186, 1112, 1093. M.p. (°C) 
50-52. HRMS (EI) calcd for C74H73N6O6S [M + H]
+ 1175.5463, found 1175.5479. UV: 
max(MeCN)/nm ( / mol
-1cm-1dm3) 381 (10674). 
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Thread 155 
 
Azide 143 (45 mg, 0.093 mmol), alkyne 123 (20 mg, 0.093 mmol) and [Cu(MeCN)4]PF6 (8.7 
mg, 0.023 mmol) were weighed dry into a sealed flask and purged with N2. CH2Cl2 (1 mL) 
was added, followed by DIPEA (1 drop) and the mixture stirred at r.t. for 4 h. The solvent 
was diluted with CH2Cl2 (4 mL) and washed with 16% aqueous EDTA tetrasodium-saturated 
ammonia solution (5 mL). The organic layer was retained and the aqueous layer extracted 
twice further with CH2Cl2. The organic extracts were combined, dried over MgSO4, filtered 
and dried in vacuo. The crude mixture was purified by flash column chromatography (1:1 
Petrol/CH2CL2 to 10% MeCN/1:1 Petrol-CH2CL2) to yield the product 155 as a pale yellow 
residue (62 mg, 96%). 1H NMR (400 MHz, CDCl3) H 8.53 (d, J = 7.2, 1H, Hf), 8.51 (d, J = 8.5, 
1H, Hh), 8.42 (d, J = 7.8, 1H, Hi), 7.73 (s, 1H, Hm) 7.71 (dd, J = 8.1, 7.3, 1H, Hg), 7.65 (d, J = 1.7, 
2H, Hj), 7.92 (d, J = 1.7, 2H, Hn), 7.43 (t, J = 1.7, 1H, Ho), 7.39-7.31 (m, 4H, Hc), 7.26-7.20 (m, 
4H, Hb), 7.17-7.13 (m, 2H, Ha), 4.86-4.82 (m, 3H, Hd and He), 4.69 (t, J = 6.7, 2H, Hk), 3.70 (t, 
J = 6.7, 2H, Hl), 1.28 (s, 18H, 2 x 
tBu). 13C NMR (101 MHz, CDCl3) C  163.8, 151.4, 148.8, 
141.7, 131.7, 130.6, 130.2, 129.4, 128.5, 128.4, 127.2, 126.6, 126.4, 125.2, 123.2, 123.1, 
122.6, 120.6, 120.1, 120.0, 48. 8, 44.5, 34.9, 32.9, 31.4, 31.3. IR: ( max/cm
-1) 2970, 2901, 
2839, 2353, 1711, 1656, 1569, 1202, 1186, 1112, 1093. HRMS (EI) calcd for C44H44N4O2S [M 
+ H]+ 693.3258, found 693.3255 UV: max(MeCN)/nm ( / mol
-1cm-1dm3) 378 (12228). 
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Chapter 6: Supplementary Data 
 
6.1. Aggregation Studies of Sensor 105 
6.1.1. Effect of Probe Concentration of the Fluorescence Response of Probe 105 
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Fig. S1  Fluorescence response of the titration of sensor 105 (100 M) with increasing 
amounts of Zn2+ in aqueous buffer (0.1 mM HEPES, pH 7.4, ambient temperature, λex = 347 
nm. 
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Fig. S2  Fluorescence response of the titration of sensor 105 (50 M) with increasing 
amounts of Zn2+ in aqueous buffer (0.1 mM HEPES, pH 7.4, ambient temperature, λex = 347 
nm). 
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Fig. S3  Fluorescence response of the titration of sensor 105 (10 M) with increasing 
amounts of Zn2+ in aqueous buffer (0.1 mM HEPES, pH 7.4, ambient temperature, λex = 347 
nm).  
360 410 460 510 560 610
0
20000
40000
60000
80000
100000
120000
140000
0eq
1eq
23nm
wavelength nm
F
lu
o
re
s
c
e
n
c
e
 a
.u
 
Fig. S4 Graphical representation of the red-shift in λem upon binding of 1 equiv. Zn
2+ with 
sensor 105 (100 M) in aqueous buffer (0.1 mM HEPES, pH 7.4, ambient temperature, λex = 
347 nm).  
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6.1.2. Effect of Solvent Composition on the Fluorescence Response of Probe 105 
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Fig. S5 HEPES/MeCN titration of sensor 105 (100 M) (0.1 mM HEPES, pH 7.4, ambient 
temperature, λex = 347 nm).  
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Fig. S6 HEPES/MeCN titration of sensor 105 (100 M) with 5 equiv. of Zn2+ (0.1 mM HEPES, 
pH 7.4, ambient temperature, λex = 347 nm). 
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6.1.3. Dynamic Light Scattering Study 
 
Dynamic light scattering (DLS) experiments were performed at a sensor concentration of 30 
M in HEPES buffer (1% DMSO). Sensor 105 demonstrates aggregation phenomena in 
aqueous solution, as demonstrated by the large particle size observed in these samples. 
The aggregates are at their largest with no Zn2+ present; in the presence of Zn2+ the particle 
size decreases greatly, coinciding with an increase in fluorescence emission upon addition 
of Zn2+ to the sensor. Samples containing 116 on the other hand, structurally similar to 6 
but with a different biological targeting unit, show no significant aggregation as 
demonstrated by the low degree of scattering and poor signal quality, demonstrating the 
difference small structural changes can have on the behaviour of these probes. 
  
Supplementary Data 
 
 
253 
 
 Sensor 105 
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 Sensor 105 + 1 equiv. Zn2+: 
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 Sensor 105 + 5 equiv. Zn2+: 
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 Sensor 105 + 15 equiv. Zn2+: 
 
 
 
 
Supplementary Data 
 
 
257 
 
 Sensor 116 blank: 
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 Sensor 116 + 1 equiv. Zn2+: 
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 Sensor 116 + 5 equiv. Zn2+: 
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 Sensor 116 + 15 equiv. Zn2+: 
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6.2. Experimental Procedures for the Evaluation of Sensors in Pancreatic Islets  
Female CD1 mice (8-12 weeks of age) were housed under specific pathogen free conditions 
with ad libitum access to food and water. Animals were euthanized by cervical dislocation 
before isolation of islets by collagenase digestion, as previously described (PMID: 
20204627). Animal procedures were approved by the Home Office according to the 
Animals (Scientific Procedures) Act 1986 of the United Kingdom (PPL 70/7349). Following 
24-48 h culture, islets were incubated for 60 min. with the sensor under study before 
imaging using a Zeiss Axiovert 200 inverted widefield stereomicroscope. Illumination was 
delivered through a 20× 0.4NA objective (LD Plan Neofluar) using a halogen light source 
and a DAPI filter set (λex = 365/12, λem = 447/60). Emitted signals were detected using a 
highly-sensitive 1344 x 1024 CCD camera (Hamamatsu ORCA-ER). Throughout, islets were 
incubated at 36 ⁰C and irrigated with HEPES-bicarbonate buffer (120 mM NaCl, 4.8 mM KCl, 
24 mM NaHCO3, 0.5 mM Na2HPO4, 5 mM HEPES, 2.5 mM CaCl2 and 1.2 mM MgCl2) 
saturated with 95% O2/5% CO2 and adjusted to pH 7.4. Offline signal analysis was 
performed using Volocity (Perkin Elmer) and Igor Pro (Wavemetrics) softwares. For two-
photon imaging of probe distribution, islets were incubated with sensor as above before 
imaging using a Leica SP5 multiphoton microscope equipped with a 25× 0.95NA water-
dipping objective adjusted for infrared wavelengths (HCX IRAPO). Two-photon excitation 
was achieved using a Spectraphysics Mai Tai femtosecond-pulsed laser (λex = 850 nm) and 
emitted signals were collected using a PMT (λem = 400-550 nm). Image analysis was 
performed using Image J (NIH). 
6.2.1.  Cytotoxicity Assay 
Islets were incubated with 3 µM calcein-AM (Life Technologies) and 2.5 µM propidium 
iodide (PI; Sigma-Aldrich) before detection of absorbance/emission at 491/525nm and 
561/620nm, respectively. Calcein AM is a vital stain and requires cleavage by intracellular 
esterases for fluorescence. Conversely, PI is a necrosis stain which only enters the nucleus 
in membrane-compromised cells. The islet area occupied by dead cells was expressed as a 
unitary ratio versus that occupied by live cells. Non-multifactorial pairwise comparisons 
were performed using Student’s t-test. Interactions between multiple treatments were 
assessed using Kruskal-Wallis test followed by pairwise comparisons using Dunn’s post-hoc 
test. In all cases, analysis was performed using Graphpad Prism (Graphpad Software) and 
results considered significant at P<0.05. 
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Fig. S7 Cytotoxicity assays for probes 105, 112 and 114. A. Incubation of mouse islets with 
probes 6, 112 and 114 does not significantly induce cell death (necrosis) versus DMSO-
alone (1:333) (NS, non-significant; P<0.54).  B.  Representative images showing calcein and 
PI staining in islets treated with DMSO and probes 105, 112 and 114. Below is a positive 
control (Triton X-100; to permeabilise the membrane).  
6.2.2. Live Imaging of Dye Co-localisation 
MIN6 beta cells were incubated for 1-2 h with each Zn2+-binding probe (30 μM for probes 
105 and 112; 300 μM for probe 114 before 30 min incubation with either 200 nM 
Mitotracker Red FM or 200 nM Lysotracker DND-99 (both Life Technologies). Cells were 
washed three times with PBS before live-imaging using a confocal microscope equipped 
with an acousto optical beam splitter (AOBS) and spectral detectors (Leica TCS SP5). The 
Zn2+-binding probes were excited using a 405 nm diode laser and emissions collected at 
460/70 nm (63 x oil-immersion objective; NA 1.4). The organelle-specific dyes were excited 
using a 543 HeNe laser and emitted light captured using PMTs centred on 650/50 nm and 
595/50 nm for Mitotracker and Lysotracker, respectively.  Analysis of co-localisation was 
performed after background fluorescence correction using the Pearson’s correlation 
coefficient embedded within the Intensity Correlation Analysis (ICA) plugin for ImageJ 
(NIH). Uniform linear adjustments were applied to contrast/brightness to improve image 
quality for analysis/presentation purposes. 
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Fig. S8 Cellular distribution of probes 105, 112 and 114. A. Probe 112, expected to 
sequester in mitochondria, is co-localised with Mitotracker. B. Probe 115, expected to 
aggregate at the plasma membrane, does not co-localise with Mitotracker. C. Probe 114, 
expected to aggregate in lysosomes, does not co-localise with Mitotracker. D. Probe 114 
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co-localises with Lysotracker, a marker of acidic organelles. E. Probe 112 does not co-
localise with Lysotracker, further confirming its mitochondrial specificity. Scale bar 
represents 10 µm.  
 
Fig. S9 Statistical analysis of probe localisation with a) mito- and b) lyso-tracker. 
Image analysis demonstrates that the signals from probe 112 and Mitotracker are strongly 
correlated. By contrast, fluorescence from both probe 114 and probe 105 poorly correlates 
with that of the organelle-specific dye (*P<0.05 and **P<0.01 versus probe 112) (Kruskal-
Wallis test). Note that some co-localisation is still apparent due to the inability to fully 
resolve sub-cellular structures close to the diffraction limit. We also observe a strong 
correlation between probe 114 and Lysotracker DND-99, but not probe 112 and the 
organelle-specific dye (**P<0.001 probe 112 versus probe 114) (Student’s t-test). 
 
  
a) 
b) 
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6.3. Supplementary Spectroscopic Data for compounds 89, 111 and 112. 
31P NMR of 89 
 
F NMR of 89 
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31P NMR of 111 
 
F NMR of 111 
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31P of 112 
 
F NMR of 112 
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